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Summary
For many positive strand RNA viruses, genomic RNA can initiate productive 
infection in the absence of preformed viral proteins when introduced into 
susceptible cells. RNA transcribed in vitro from cDNA copies of positive strand 
virus genomes is also infectious. This property has enabled the powerful 
techniques of recombinant DNA technology to be applied to produce viruses 
carrying defined mutations by manipulation of cDNA clones. In contrast, 
deproteinised genomes of negative strand RNA viruses are non infectious. The 
study of negative strand viruses has therefore been hampered by the absence o f  
methodology enabling the manipulation of their genomes. The non infectious 
nature of negative strand genomes is due to the requirement of viral proteins to 
transcribe translation competent positive strand mRNA. The template for 
transcription by the RNA dependent RNA polymerases of negative strand 
viruses is a ribonucleoprotein complex (RNP). Production o f infectious RNA  
from cDNA of negative strand RNA virus genomes is therefore thought to 
require correct assembly of the synthetic RNA into RNP which can then be 
expressed and replicated by viral RNA polymerase.
This thesis describes work carried out with the overall aim of establishing a 
system to produce Bunyamwera virus, a segmented negative strand RNA virus, 
carrying defined nucleotide alterations to its genome. Towards this goal, two 
broad approaches were investigated to attempt to present replicating virus with 
synthetic RNA in a form in which it could be recognised as a transcription 
template by the viral polymerase. The first approach involved transcribing viral- 
like RNA in vivo  from transfected cDNA constructs in the presence of 
replicating Bunyamwera virus in the hope that the intracellular pool of viral 
proteins would enable encapsidation and replication of the synthetic RNA. The 
second approach involved attempts to reconstitute RNP in vitro by incubating 
synthetic RNA with nucleocapsid protein derived from Bunyamwera virus.
For in vivo  transcription of bunyavirus-like RNA from transfected plasmids, a 
recombinant vaccinia virus (vTF7-3) which expresses T7 RNA polymerase was 
investigated to assess its suitability for producing a Bunyamwera virus small (S)
segment RNA from transfected cDNA in the presence of a replicating helper 
bunyavirus. The helper virus used was an existing reassortant virus 
(Bun/Bun/Mag) containing Bunyamwera virus large (L) and middle (M) genome 
segments and a Maguari vims S segment. Successful replication of the plasmid 
derived Bunyamwera S segment by the Bun/Bun/Mag helper virus would result 
in a proportion of progeny virus having all three gene segments of Bunyamwera 
virus.
Dual infection experiments were performed to investigate the compatibility of 
the component viruses of the rescue strategy. Metabolic labelling and Northern 
analysis suggested that the general strategy of rescuing a Bunyamwera virus S 
segment RNA, transcribed in vivo by vTF7-3, using the Bun/Bun/Mag 
reassortant vims, was feasible with regard to interactions o f the component 
viruses.
Transcription o f Bun S segment RNA in vivo from transfected cDNA by T7 
RNA polymerase supplied by vTF7-3 was investigated by Northern blot 
analysis. It was not possible to detect RNA of the expected size. Transcription 
did occur since N protein could be detected in vTF7-3 infected cells transfected 
with a cDNA construct designed to produce positive strand S segment RNA  
from a T7 promoter.
In an attempt to rescue plasmid derived Bunyamwera virus S segment RNA into 
a Bun/Bun/Mag reassortant virus, supernatants were retained from cells which 
had been infected with vTF7-3 and the Bun/Bun/Mag reassortant virus and 
transfected with Bunyamwera virus S segment cDNA. 200 individual plaques of 
progeny vims were screened by metabolic labelling to determine the origin of 
their N protein. No Bun/Bun/Bun virus was recovered indicating that if  rescue 
occured, it did so at a frequency of <1/200.
As an alternative to screening larger numbers o f progeny vim s, a counter- 
selectable rescue vims was sought to enable selection of any progeny vims 
containing plasmid derived (wild type) S segment RNA. Temperature sensitive 
(ts) mutants of Maguari vims were further characterised in attempt to identify a 
vims with a S segment lesion.
To enable the S segments o f mutants from each of the three reassortment 
groups to be sequenced, a rapid PCR-based procedure was developed which 
allowed full-length S segment cDNA to be amplified in a single step from RNA  
isolated from cmde preparations of virus. Using this method, full-length S
segment cDNAs were amplified and cloned from a representative of each of the 
three reassortment groups(rs6, As 17 and a s23) and from wild type Maguari virus. 
Three cDNA clones of each segment were sequenced by the Sanger di-deoxy 
chain termination method. A single point mutation was found in the S segment 
cDNA of Maguari virusAs23. This vims was used as a helper virus in attempt to 
replicate RNA transcribed in vivo from a Bunyamwera vims S segment cDNA  
by the vTF7-3 expression system. Progeny vims were amplified and grown at 
38.5°C to suppress the ts helper virus. Any plaques forming were expected to 
contain a reassortant virus containing a Bunyamwera virus S segment (derived 
from cDNA) and Maguari virus L and M segments. No plaques formed even at 
the^ ^permissive temperature indicating that the poorly growing ts23 mutant ^  
may not be suitable for this type of experiment.
The PCR based method developed for amplification of S segment cDNAs from 
the Maguari virus ts mutants was further exploited to clone several previously 
uncloned S segments from other bunyaviruses.
To increase the sensitivity of detection of replication of plasmid derived RNA,
(if this was occufang), two reporter constructs were assembled containing 
Bunyamwera virus S segment non-coding sequences flanking the gene for 
chloramphenicol acetyl transferase (CAT). These were under control o f T7 
promoters and so could be transcribed in vivo using the vTF7-3 expression 
system.
The first o f these constructs, pBunS(+)CAT, produces a Bunyamwera virus S 
segment cRNA-like transcript containing a message sense copy of the CAT 
gene. This construct was used in transfection experiments to determine suitable 
expression conditions. Packaging o f the synthetic reporter RNA into 
Bunyamwera virus particles could not be demonstrated.
The second construct, pBunS(-)CAT, was designed to produce a vRNA like 
transcript containing an anti sense CAT gene and so was only expected to result 
in CAT activity if the T7 transcript was First copied by Bunyamwera virus 
proteins. However, transfection of this construct into vTF7-3 infected cells 
produced CAT activity even in the absence of Bunyamwera virus. This 
unpredicted activity could also be induced by infection with non recombinant 
(WR strain) vaccinia vims. Comparison of the construct sequence with the well 
characterised promoter sequences of vaccinia virus indicated a potential 
vaccinia virus late promoter-like sequence in the 5' non-coding region o f the 
Bunyamwera virus S segment cDNA, just upstream of the protein coding
sequences. This sequence is thought to act as a cryptic promoter producing 
positive stranded (mRNA like) transcripts from pBunS(-)CAT in the presence 
of vTF7-3 and so account for the unexpected CAT activity. The potential 
cryptic promoter sequence was also present in the Bunyamwera virus S 
segment constructs discussed earlier and so would be expected to have given 
rise to incorrect RNA transcripts in these earlier studies and may therefore have 
been partly responsible for the failure of this approach.
Possible ways of overcoming the problems identified with the vTF7-3 
expression system are discussed in context of a recent published precedent for 
the use of the system for in vivo replication of plasmid derived RNA.
Various approaches were investigated in attempts to reconstitute RNP in vitro 
using plasmid derived RNA. Successful in vitro RNP reconstitution might allow 
rescue of plasmid derived RNA by transfection of RNP into virus infected cells. 
Preformed continuous CsCl density gradients were used to assess formation of 
RNP which have a characteristic density of 1.31g/ml and so can be banded in 
20-40% CsCl gradients while naked RNA forms a pellet.
Transcription of Bunyamwera virus S segment-like RNA in a rabbit reticulocyte 
lysate in which N protein was being translated failed to produce a complex of 
the density expected for RNP. Similarly, efforts to renature N protein from RNP 
denatured with guanidinium salt onto synthetic RNA failed. More promising 
results were obtained using nuclease treated RNP as a source o f N  protein. 
When analysed on CsCl gradients, reactions containing radiolabelled synthetic 
RNA and MCN treated RNP (with the nuclease inactivated by addition of 
EGTA) were found to contain a RNA/protein complex which banded at a 
density similar to that expected for native Bunyamwera virus RNP.
Using RNA transcribed in vitro from pBunS(-)CAT, which contains antisense 
CAT sequences flanked by S segment vRNA termini, several attempts were 
made to demonstrate Bunyamwera virus dependent CAT activity in cells 
transfected with reconstituted RNP. For all conditions tested no CAT activity 
could be detected. Comparison of the mobility on agarose gels of the RNA  
transcribed from linearised pBunS(-)CAT with RNA transcribed from 
theoretically identical template generated by PCR suggested that the linearised 
plasmid DNA may not be producing RNA of the correct length. This anomaly 
may be due to aberrant cleavage of the plasmid during transcription template 
preparation. Due to lack of time, this problem remains to be resolved but if an 
incorrect transcript was being produced this would account for the inability to
detect bunyavirus dependent CAT activity in cells transfected with the 
reconstituted RNP.
Preliminary evidence suggests that MCN treated RNP can be prepared which 
retains L protein activity. A combined CsCl/glycerol step gradient was designed 
to allow isolation of RNP in reduced concentrations of CsCl. RNP purified in 
this manner was digested with MCN and a 32P CTP transcription mixture added 
to see if transcription, templated by the endogenous RNA fragments remaining 
after nuclease treatment, could be detected. When analysed on 20% acrylamide 
denaturing gels, a predominant signal could be detected by autoradiography. 
The strength of the signal could be increased by including dinucleotide ApG in 
the transcription reaction which is known to moderately stimulate bunyavirus 
transcription in vitro. The signal was stronger when the reaction was performed 
at 25°C than at 30°C and was weakest at 37°C. While formal proof that the 
signal represents an RNA transcript remains to be conducted, the observed 
stimulation by ApG and suppression by increasing temperature is consistent 
with the known properties of the L protein.
MCN digested RNP may therefore prove useful for in vitro transcription assays 
using short synthetic RNA transcription templates. Such technology should 
allow the promoter requirements for the L protein to be defined and would 
demonstrate that functional RNP can be assembled in vitro and therefore that 
rescue of synthetic RNA by transfection o f in vitro reconstituted RNP into 
helper virus infected cells is feasible.
Chapter 1: RNA Viruses and their 
Genetic Manipulation.
1.1 Introduction.
In 1981 production of infectious poliovirus following transfection of a plasmid 
containing a DNA copy of the virus genome was reported (Racaniello & 
Baltimore 1981) and poliovirus became the first animal RNA virus to be 
recovered from cloned cDNA. It was immediately apparent that it would now be 
possible to produce virus which contained alterations deliberately introduced into 
a corresponding cDNA clone. This methodology provided a powerful tool for 
dissecting the functions of various components of the viral genome. It was 
speculated that such technology might also be developed for other RNA viruses. 
The success of rescuing poliovirus, and subsequently many other positive strand 
RNA viruses, from plasmid-derived RNA, was possible because a single RNA 
molecule could serve both as mRNA to produce viral proteins and as template for 
replication. As discussed in section 1.2, the RNA used as a replicative 
intermediate by negative strand RNA viruses is always different to mRNA. Until 
the recent advances made for influenza virus (Luytjes et al 1989), no DNA- 
derived RNA had been introduced into the genome of any negative strand RNA 
virus. Lack of such a system has prevented application of the powerful methods 
of recombinant DNA technology to produce defined mutants for functional 
analysis. The study of negative strand viruses has been greatly hindered by the 
absence of this methodology.
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This thesis describes work carried out with the aim of establishing a system to 
produce a negative strand RNA virus (Bunyamwera virus) carrying defined 
nucleotide alterations to its genome. This ambitious goal remains to be achieved 
for Bunyamwera virus. However, it is hoped that the progress made and lessons 
learnt from this work, together with work on other negative strand RNA viruses 
from other groups working towards similar goals, will help towards achieving 
this goal for bunyaviruses in the near future.
1.1.1 Scope of this chapter
This chapter surveys selected animal viruses, briefly discussing some of the 
detailed knowledge known about the molecular mechanisms involved in 
expression and replication of their genomes. For the positive strand viruses much 
of this knowledge is due to the ability to produce defined mutants by manipulating 
cloned cDNA. For reasons o f space and time this chapter does not set out to be 
comprehensive and covers only a few animal viruses. The choice of those 
covered reflects either direct relevance to the project (negative strand viruses) or 
personal choices which are felt to be interesting examples of engineering strategy 
(positive strand viruses).
No discussion of picornaviruses, retroviruses, bacteriophage or plant viruses is 
included even though a vast volume of molecular studies have been conducted on 
them. The interested reader is directed to any well stocked life science library for a 
life time of reading on these topics.
The positive strand alphaviruses have been discussed in preference to poliovirus 
since, in addition to having a genome which serves as mRNA, alphaviruses also 
produce subgenomic mRNA and therefore have additional control features 
making them perhaps more representative o f positive strand RNA viruses. Also, 
alphaviruses have been engineered to produce efficient vectors for the expression 
of heterologous proteins and serve as a model for the type o f RNA expression 
systems which may be developed for other RNA viruses.
Coronaviruses are included as an interesting plus stranded RNA virus for which 
genome manipulation has been achieved without it so far being possible to 
synthesise infectious RNA in vitro.
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Reovirus, a double stranded segmented RNA virus, is included since, like the 
negative strand viruses, the genome RNA alone cannot establish infection without 
the presence of preformed viral proteins. Recent developments have enabled 
production of virus starting with naked RNA and similar methodology may prove 
applicable to some negative strand RNA viruses.
Moving to the negative strand RNA viruses, the rhabdovirus vesicular stomatitis 
virus and the paramyxoviruses are included as model non-segmented negative 
strand RNA viruses. For both these vims groups recent progress has established 
systems with the potential to investigate the cis acting signals involved in genome 
expression and replication. Although no report of production of rationally mutated 
virus has yet been forthcoming for either of these two virus groups, at least for 
VSV, major advances towards the goal of producing engineered virus have been 
made.
The remaining sections discuss influenza and Bunyamwera viruses. Both are 
negative strand segmented viruses and both share many distinctive features which 
set them apart from the other virus groups. For influenza virus it has recently been 
possible to produce viable virus containing genetic information derived from 
cDNA. This methodology has already been used to address interesting points 
concerning the replication of influenza virus which could not previously be 
directly tested. Establishment of an analagous system for members o f the 
Bunyaviridae, the largest group of animal viruses, will undoubtedly enable similar 
studies to be conducted and should greatly increase our knowledge of the 
molecular characteristics of this group of viruses.
1.2 Key differences between positive and negative 
strand RNA viruses.
The genome of positive strand RNA viruses is also a functional mRNA. This 
property allows the input genome to be translated directly by cellular ribosomes to 
produce the viral proteins required for replication and production of progeny 
virus. These proteins use the input genome as a template to synthesise more 
genomes via a complementary negative strand replicative intermediate RNA, and 
package new genomes into virions (see figure 1.2.1). For this reason, naked viral 
genome RNA, if introduced into the suitable host cell, can establish replication in 
the absence of preformed viral proteins.
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Conversely, negative strand RNA virus genomes are the complement of mRNA 
and therefore cannot be directly translated to give viral proteins without first being 
copied into complementary mRNA. RNA dependent RNA polymerase activity is 
required for this primary transcription and, since animal cells do not possess such 
an enzyme, this function must be supplied preformed in the input virion (Figure
1.2.2). For this reason the deproteinised genomic RNA of negative stranded 
viruses cannot initiate infection.
Figure 1.2.1 Replication o f  positive strand RNA v ir u s  genome. Upon infection, 
viral RNA is released from its nucleocapsid (an icosahedral structure for all positive strand 
viruses except die coronaviruses which have a helical nucleocapsid) and is free to serve as a 
messenger RNA. The input genome is usually modified at its 5' end either by the presence o f a 
cap (as in die case of the alpha-, flavi- and corona-viruses) or by a viral peptide VPg (picoma and 
calici viruses). 3' ends o f die genome are usually polyadenylated (exceptions being the 
nodaviruses— die only + sUanded animal virus group with a segmented genom e, and the 
flaviviruses). Primary translation of die input genome may produce all viral proteins, catalydc 
and structural, (e.g. poliovirus where a single polyprotein is encoded), or only replicadon  
proteins widi structural genes being uanslated from subgenomic mRNA transcribed off negadve 
strand replicadve intermediate RNA (as occurs for die alphaviruses—  see figure 1.3.1).
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The picture is complicated further by the fact that mRNA transcribed from 
negative strand genomes is always different to the plus strand replicative 
intermediate used as a template for new genome production. These replicative 
intermediates resemble genomes in being always associated with viral proteins to 
form a ribonucleoprotein (RNP) complex which is the functional template of 
transcription. RNP cannot be translated by ribosomes. mRNA is not encapsidated 
to foim  RNP and can be translated but is never an exact complement o f the 
genome. For the non-segmented negative strand viruses (the F iloviridae, 
Paramyxoviridae and Rhabdoviridae), several subgenomic mRNAs are produced 
while for the segmented negative strand viruses (Arenaviridae, Bunyaviridae and 
O rthom yxoviridae), mRNAs are 3' truncated relative to the positive strand 
replicative inteimediate and also contain additional heterologous sequences at their 
5' ends. Therefore, even if mRNA could serve as template for transcription, it 
would not contain all the viral specific information required for production of new 
genomes.
The infectivity of the positive strand virus genomes has made it possible, in many 
instances, to produce RNA molecules from cloned cDNA corresponding to viral 
sequences which can give rise to infectious virus when transfected into cells. 
Introducing the DNA step into virus production enables the use of recombinant 
DNA technology to alter the genome of the virus and so produce mutants carrying 
defined and rationally designed nucleotide alterations. Such technology has 
allowed the full force of reverse genetics to be applied to many positive strand 
viruses and has led to a rapid increase in our detailed understanding o f the 
molecular biology o f these viruses. For many years the absence of similar 
systems for manipulation of the negative strand viruses has hampered progress in 
defining their life cycles in molecular terms. Such systems are finally becoming 
available for negative strand viruses.
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Figure 1.2.2 Replication o f  negative strand RNA virus genome. The input 
genome is a ribonucleoprotein (RNP) complex which cannot be translated. RNA dependent RNA 
polymerase is associated with the input genome and transcribes mRNA m olecules as the first 
step to replication. Translation of primary transcripts produces proteins which can assemble full 
length + strand complementary RNA into RNP replicative intermediates. These can serve as 
templates for new genome synthesis. The mRNAs are truncated compared to the cRNA and are 
not encapsidated into RNP. Their 5' ends are capped whilst the 3' ends may or may not be 
polyadenylated depending on the virus.
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1.3 Alphaviruses
The Togaviridae family is subdivided into the Alphavirus and Rubivirus genera 
(Schlesinger & Schlesinger 1990). Two alphaviruses, Sindbis virus and Semliki 
Forest virus, have been studied in great depth and both have been manipulated by 
reverse genetics. The Alphavirus genus also includes the equine encephalitis virus 
and Ross River virus.
1.3.1 Biology of alphaviruses
The alphaviruses are group A arboviruses, animal viruses having an arthropod 
host but also infecting mammals and avian species. In tissue culture, the 
alphaviruses grow lytically in vertebrate cells but readily establish persistent 
infections in mosquito cells.
The alphavirus genome is contained in an icosahedral core composed of a single 
type of capsid protein. The core is enclosed in a lipid bilayer containing two viral 
glycoproteins E l and E2. Alphaviruses are taken into cells by endocytosis via 
clathrin coated pits (Marsh & Helenius 1990) followed by acid fusion (Edwards et 
al 1983), releasing the nucleocapsid into the cytoplasm where the RNA is 
uncoated and initiates replication. After genome replication and accumulation of 
structural proteins, virus is assembled by capsid protein subunits interacting with 
the genome RNA to form the icosahedral core. The core then associates with the 
viral glycoproteins inserted in the infected cell membrane (Fuller 1987) resulting 
in release, by budding, of the mature enveloped virion.
1.3.2 Molecular biology of alphaviruses
The alphaviruses have a non segmented single standed RNA genome of positive 
polarity. Genome RNA, free from all viral proteins, is infectious as is RNA  
transcribed in vitro from precise full length cDNA clones. The 12kb genome has a 
7-methylguanosine 5' cap and a polyadenylated 3' tail (Strauss et al 1984). The 
input genome serves as a messenger RNA being directly translated to produce a 
polyprotein which is cleaved to give the nonstructural proteins required for 
expression of the structural proteins and genome replication (Figure 1.3.1). The 
AUG codon at nucleotide 59 is the only translation initiation site recognised on 
intact virion RNA (Cancedda et al 1975). The polyprotein is processed to give 
four nonstructural proteins, NSP1-4 (Strauss & Strauss 1990). These function in
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transcription initiation (for full length negative strand RNA, full length positive 
strand RNA and subgenomic mRNA), elongation, 5' capping and methylation, 3' 
polyadenylation of positive strand RNA and self cleavage of the polyprotein as it 
is translated. The precise role of each nonstructural protein and any interactions 
required of host functions are not clearly understood (Schlesinger & Schlesinger 
1990).
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Figure 1.3.1 E x p re ss io n  and r e p lica tio n  o f  th e a lp h a v iru s  g e n o m e . Input genome 
serves as a messenger RNA for translation o f a self-cleaving polyprotein to provide replicase 
functions (1). The newly synthesised replicase com plex (NSP 1-4) transcribes full length 
negative strand antigenome using the input genom e as template (2). This replicative 
intermediate serves as a template for transcription o f capped and polyadenylated subgenomic 
mRNA (3a) and full length positive strands to serve as new genom es (3b). The subgenomic 
mRNA is translated to a polyprotein (4) which is cleaved to give virion structural proteins.
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The structural proteins are translated, as a polyprotein, from a subgenomic 
mRNA corresponding to the 3' most 4kb of the genome. This subgenomic 
mRNA is transcribed from full length negative strand RNA, initiation occuring at 
an internal promoter situated in the junction region between the nonstructural and 
structural genes (Bredenbeek & Rice 1992). The use of a subgenomic mRNA 
allows temporal control with the structural genes being expressed after translation 
of replicative genes and replication. The intergenic promoter also appears to be 
more active than the promoter involved in replication, resulting in a ten-fold 
higher abundance of subgenomic mRNA molecules compared to full length 
positive strand genome RNA (DL Sawicki et al 1981; SG Sawicki et al 1981). 
This observation has been exploited in designing recombinant alphaviruses to 
express foreign genes to high levels (Bredenbeek & Rice 1992)
Infectious cDNA clones have been constructed for several alphaviruses including 
Ross River virus (Kuhn et al 1991), Semliki Forest virus (Liljestrom et al 1991), 
Sindbis virus (Rice et a I 1987) and Venezuelan equine encephalitis virus (Davis et 
al 1991). Reverse genetics has been used to investigate the cis-acting regulatory 
elements involved in genome replication, transcription and encapsidation. 
Comparison of several alphavirus nucleotide sequences (Strauss & Strauss 1986) 
identified conserved regions as potential cis-acting control elements (Figure
1.3.2). Site directed mutagenesis of infectious cDNA clones has been used to 
define these regions.
For genome and antigenome replication three conserved regions have been shown 
to be important. Two regions, one in the 5' nontranslated region of genomic RNA 
(Niesters & Strauss 1990a) and a 51 nucleotide stretch in the coding region of 
NSP1 (Niesters & Strauss 1990b) appear to control full-length positive strand 
transcription from negative strand template RNA while a single element, 19 
nucleotides in length and situated adjacent to the 3' poly A tail, is the promoter for 
negatve strand synthesis (Kuhn et al 1990; Levis et al 1986).
AUG AUG
K I — AAAn3
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Figure 1.3.2 M ap  o f  the alphavirus genome showing the arrangement o f  protein 
coding regions and cis-acting regulatory elements. Genome and antigenome promoters reside in 
the termini. The internal promoter for expression o f structural genes is situated in the junction 
region (J). The shaded box, inside the replication genes, represents sequences required for 
packaging RNA into virions.
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Encapsidation signals are located in the NSP1 coding region between nucleotides 
746 and 1226 of Sindbis virus genomic RNA (Weiss et al 1989). This region 
alone appears to provide specificity for encapsidation of positive strand full-length 
RNA molecules and excluding subgenomic mRNA and full-length negative strand 
molecules.
The internal promoter responsible for transcription of subgenomic mRNA from 
full-length negative suands is located in the junction region. A 24 nucleotide core 
promoter (Grakoui et al 1989; Levis et al 1990) is sufficient for subgenomic 
mRNA production. Flanking regions can be mutated resulting in enhanced (Raju 
& Huang 1991) or depressed (Rice et al 1987) transcription levels.
The availability of infectious cDNA clones has therefore contributed firm evidence 
relating to the control of transcription and replication of alphaviruses for which 
RNA sequence data alone could only allow speculation of function.
1.3.3 Heterologous gene expression in alphaviruses
The first expression of heterologous genes in alphaviruses used cDNA constructs 
based on defective interfering (DI) particles o f Sindbis vims. DI particles can be 
replicated and packaged in the presence of wild-type helper vims and therefore 
must contain the necessary c/'s-signals for these functions. Levis et al (1987) 
constructed chimeric DNA templates containing the bacterial gene for 
chloramphenicol acetyl transferase (CAT) flanked by cDNA termini derived from 
a DI particle RNA of Sindbis virus. RNA transcribed in vitro from this construct, 
when transfected into avian cells, could be replicated by a wild-type helper 
Sindbis vims which provided replication enzymes and virion structural proteins in 
trans. Progeny virus stocks were shown to contain both helper vims genomes 
and the CAT/DI RNA. After several passages, the CAT RNA was the 
predominant species in infected cells although expression as measured by CAT 
activity was low. The poor level of translation was probably due to the reporter 
gene being expressed in an analagous manner to the replication genes of wild type 
genomes which provide catalytic functions and are therefore only required at low 
levels compared to structural proteins and maybe only early in infection (DL 
Sawicki et al 1981; SG Sawicki e ta l  1981).
To improve the low expression level, the reporter gene under control of the 
subgenomic mRNA promoter, was placed downstream of a truncated genome 
containing the 5' cap and untranslated region and a portion of the replicase gene 
containing the internal packaging signals (Levis et al 1990; Figure 1.3.3). 
Cotransfection of this recombinant RNA with wild-type helper RNA resulted in 
high level expression of the reporter gene. The chimeric RNA alone could also be
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replicated and packaged by proteins supplied in trans from either recombinant 
vaccinia virus ( Li et al 1991) or baculovirus (Buzan & Schlesinger 1992).
Foreign
AAAn3
Figure 1.3.3 Expression of heterologous gene from alphavirus internal 
promoter. This construct has cis-replication/packaging signals and can be complemented by 
wild-type helper virus or recombinant virus to supply structural and replication proteins in trans. 
The internal promoter drives high level expression of the foreign gene. (See Fig 1.3.2 for 
alphavirus features).
Another approach was to build replication competent but packaging deficient 
chimeras by directly replacing the structural genes with the foreign gene (Figure 
1.3.4 A). This was done for Semliki Forest virus (Liljestrom & Garoff 1991) and 
Sindbis virus (Xiong et al 1989), the strategy being originally developed for 
tobacco mozaic and bromegrass mozaic viruses (Takamatsu et al 1987; French et 
al 1986). After transfection into cells the 5' portion of the RNA is translated to 
give proteins required for replication. These transcribe negative strands which in 
turn are templates for amplification of positive strand genomes and efficient 
transcription of mRNA from the internal promoter. After 16 hours, high levels of 
foreign proteins could be detected, in the range of 108 protein molecules per 
transfected cell for Sindbis constructs (Xiong et al 1989). Having no structural 
genes, no RNA is packaged and so careful optimisation of transfection to 
establish replication in as many cells as possible was required.
Similar constructs were then complemented with replication gene-deficient 
recombinant RNA coding for structural proteins (Figure 1.3.4B). Following 
cotransfection the replicative functions from the chimeric RNA could replicate 
itself and the helper RNA containing the structural genes. The gene products of 
the helper RNA could package both the helper and chimeric RNA giving rise to 
virus containing two genome segments. For Sindbis virus, infectious particles 
with bipartite genomes could be purified and stably passaged (Geigenmuller- 
Gnirke et al 1991).
The logical progression from this system was to create helper RNA molecules 
which lacked the cA-signals required for packaging (Figure 1.3.4 C). This would 
prevent the helper molecule from being packaged while producing high titre 
stocks of packaged chimeric RNA capable of high levels of expression when used
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to infect fresh cells. For Semliki Forest virus > 108 infectious particles per ml, 
free of helper RNA, could be generated (Liljestrom & Garoff 1991).
Such an approach might one day be applied to deliver genes to humans for 
therapeutic purposes. Early attempts to establish the system using replicons based 
on Sindbis virus have resulted in stock titles up to 104 fold less than those 
obtained with Semliki Forest virus. This is because deletion of the packaging 
signals in Sindbis virus appears to interfere with subgenomic mRNA production 
(Weiss et al 1989) and therefore produces too little structural proteins to 
efficiently package progeny genomes.
a K 3 — AAAn3
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Figure 1.3.4 Packaging-deficient alphavirus vector (A) lacks internal structural 
genes but contains till c/.v-sequences required for replication and packaging. Alone, this RNA can 
replicate and express to high levels in transfected cells. The use of a helper construct carrying 
structural genes (B) enables packaging of both chimeric and packager RNA into viruses with 
bipartite genomes. An alternative helper RNA (C) has deleted packaging signals and so provides 
structural proteins which package die chimeric RNA alone. (Figure redrawn from Bredenbeek & 
Rice (1992), see text for original references).
Double subgenomic constructs have been produced which are complete 
alphavirus genomes with an extra, heterologous, gene inserted with a duplicated 
internal promoter either upstream or downstream of the structural genes (Figure 
1.3.5). These constructs express well and give progeny titres of 108-1 0 9 pfu/ml
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(Raju & Huang 1991; Hahn et al 1992). Inserted sequences of >3kb  suffer 
deletions, possibly caused by packaging restrictions imposed by the icosahedral 
core although the 5' constructs appear to be more stable than those where the 
heterologous gene is downstream of the structural genes. Double subgenomic 
constructs have been used in a number of expression studies for human, 
Drosophila and viral genes (Bredenbeek & Rice 1992).
H I -AAAn3
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Figure 1.3.5 D o u b le  subgenomic alphavirus expression vector. The foreign gene 
is inserted into an intact alphavirus genome along with an additional junction region containing 
a second promoter for subgenomic mRNA production. In this example die foreign gene is 
downstream (3') of the structural genes but can also be inserted between the structural and 
replication genes.
Another strategy attempted was to insert the heterologous gene downstream of the 
structural genes and include a site for internal ribosome initiation derived from a 
picomavirus. This results in production of a di-cistronic subgenomic mRNA with 
the structural genes being translated as normal and the heterologous gene being 
translated by internal initiation. The system was found to produce heterologous 
protein to around one-fifth the level observed for double subgenomic constructs 
(Bredenbeek & Rice 1992).
H i l l } —AAAn3'
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Figure 1.3.6 Alphavirus expression vector employing internal translation 
initiation signal. Viral transcription produces one subgenomic mRNA from the internal 
promoter (arrow). The mRNA is di-cistronic with the structural polyprotein being translated in a 
cap-dependent fashion and the foreign gene being translated by internal initiation directed by 
picomavirus ribosome-binding sequences ( I ) .
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Because of the ease of manipulating alphavirus genomes at the cDNA level, their 
replication is well understood and fairly advanced expression systems for 
heterologous proteins have been developed. Establishment o f such versatile 
methodology for other RNA viruses, particularly the negative strand viruses, will 
undoubtedly lead to a rapid growth in our understanding of their replication cycles 
and may ultimately play an important role in the development of new improved 
therapeutic agents.
1.4 Coronaviruses.
Although naked coronavirus RNA is infectious when transfected into cells 
(Schochetman et al 1977), infectious cDNA clones are not yet available. Useful 
progress enabling their genetic manipulation has however been achieved by 
exploiting the high recombination frequency of genomes during infection (section 
1.4.3).
1.4.1 Biology of coronaviruses.
The coronaviruses are large enveloped viruses causing highly prevalent disease in 
humans and domestic animals. Each virus has a specific host range usually only 
infecting one or a few, closely related species or tissue types. Isolation of virus 
from an infected host can be difficult and may require differentiated cell lines from 
the same species (Larson et al 1980).
Coronavirus virions are enveloped. The lipid bilayer, derived from intracellular 
membranes, contains at least two viral glycoproteins. Glycoprotein E2 has a large 
external domain visible as spikes by electron-microscopy. E l, or matrix protein, 
extends through the membrane and has a significant domain inside the virion. 
This domain interacts with the large helical nucleocapsid formed from the genome 
RNA and a phosphorylated nucleocapsid protein (N). A third glycoprotein, E3, 
may be present, depending on the virus, and confers haemagglutination properties 
(Holmes 1990).
In tissue culture, coronaviruses grow either lytically or establish persistent 
infection depending on virus-host combination (Wege et al 1982). For some 
viruses cells may fuse to form syncytia.
After replication, newly transcribed genome RNA associates with N protein to 
form helical nucleocapsids (Stohlman et al 1988). These align and bud through 
membranes between the rough endoplasmic reticulum and the Golgi apparatus 
where viral glycoproteins have localised (Tooze et al 1984). Mature virions are
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released by cell lysis or by transportation in secretory vesicles (Holmes et al 
1984).
1.4.2 Molecular biology of coronaviruses.
The genome of coronaviruses is single stranded RNA of unusually large size 
which can exceed 30kb (Spaan et al 1988). The genome is positive stranded, 5’ 
capped and 3' polyadenylated. Input genome is directly translated to give the non- 
structural proteins involved in replication. ~20kb at the 5' end of the genome is 
thought to be translated, by a ribosome frame-shifting mechanism, to yield a very 
large self-processing polyprotein (Brierley et al 1987).
The replication enzymes use input genomes as transcription templates to make full 
length negative strands which form a double sanded replicative intermediate with 
the positive strand template (Sawicki & Sawicki 1986).
The structural genes are expressed from 5-8 subgenomic mRNAs which form a 
3’ nested set (Stern & Kennedy 1980). Usually only the 5' most open reading 
frame is translated (Siddell 1983) although exceptions have been found (Holmes 
1990).
The subgenomic mRNAs all share a common leader sequence of 60-70 bases 
which appears to be coded for at the 5' end of the genome (Lai e ta l  1982). This 
obsejyation led to the proposal for discontinous, leader-primed transcription of 
mRNA. Leaders transcribed from the 3' end of the negative stand template would 
dissociate and anneal at intergenic regions, where short leader-complementary 
sequences are found, and prime mRNA synthesis (Baric et al 1985). The ability 
of the RNA dependent RNA polymerase to elongate annealed primers may 
account for the high recombination rate observed for coronaviruses which may be 
as high as 25% for the whole genome (Lai 1990).
1.4.3 Reverse genetics of coronaviruses
Two complete coronavirus sequences have been published (Boursnell e ta l  1987; 
Lee e ta l  1991). Naked RNA purified from virions is infectious when transfected 
into cells (Schochetman e ta l  1977) although recovery of complete virus from 
cDNA has not been achieved (Bredenbeek & Rice 1992). Two approaches have 
however been used to apply reverse genetics to coronaviruses.
Naturally occuijing defective interfering (DI) particles, containing the cis elements 
required for replication and packaging, have been used to construct cDNA clones 
from which in vitro transcribed RNA can be replicated in the presence of wild- 
type helper virus. Such clones have been used to map cis acting signals (van der
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Most et al 1991). In a recent study a DI cDNA construct was modified by 
insertion of coronavirus intergenic sequences (Makino e ta l  1991). In the presence 
of helper virus, transfected RNA transcribed from this construct could be 
replicated and used as a template for transcription o f subgenomic mRNA, 
demonstrating the crucial role of the intergenic sequences in the transcription of 
mRNA from coronaviruses.
Reverse genetics has also been used to rescue a temperature sensitive (ts) 
coronavirus mutant containing a deletion in the nucleocapsid gene. Exploiting the 
high recombination frequency observed for coronavirus RNA (Lai 1990), an in 
vitro  transcribed RNA containing wild-type nucleocapsid gene sequence was 
transfected into cells infected with the ts mutant. Progeny virus contained wild- 
type virus produced by replacement of the ts lesion by recombination o f the 
transfected RNA sequences into the mutant genome (Koetzner et al 1992).
Since coronaviruses contain several genes which appear to be dispensable for 
growth in tissue culture (Yokomori & Lai 1991) it may prove possible to introduce 
foreign genes into coronavirus genomes by recombination o f a plasmid derived 
RNA containing the foreign gene Hanked by viral sequences directed against the 
non essential genes.
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1.5 Reovirus
Reovirus has a segmented double stranded RNA genome (Wiener at al 1989). 
Purified reovirus RNA is non-infectious since double stranded RNA cannot be 
translated and eukaryotic cells do not possessRNA polymerases which can use 
RNA as a template for transcription. For these reasons, like negative strand 
viruses, reovirus has a virion associated RNA dependent RNA polymerase 
activity which is essential for viral replication.
Primary transcription of reovirus RNA occurs without release of the genome 
segments into the cytoplasm. The polymerase complex forms part of the virion 
and newly transcribed mRNA is passed out of the virion into the cytoplasm where 
it is translated and initiates replication (Shatin & Kozak 1983). The mRNA 
molecules are 5' capped but are otherwise identical to the + strands of the double 
stranded genome segments (Hay & Joklik 1971), and also serve as replicative 
intermediates for new genome synthesis. As such, mRNA representing all ten 
segments might be expected to be infectious if simultaneously introduced into 
cells. However, so far this approach to virus recovery has proved unsuccessful.
The use of a counter-selectable helper virus enabled rescue of naked RNA 
corresponding to the ten reovirus segments (Roner et al 1990). The ST2 strain of 
reovirus was used to infect cells after transfection of viral RNA. ST2 is a slow  
growing strain, not forming plaques until 10 to 12 days compared to five days for 
another reovirus, ST3. If both single stranded (ss) and double stranded (ds) RNA 
corresponding to the ten segments of reovirus ST3 (the faster growing variant), 
were transfected into cells which were then infected with ST2 virus, viable ST3 
virus appeared in the supernatant at 48 hours post transfection. Both ss and ds 
RNA were required and either alone failed to produce virus.
If ss RNA was added to a rabbit reticulocyte lysate and the whole mix transfected 
into cells, vims could be recovered at the same efficiency as cotransfected ss and 
ds RNA which had not been translated. If melted ds RNA replaced ss RNA in the 
reticulocyte lysate, a twenty-fold increase in virus recovery was observed and 
where both ss and ds RNA were transfected in a primed reticulocyte lysate, the 
yield increased a further ten fold. The reason for the enhanced infectivity when 
both ds and ss RNA was present is not clear although it was demorjjfrated that the 
ds RNA increases infectivity of ssRNA and not the otherway round.
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1.6 Paramyxoviruses
The Paramyxoviridae is subdivided into three genera: Paramyxovirus, which 
includes Sendai and mumps viruses; Morbillivirus including measles virus; and 
Pneumovirus which includes respiratory syncytial virus (Kingsbury 1990). The 
Paramyxoviridae share many features with another family o f non-segmented 
negative strand RNA viruses the R h a b d o v ir id a e . The P a ra m yx o -  and 
M orbillivirus  genera are remarkably similar in their structure and genome 
arrangement and differ in many respects to the Pneumovirus genus. This section 
will discuss briefly only Sendai and respiratory syncytial viruses. These viruses 
are of interest because systems with the potential o f investigating c/s-acting 
regulatory elements have been described for both.
1.6.1 Sendai virus
Sendai vims is enveloped and has three membrane proteins (HN, Fo and M). The 
virus is thought to adsorb to cells via interactions of the haemagglutinin/ 
neuraminidase (HN) protein followed by fusion mediated by F 1/F2 (cleavage 
products of Fo) resulting in delivery of the nucleocapsid into the cytoplasm. 
Replication occurs entirely in the cytoplasm (Kingsbury 1977).
The Sendai virus genome is non-segmented, single stranded RNA of negative 
polarity 15kb long. The genomic RNA is encapsidated in nucleocapsid protein 
(NP) to form a nuclease resistant ribonucleoprotein (RNP) complex. Two other 
proteins (termed P and L) are associated with the nucleocapsid and are presumed 
to form the RNA dependent RNA polymerase. During infection the virion RNP 
serves as template for transcription of a short leader RNA complementary to the 
3' end of the genome (Leppert et al 1979), a feature shared with rhabdovirases. 
Several mRNA are transcribed in the order NP, P, M, Fo, HN, L (Glazier et al 
1977; Shioda et al 1983; Shioda et al 1986). The P mRNA also encodes two 
small non-structural proteins (C and C1) of unknown function (Giorgi et al 1983). 
After translation has occurkd, full-length positive strand cRNA is produced which 
serves as a replicative intermediate for production of new genomes. This cRNA is 
alw ays encapsidated as an RNP with encapsidation occuring co- 
transcriptionally— 'Y-form' structures can visualised by electron microscopy 
which represent RNP templates with partially transcribed encapsidated cRNA still 
attached (Kingsbury 1977).
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1.6.2 Rescue of synthetic RNA by Sendai vims
In vitro systems for studying transcription of Sendai virus had relied on using 
native RNP purified from infected cells or virus particles. These could be 
replicated and the newly transcribed RNA co-transcriptionally encapsidated in the 
presence of extracts made from infected cells (Carlsen et al 1985). NP alone could 
encapsidate preinitiated transcription products but was unable to initiate Sendai 
virus transcription for which the L and P proteins are required (Baker & Moyer
1988).
To enable investigation of the cis signals involved in transcription and replication, 
it was necessary to define conditions which would allow replication of plasmid 
transcribed RNA. This was done using a similar reporter system that had 
previously been applied to influenza virus (Luytjes e ta l 1989; see Section 1.8.5). 
A plasmid construct containing the bacterial gene for chloramphenicol acetyl 
transferase (CAT) flanked by cDNA corresponding to the Sendai 5' and 3' non­
coding termini was built. This was used to produce transcripts in vitro which 
were Sendai virus genome-like RNAs with the whole of the protein coding 
regions replaced by an antisense copy of the CAT reporter gene (Park et al 1991). 
Transfection of this chimeric RNA into cells failed to produce CAT activity since 
the RNA is antisense to mRNA. Transfection of the same RNA into cells which 
were infected with Sendai virus resulted in CAT activity: the viral proteins acted 
in trans to encapsidate and express the transfected RNA. This was in marked 
contrast to studies with influenza virus where the RNA had to be assembled into 
a nucleocapsid structure prior to transfection for recognition and replication to 
occur (Section 1.8.5). For Sendai virus the level of expression of the synthetic 
RNA could be substantially enhanced by incubating the RNA with extracts of 
infected cells prior to transfection (Park e ta l  1991). Nuclease sensitivity data 
suggested that this enhancement was not due to the formation o f synthetic Sendai 
virus RNP since these are highly resistant to nucleases in their native form. 
Further investigation demonstrated similar levels of enhancement if the RNA was 
incubated with extracts from uninfected cells, suggesting a role for cellular 
factors. Whether the cell extracts specifically aided recognition of the RNA by the 
helper virus or whether the enhancement was due to a non-specific effect or 
facilitated uptake by the cells is not clear. The CAT activity observed declined 
when high levels of extract were used, with the optimum conditions depending 
on whether infected or uninfected cell extract was employed.
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Figure 1.6.1 Rescue of in vitro transcribed RNA by Sendai virus.Sendai virus- 
like RNA containing an antisense copy of CAT was transcribed in vitro and transfected into 
cells. No CAT was produced in these cells unless they were also infected with Sendai virus to 
replicate and express the synthetic RNA. See text for details. (Figure based on Park et al 1991).
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An RNAse protection assay, using a probe directed against negative strand Sendai 
virus RNA, was used to demonstrate that the input RNA was not only expressed 
to give CAT mRNA but also served as a template for replication and was thus 
amplified by the helper virus. Supernatants from the transfected cells contained 
virus particles which had packaged the synthetic CAT RNA. This was 
demonstrated by observing CAT activity after serial passage o f the supernatant 
and by the ability to specifically abolish CAT activity by pretreating supernatants 
with anti Sendai virus sera but not with heterologous anti sera.
1.6.3 Respiratory syncytial virus
The P n eu m oviru s  genus is relatively distinct from other genera o f the 
Paramyxoviridae having extra mRNA and proteins, and differences in gene order 
and sequence (Collins 1991). However, using analagous constructs and 
procedures as those used for replication of synthetic Sendai virus RNA (section
1.6.2), rescue of synthetic respiratory syncytial virus-like RNA was achieved 
(Collins et al 1991) . C is -acting replication and packaging signals were 
investigated by attempting to rescue RNAs having truncations or mutations of the 
viral sequences at their termini. Replacement of the 3' terminal 44 nucleotide 
vRNA leader region by the 50nt trailer complement, representing the 3' terminus 
of positive stranded replicative interm ediate R NA , demonstrated  
interchangeability of the two 3' ends since rescue occupied to a similar efficiency 
as for wild-type ends. This is in contrast to influenza virus where the vRNA and 
cRNA promoters have markedly different expression rates (see Section 1.8.4). 
Addition of 11 nucleotides of heterologous RNA to the 3' end prevented rescue, 
demonstrating the importance of the positioning of the ds-acting signals relative 
to the viral genome termini. This finding is in contrast to one influenza virus 
study (Yamanaka et al 1991) where efficient rescue of an RNA containing an 
additional stretch of 20-30 heterologous 3' nucleotides was reported. Despite high 
conservation between the positive and negative strands, the first five nucleotides 
of the RSV leader region did not appear to be critical since deletion o f the first 
three nucleotides or mutation of the 4th and 5th nucleotides still resulted in 
efficient rescue.
The systems developed for Sendai virus and RSV provide a useful means to 
investigate the ds-acting signals of the genome termini which should yield
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important information concerning promoter and packaging signals. Further 
progress has yet to be reported although preliminary data suggests that the system 
can be modified to study events occuring at the junctions between genes 
(Kolakofsky, unpublished data) which includes RNA editing as well as 
reinitiation of transcription required for expression of the various mRNAs. The 
stage is set for definition in molecular terms for the varied and interesting 
properties of this important group of viruses.
1.7 Vesicular stomatitis virus
The Rhabdoviridae contains over 100 viruses infecting a wide range of organisms 
including plants, fish, reptiles, crustaceans and mammals. The rhabdoviruses 
which infect mammals are classified, according to the type of disease they 
produce, into two genera: Lyssavirus which infect the central nervous system, the 
best known and most feared lyssavirus being rabies virus; and Vesiculovirus 
which infect epithelial cells, especially of the toSige, to cause vesicles. Vesicular 
stomatitis virus (VSV) is the prototype member of this genus and infects cattle 
resulting in epidemic disease. VSV is one of the most studied negative strand 
RNA viruses and has contributed to our knowlege of cellular processes such as 
protein processing and transport. The Rhabdoviridae have been recently reviewed 
(Wagner et al 1990) and will only be discussed briefly here with emphasis on 
recent progress in establishing a reverse genetics system for the study o f this 
important group of viruses.
1.7.1 Molecular biology of VSV.
VSV has a non-segmented, negative stranded RNA genome llk b  long. Five viral 
proteins are encoded: the nucleocapsid protein (N); a phosphoprotein (P or NS); a 
matrix protein (M); a single glycoprotein (G) and the RNA dependent RNA 
polymerase (L). The genome of VSV is encapsidated in nucleocapsid protein as a 
ribonucleoprotein (RNP) complex. As with all negative strand RNA viruses 
studied, the RNP is the functional template for transcription, whereas naked RNA 
is not recognised by the viral polymerase. The VSV nucleocapsid has two minor 
proteins associated with it, the L and P proteins. This complex alone can initiate 
RNA synthesis in vitro and is infectious when introduced into cells (Szilagyi & 
Uryvaev 1975). Activity is lost if the L and P proteins are dissociated (Emerson 
& Yu 1975) but can be regained by addition of purified L and P proteins. For
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processive transcription to occur excess N protein is required to facilitate read- 
through of termination signals (Patton et al 1984).
1.7.2 Replication of VSV DI particles by recombinant proteins.
RNP purified from DI particles of VSV could be replicated in cells transiently 
expressing the N, P and L proteins from recombinant DNA molecules (Pattnaik & 
Wertz 1990). This established an in vivo system capable o f dissecting the 
functions of proteins required in replication. The system was developed further, 
still using purified DI RNP as template, but co-expressing all five VSV genes 
instead of just those required for replication. Where all five genes were 
expressed, the DI template could not only be replicated but also packaged into DI 
particles which were released from cells by budding and could infect other cells 
(Pattnaik & Wertz 1991). Using this system, reverse genetics can be applied to 
investigate the functions of all five VSV proteins.
The success of these types of experiments, where recombinant expressed proteins 
can mimick all the functions of a virus, gives an interesting insight into the 
evolution of VSV. The recombinant proteins expressed from DNA genes are 
produced with little, if any, quantitative or temporal control but can still function 
to perform all the essential replication and packaging functions required of a 
virus. This is in contrast to the VSV genome where the arrangement of genes and 
presumably cis signals, give controlled expression with proteins required in large 
amounts, e.g. the N protein, being expressed to much higher levels than those 
required at lower levels for catalytic roles, such as the L protein. While the 
recombinant proteins may not produce DI particles as efficiently as authentic virus 
infection would, they do function—  demonstrating that a less highly controlled 
system could have existed as fodder for natural selection to improve to the 
organised arrangement found in VSV today.
1.7.3 Assembly of synthetic VSV RNPs
To enable dissection of c7.v-regulatory elements by introduction o f nucleotide 
alterations, the RNP template would have to contain RNA derived from cDNA  
which requires the ability to reconstitute a functional RNP from naked RNA and 
proteins. For influenza virus, RNP could be reconstituted by mixing purified 
proteins with naked RNA while for Sendai virus, naked RNA transfected into 
infected cells could be encapsidated in vivo. Although functional RNP for VSV 
had been reconstituted in vitro, using extracts of infected cells to encapsidate 
naked RNA purified from DI particles (Mirakhur & Peluso 1988), no report of
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replication of a plasmid derived RNA using this system was forthcoming. This is 
surprising since the study demonstrated in vivo replication of the reconstituted 
RNP in the presence of helper virus. Why studies involving plasmid derived 
RNA were not reported is unclear, especially since the authors commented on the 
importance of the work in the context of applying reverse genetics to study VSV  
(Mirakhur & Peluso 1988). More recently purified N protein has been used to 
encapsidate small synthetic RNAs in vitro which are competent transcription 
templates (Moyer et al 1991). The usefulness of this system is somewhat limited 
by the size of the RNA which can be encapsidated which is small even compared 
to DI genomes.
1.7.4 VSV DI genomes from cDNA
Plasmid derived RNA was successfully replicated by transcribing it in vivo, in the 
presence of VSV proteins (Pattnaik et al 1992). The cDNA corresponding to a DI 
genome was placed under control of bacteriophage T7 promoter such that 
transcription would initiate on the first Di-specific nucleotide. The 3' end of the 
T7 transcript was cleaved precisely at the last DI nucleotide by inclusion of 
ribozyme sequences adjacent to the DI RNA. Sequence-authentic DI RNA could 
be produced in vivo by transfecting this construct into cells previously infected 
with a recombinant vaccinia virus, vTF7-3 (Fuerst et al 1986), which produces 
T7 RNA polymerase in vivo. Co-transfection of further T7 constructs containing 
VSV genes enabled efficient encapsidation and replication of the DI RNA. When 
all VSV genes were present, the DI RNA could be packaged into VSV DI 
particles which budded from the cells (Figure 1.7.1). This work is a major 
achievement considering that the particle formed originates entirely from cDNA. 
This enables rescue, without VSV helper virus, of virus like particles and so 
opens the way for detailed mutagenic analysis of all cis and trans acting functions 
of VSV.
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VTF7-3
Cells express T7 pol
Cells express VSV proteins 
and synthetic DI RNA
DI replication and budding
Figure 1.7.1 Production of VSV D I particles from  cloned cDNA. BHK cells were 
infected with vTF7-3, a recombinant vaccinia virus which expresses bacteriophage T7 RNA  
polymerase. After accumulation of T7 polymerase, T7-expression constructs coding for the five 
VSV genes (N, M, L, P & G) were transfected along with a plasmid containing a cD N A  
corresponding to a VSV DI genome. The DI RNA is transcribed by T7 polym erase, 
encapsidated, replicated and packaged into budding virions by die co-expressed VSV proteins. 
(Figure redrawn from Pattnaik et al 1992)
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1.8 Influenza A virus
1.8.1 Influenza vims
Influenza A vims is a member of the Orthomyxoviridae along with influenza B and 
C viruses. All three have segmented RNA genomes which are negative stranded 
and non infectious. Virus particles are enveloped and contain two types of  
membrane proteins (one for influenza C virus), the haemagglutinin (HA) and 
neuraminidase (NA) proteins. Internally, the eight genome segments (seven for 
influenza C vims) occur as helical nucleocapsids formed by association of the RNA 
with many copies of the nucleocapsid protein (NP) and a few copies of the 
polymerase complex (PBl, PB2 and PA for influenza A virus). Matrix protein 
occurs between the helical nucleocapsids and the viral envelope. (For review see 
Murphy & Webster 1990; Krug e ta l 1989; Kingsbury 1990).
Influenza A virus is an extremely important human pathogen causing pandemics 
which can lead to substantial loss of life. Influenza virus has several animal 
reservoirs. The inherent high mutation rate associated with RNA genomes results in 
antigenic drift and helps the virus evade the immune system. Having a segmented 
genome, reassortment of gene segments results in viruses with new genome 
combinations (antigenic shift) which emerge and cause world wide outbreaks of 
disease at strikingly regular intervals (Muiphy & Webster 1990). Recently it has 
become possible to apply recombinant DNA technology to produce genetically 
altered influenza virus. This technology holds much promise for further 
investigating the molecular biology of this vims and may prove useful in producing 
improved vaccines.
1.8.2 RNA species of influenza virus infected cells
For each genome segment of influenza virus, three types of RNA are found in 
infected cells (see Figure 1.8.1): i) Viral genomic RNA (vRNA) is of negative 
polarity and is always associated with viral proteins as a ribonucleoprotein (RNP)
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nucleocapsid; ii) mRNA is complementary to genomic RNA, has additional 5 ‘ 
heterogeneous sequences which are capped, is missing 17-20 3'-terminal 
nucleotides complementary to the genome RNA 5' end and is 3' polyadenylated. 
mRNA is not found in nucleocapsids or in virions; iii) genomic-complementary 
RNA (cRNA) is the same polarity as mRNA but is a faithful complement of 
genomic RNA lacking the capped leader and poly-A tail found in mRNA. cRNA, 
like vRNA, is only found in RNP form. Unlike vRNA, cRNA is found only in 
infected cells and not in the virus particle.
3'- 5' (-) vRNA
AAAAn 3' (+) mRNA
Figure 1.8.1 Infected cell RNAs of influenza virus. Both vRNA and cRNA are encapsidated in 
NP protein ( © )  and are exactly complementary. mRNA contains additional 5' sequences derived 
from host cell capped mRNA (^ * vvv)> are 3' truncated and polyadenylated.
The functional template for transcription in influenza vims is the RNP. Naked RNA 
is not recognised by the polymerase complex. Early studies o f influenza 
transcription used native RNP from disrupted cells or virions (Beaton & Krug 
1986; Takeuchi e ta l  1987; Shapiro & Krug 1988). Such studies were able to 
determine conditions under which synthesis of the different forms of RNA could 
occur in vitro. For example, mRNA production requires added capped 
heterologous mRNA from which short leaders are cleaved to prime transcription 
(Shapiro & Krug 1988). Addition of dinucleotide ApG (McGeoch & Kitron 1974), 
or the absence of added primer resulted in the synthesis of cRNA (Hay e ta l  1982). 
Full length cRNA synthesis is also dependent on the presence o f an excess of NP 
protein (Beaton & Krug 1986; Honda et al 1988).
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1.8.3.Transcription Initiation
The additional heterologous sequences found at the 5' end o f influenza virus 
mRNA are cleaved from host cell mRNA in the nucleus (Krug et a l 1939). The 
sensitivity of influenza virus transcription to a-amanitin, an inhibitor of cellular 
RNA-polymerase II transcription, demonstrates that newly synthesised transcripts 
are required (Mark et al 1979). PB2 is involved in binding host cell mRNA by cap 
recognition. A cap 1 structure (m7GpppNm) is prefered (Bouloy et al 1980). The 
cellular message is cleaved 10-15 nucleotides downstream o f the cap at a purine 
residue. While priming does not require base pairing of the host derived leader to 
the genomic vRNA (Krug et al 1980), the first base to be added to the cleaved 
primer by the influenza PB1 protein appears to be G templated by a C next to the 3f 
teminal U residue of the vRNA (Braam et al 1983; see figure 1.8.4 for vRNA 3' 
terminal sequence). This suggests some interaction of the template terminal U with 
the 3' terminal nucleotide of the primer which was preferentially cleaved at a 
purine, A or G— both of which can form hydrogen bonds with U residues in RNA. 
Evidence of a role for hydrogen bonding of complementary nucleotides to initiate 
transcription, at least for dinucleotide-primed in vitro transcription, comes from the 
finding that RNP containing mutated termini can be primed for RNA synthesis if a 
complementary dinucleotide is included in the reaction but not if it is absent or 
replaced by a non-complementary dinucleotide (Seong & Brownlee 1992b).
1.8.4 Synthetic influenza virus RNPs and their use in promoter 
analysis
To enable study of the cis sequences required for transcription and replication, it is 
necessary to use mutated RNAs as promoter elements. Since the template for 
transcription is not naked RNA but the RNP complex, mutational analysis can only 
occur if  synthetic RNA can be reconstituted into transcription competent RNP. In 
recent years, various methods have been developed for in vitro reconstitution of 
active RNP. All these methods use proteins from native RNP, which have been 
separated from the influenza virus genome RNA, to complex with in vitro  
synthesised RNA of defined sequence.
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1.8.4.1 Influenza virus RNP reconstitution using gel purified 
proteins.
The first successful attempt at reconstituting transcriptionally active influenza virus 
RNP used virus RNA mixed with proteins purified by denaturing gel 
electrophoresis (Szewczyk et cd 1988). Virion RNP complexes were boiled in SDS 
under reducing conditions and the components separated by SDS PAGE. The gels 
were blotted to membranes from which bands containing each protein (PB1, PB2, 
PA and NP) were cut and the proteins eluted (see Figure 1.8.2). When genomic 
RNA, purified from virus by phenol extraction, was combined with the purified 
proteins in the presence of the bacterial enzyme thioredoxin to refold the proteins, 
transcriptionally active complexes formed. For transcription to occur the three 
polymerase proteins and NP were required suggesting that the polymerase complex 
could not recognise template RNA unless it was associated with NP. This system 
might have allowed detailed examination of cis signals involved in transcription 
although no further reports of its use have been forthcoming. Although the authors 
claimed restoration of 10-30% of the starting activity, the original activity of their 
RNP was much lower than that obtained by other workers (Krug et al 1989) and 
therefore the overall efficiency of the system may be questionable.
SDS/PAGE
Proteins eluted into buffer
^  FBI
PA I \  i
Naked RNANP
Blot
+ Thioredoxin 
+ ApG/mRNA 
+ NTPs
Membrane 
cut up to 
isolate 
proteins
Figure 1.8.2 Thioredoxin renaturation of influenza virus RNP.
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1.8.4.2 Reconstitution using gradient purified proteins
A more efficient procedure for reconstituting synthetic influenza virus RNP for in 
vitro transcription studies used NP and polymerase proteins depleted of viral RNA 
by CsCl/glycerol gradient centrifugation (Parvin et al 1989). Influenza virus RNP 
complexes centrifuged through CsCl/glycerol gradients dissociate into dense 
polymerase/RNA complexes and less dense free NP (Kato et al 1985). The 
polymerase/RNA complex al the bottom of the gradient was found to be active for 
transcription initiation when primed with ApG but produced only short transcripts 
of 12- 19nt long unless free NP, purified from higher up the gradient, was added 
(Honda et al 1987; Honda et al 1988). The upper NP fractions (see Figure 1.8.3) 
contain no RNA but were found to contain small amounts of polymerase proteins 
(Parvin et al 1989).
Lysed influenza 
virions s epa ra ted  
on CsCl/glycerol 
gradient
NP,c
o RNA
Polymerase
complex
CDOc=
oo
FractionBottom
Figure 1 .8 .3  Gradient profile of disrupted influenza v ir io n s . NP dissocates from the 
RNP in high salt and bands free of RNA near the top o f CsCl/glycerol gradients . The RNA, with 
polymerase proteins (PB1, PB2 and PA) is found at the bottom o f die tube. Small amounts of 
polymerase complex is also found free o f RNA in the NP band. See text for details. (Figure based 
on the findings of Parvin el al 1989).
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Incubation of influenza virus naked RNA, either purified from virions by phenol 
extraction or transcribed from plasmids in vitro, with free NP/polymerase fractions, 
resulted in the formation of transcriptionally active complexes. The reconstituted 
RNP resembled native RNP in in vitro transcription reactions with regard to 
temperature and salt optima and kinetics of label incoiporation.
Using short model RNA templates transcribed in vitro from plasmids containing 
mutated influenza virus sequences, a number of deductions could be made: Firstly, 
although it had long been speculated that the double-stranded panhandle formed by 
the termini of all influenza virus gene segments (Desselberger et al 1980; Hsu et al 
1987) might be involved in polymerase recognition, it was found that 3' terminal 
sequences alone could optimally function as a promoter (Parvin et al 1989). The 
terminal 15nt were sufficient. Surprisingly, sequences corresponding to the 3' 
terminus of cRNA (i.e. the expected promoter for vRNA synthesis), which differs 
from the vRNA 3' terminus by three point differences and a single insertion (see 
Figure 1.8.4), was not an efficient template in this system— the activity was 
reduced to 20% of that observed for vRNA. Mutational analysis was used to define 
which differences resulted in the lower level observed for the vRNA promoter. 
Single changes at positions 5 or 8 of vRNA to their cRNA counterparts, had no 
effect on promoter activity although the double mutation resulted in only 30% 
activity. Position 3 seemed more critical with single mutation reducing activity to 
40%. This activity was further greatly reduced by insertion o f the additional U  
residue at position 10 (only 0.06% activity) although activity returned to 20% by 
the additional change C-U at position 8.
In the absence of in vivo data it is difficult to comment on the lower activity of 
cRNA compared to vRNA sequences in this assay. The observation suggests that 
vRNA sequences, which have to promote cRNA and high level mRNA synthesis, 
are inherently stronger than the cRNA sequences which only have to promote 
vRNA synthesis. An alternative possibility would be that transcription to produce 
genomic vRNA is temporally controlled to occur late in infection and efficient 
transcription requires accumulation or modification of viral proteins or the presence 
of a cellular factor.
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1 3 5 8 10
3' oh-UCGUUUUCGUCCCAC vRNA
3' oh-UCAUCUUUGUUCCCAC cRNA
Figure 1.8.4 In flu en za  virus v R N A  and c R N A  3’ term ini. The nucleotides are 
numbered from llie 3’ terminus for discussion in the text. The cRNA terminus differs from vRNA 
by three point differences (underlined) and by insertion of an extra U residue at position 11.
1.8.4.3 Reconstitution using nuclease treated RNP as protein source.
More recent in vitro studies mutated each of the twelve 3' terminal bases of influenza 
virus vRNA (Seong & Brownlee 1992b). Short model templates were reconstituted 
into transcriptionally active complexes using protein derived from disrupted virions 
which had been depleted of viral RNA by micrococcal nuclease digestion followed 
by inactivation of the calcium-dependent nuclease by chelation using EGTA (Seong 
& Brownlee 1992a). This system could mimick all three influenza virus 
transcription activities: capped primer dependent mRNA synthesis, primer- 
independent cRNA synthesis, and ApG-primed vRNA synthesis (Seong & 
Brownlee 1992a; Seong et al 1992). Surprisingly it was found that only three of the 
conserved twelve 3' terminal vRNA nucleotides were essential for all three 
activities. These formed a triplet (3' GUC 5') at position 9-11 bases in from the 
teminus. Mutation of any of these three nucleotides reduced activity to <10% of that 
observed for the wild-type sequence. At other positions mutations were found 
which led to premature termination of the transcript and some mutations had a 
stimulatory effect. For ApG-primed synthesis, mutations at positions 1 and 2 
moderately reduced activity with position 1 being more important than for position 
2— mutation of which could still give high level of activity if  the corresponding 
complementary dinucleotide was used to prime instead of ApG. Mutation at 
positions 3 or 4 resulted in strong stimulation o f unprimed RNA synthesis. 
Interestingly, position 4 is the only site where an alternative base is present in some 
segments of influenza virus (Robertson 1979; Winter & Fields 1980; Desselberger 
e ta l  1980; Allen e ta l  1980). Position 4 may therefore play a role in segment-specific 
regulation of expression. Based on the detailed in vitro analysis of the vRNA  
promoter, it was suggested that the polymerase complex specifically recognises two 
sites o f the 12 nucleotide promoter— the 3' terminal three nucleotides and three or 
four nucleotides, adjacent to each other, starting at position 9. These two contact 
points are separated by a short stretch of U residues, mutation of which leads to 
premature termination of transcription (Seong & Brownlee 1992b).
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1.8.5 In vivo expression, replication and packaging 
of synthetic influenza virus RNPs.
The successful in vitro reconstitution of transcriptionally active influenza virus 
RNPs (Parvin et al 1989) led to the system being applied to the rescue, into 
infectious virions, of RNA transcribed in vitro from cDNA (Luytjes et al 1989). A 
chimeric DNA version of influenza virus segment eight was constructed, in which 
the coding region for the NS gene was replaced by the CAT gene. In vitro  
transcription from an appropriately positioned T7 promoter to a run-off site formed 
by restriction enzyme cleavage of the plasmid resulted in a RNA molecule 
containing the terminal non-coding sequences, exactly matching those found in 
influenza virus segment eight, flanking an antisense copy of the CAT gene. Being 
of negative polarity, this RNA could not be translated to give active CAT protein 
unless it was first itself used as a template to make positive strand mRNA. This 
design gave a sensitive and absolute reporter system for influenza virus dependent 
transcription since eukaryotic cells contain neither CAT nor RNA dependent RNA 
polymerase activity. Using the same procedure that had been applied successfully 
to synthesise influenza virus RNPs active for in vitro transcription (Parvin et al
1989), RNP containing the chimeric CAT/segment eight RNA was synthesised and 
transfected into cells (Luytjes et al 1989). In the presence of replicating helper 
influenza virus, the synthetic RNP was expressed, replicated and packaged into 
infectious virions which could be serially passaged several times (see figure 1.8.5).
Amplification was necessary for expression to occur to detectable levels. This was 
demonstrated by including a similar chimeric CAT/segment eight RNA which 
differed by three point mutations at the 5' end which were known to interfere with 
synthesis of vRNA but not of cRNA or mRNA— the promoters for which lie 
entirely at the 3' terminus of vRNA. This mutant, although capable of primary 
transcription of the input template, did not allow measurable levels o f CAT to 
accumulate suggesting that the chimera with wild type termini are replicated as well 
as expressed.
RNA was packaged into virions, as demonstrated by the ability of the media from 
transfection experiments to induce CAT activity in cells after serial passage even 
after RNase A treatment. CAT induction was however abolished by treating the 
medium with anti-influenza virus serum to aggregate virus particles. This report 
was the first to achieve packaging of genetically manipulated RNA of any negative 
strand RNA vims.
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Figure 1.8.5 Rescue of in vitro transcribed RNA by influenza virus. See text for 
details. (Figure based on Luytjes et al 1989)
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1.8.6 Introduction of mutations into the 
influenza virus genome.
The system for packaging plasmid transcribed RNA into influenza virus (Luytjes et 
al 1989) was applied to introduce site-specific mutations into the influenza virus 
genome (Enami et al 1990). This was achieved by using a helper virus with a 
strong counter-selectable phenotype which was well charaterised. Influenza virus 
A/WSN-HK is a reassortant containing seven segments from influenza A/WSN/33 
and the neuraminidase gene segment from influenza virus A/HK/8/86. This 
reassortant can only form plaques in MDBK cells when the cell culture media is 
supplemented with a protease (Schulman & Palese 1977), whereas the parent WSN  
strain replicates and forms large plaques without the requirement for exogenous 
protease. The strategy was to provide WSN NA segment (and therefore protease- 
independence) in the form of a synthetic RNP. Any vims replicating and packaging 
the synthetic WSN/NA segment could easily be selected for by omitting protease 
from the cell culture media. Using this procedure it was possible to obtain 2-5 xlO2 
plaques/35mm transfection dish, formed by virus in which the neuraminidase 
segment was derived from the transfected synthetic RNP. To verify the plasmid 
origin of the WSN segment, further constructs were made into which five silent 
point mutations were introduced in the NA coding sequence. All the vim s 
recovered in the absence of protease contained the mutations demonstrating that 
synthetic RNP had indeed been stably incorporated into an influenza vims.
1.8.6.1 Increased efficiency of synthetic RNP formation
The efficiency of the system was considerably improved by performing the 
plasmid transcription reaction in the presence of purified influenza virus proteins 
(Enami & Palese 1991) rather than mixing preformed RNA with the protein as had 
originally been done to effect reconstitution (Luytjes et a l 1989). Using the 
optimised protocol, the rescue of synthetic W SN/NA segment into WSN/HK  
reassortant virus could be achieved at much greater efficiency with at least 100-fold 
more virus being isolated (0*5-1 xlO5 pfu/transfection compared with 2*5 xlO2 
observed earlier).
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1.8.7 Termination and polyadenylation of mRNA transcripts
Once capped-primer influenza virus mRNA synthesis has started, transcription 
continues until a stretch of 4-7 U residues close to the 5' end of the template vRNA 
is reached, where termination and polyadenylation occurs (Hay et al 1977; 
Robertson e ta l  1981). The termini of influenza virus gene segments all have 
conserved nucleotides which show extensive complementarity (Desselberger e ta l  
1980). Cross-linking experiments demonstrated that the termini o f genome RNAs 
can exist base paired as a pan handle structure in infected cells and virions (Hsu et 
al 1987). The proximity of the U stretch at which mRNA terminates to the predicted 
double stranded region of the pan handle suggested a polymerase slippage 
mechanism to account for polyadenylation. In this model the polymerase complex 
would be unable to melt the duplex region thus preventing it from transcribing 
sequences forming the pan handle, and would 'stutter' on the adjacent U tract 
resulting in poly A addition by repeatedly reading the U stretch.
The recent development of methodology enabling the application of reverse 
genetics to influenza virus (Luytjes et al 1989) has allowed models such as this to 
be tested (Luo et al 1991). In an in vivo transcription assay using synthetic RNP 
containing a CAT reporter gene flanked by influenza virus segment termini, the 
level of CAT activity was correlated with the level of polyadenylated mRNA. Thus 
for this system the level of CAT expression could be used as a measure o f the 
abundance of mRNA (Luo et al 1991). Engineered RNA in which the uridine tract 
had been displaced away from the pan handle diminished CAT activity as did 
mutations introduced into the U tract. Mutations designed to prevent pan handle 
formation reduced activity, and this could be restored if compensatory changes 
were introduced to reform a pan handle of incorrect sequence. Finally, the activity 
of the RNA with the displaced U tract could be restored if an additional double 
stranded region was introduced immediately downstream of the U tract (see Figure 
1.8 .6 ).
These experiments demonstrate that both the sequence and its context relevant to the 
double stranded region are essential for expression of influenza vims mRNA. The 
observations are entirely consistent with a polymerase slippage mechanism of poly- 
A addition although^dt? not exclude other possibilities (formal proof that the 
differences of CAT expression were due to differences in polyadenylation of 
mRNA was not demonstrated in this work).
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Figure 1.8.6 Influenza virus p o ly a d e n y la tio n  m u tan ts. Diagramatic representation of 
RNAs containing alterations to the pan handle and/or U stretch and the effect on CAT 
expression. RNAs on the left (-) produced dramatically reduced levels o f CAT while those on the 
right (+) gave high level expression. See text for details. (Representation of the results of Luo et 
al 1991).
1.8.8 Packaging of influnza virus genome segments.
Some aspects of packaging of gene segments into influenza virus can be deduced 
from observation. For example, RNP but not naked RNA is packaged into virus 
and so the ability of influenza virus to selectively package relevant RNA species 
can be controlled at one level by control of encapsidation by NP protein. Clearly 
more control is needed since influenza virus packages only RNP containing 
negative strand vRNA and not the replicative intermediate cRNA-containing 
RNP. The favoured hypothesis, for which there is no experimental evidence, is 
that diffences in the shape of the panhandle structure could account for selection
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of only negative strand RNA. The ability of guanosine to base pair with uracil in 
RNA (in addition to cytosine) results in 'allowed' mismatches which can fit into a 
helix formed in double stranded regions of RNA such as is found in the 
panhandle of vRNA and cRNA. Conversely complementary pairing of cytosine 
with adenine cannot occur and results in disruption of the helix in a region of 
RNA duplex. Because the 3' ends of vRNA and cRNA are the complements of 
the 5' ends of cRNA and vRNA respectively, the presence of the point 
differences in these two regions (see Figure 1.8.4) result in the occurence of non- 
complementary bases appearing opposite each other in the panhandles formed 
between the termini of an RNP. Because of the template used for transcription of 
each strand (i.e. the complementary strand), where a G/U allowed mismatch 
occurs in one panhandle, a dis allowed C/A pair would be present in the 
panhandle of the opposite strand (see Figure 1.8.7). These differences could 
result in significant differences in the conformation of the panhandles for the two 
polarities of RNA which might allow recognition of only RNP containing 
negative strand RNA for packaging into virions.
3 ' o h - U C G U U U U C G U  C C C A C
I I : I : I I I I  I I I I I
5' ppp-A G U A G A A  C A  G G G U G
A A
U
3' OH- UC A U C U U U G U  C C C A C  
I I  I 1 1 : 1 1  I I I  I I 
5 'p pp -A G  A a A A G C A  G G G U G
Figure 1.8.7 Differences in pan handles of vRNA and cRNA of influenza 
virus. Standard Watson-Crick base pairs are shown as vertical dashes, allowed G/U RNA base 
pairs are shown as double dots. Unpaired and misspaired bases are shown displaced from the 
duplex. These displacements occur at different positions for vRNA and cRNA and may result in 
a difference in conformation of the RNP for each panhandle.
/
\
/
\
vRNA
cRNA
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1.8.8.1 Random vs selective packaging of influenza virus RNPs
Presuming the packaging mechanism provides a means to discriminate between 
vRNA and cRNA, influenza virus also has to be able to package the correct 
complement of vRNA gene segments. This aspect o f packaging has been the 
focus of theoretical discussion and with the advent of systems enabling the rescue 
of artificial gene segments into influenza virus, has recently been addressed 
experimentally.
In order to establish infection, influenza vims particles must contain at least one of 
each of the eight types of gene segment. At the simplest level, either some means of 
selectively packaging the correct eight segments occurs or packaging is a stochastic 
event resulting in a proportion of gene-deficient viruses incapable of establishing 
infection. The observation that the ratio of different gene segments in infected cells 
differs from the ratio found in viruses (Smith & Hay 1982) supports a selective 
mechanism, since random choice should reflect the relative proportions present in 
the choice pool.
For random packaging, a high particle/pfu ratio would be expected if only eight
RNP were packaged since most particles would contain the wrong combination.
Random packaging could however be feasible if more than eight segments were
packaged (Hirst 1973). Probability calculations predict that randomly selecting
eight items from a large pool containing eight different types, would result in the
occurence of eight different items being co-selected once in around 400 trials. For a
stock of influenza virus where each particle contained only eight RNPs, this would
result in 0.24% of particles having the genome complement required for infectivity
(Enami et al 1991). This theoretical percentage rises to nearly 20% if fourteen
segments were packaged. Comparison of the theoretical values for infectious
particles obtained by stochastic packaging with observed particle/pfu ratios suggest
random choice is a feasible mechanism for packaging of influenza gene segments 
n
into virions (Compqjs & Choppin 1975; Lamb & Choppin 1983). One piece of 
evidence that influenza virus could package more than eight segments came from 
the isolation of a reassortant virus which was heterozygous for two genome 
segments (Scholtisseke ta l 1978).
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1.8.8.2 The application of reverse genetics to investigate packaging
The ability to assemble synthetic RNPs which could be rescued into infectious
influenza virus was used to investigate the means by which influenza virus
packages an infectious complement of genome segments (Enami e ta l  1991). The
experiment involved the rescue of a ts mutant with a deletion in the NS1 gene. The
£
ts mutant grows to >1()7 pfu/ml at the permjsive temperature (33°C) but at the non- 
permissive temperature (38“C) no progeny vims can be detected. The NS segment 
encodes two proteins, NS1 and NS2, both of which are essential for replication. 
By supplying a synthetic RNP encoding NS1 alone it would be possible to rescue a 
virus with non ts phenotype only if nine segments were packaged since the original 
segment containing the NS 1 deletion would still be required as the only source of 
NS2 protein.
Transfection of a synthetic RNP coding for only the NS1 protein did indeed result 
in apperance of non ts virus. Evidence from plaque assays of serially diluted virus 
indicated that complementation by coinfection of two or more vims particles, each 
with less than the required gene complement, was not responsible for the non ts 
phenotype nor was reversion of the original lesion. The ratio of the titre of the 
transfectant stock at 38UC (where nine segments are obligatory for productive 
infection) to the titre observed at 33°C (where the parental mutant can grow and so 
only eight segments are required) was consistent with that expected by calculations 
based on stochastic packaging of nine or eight segments respectively. While the 
number of segments normally packaged by influenza virus could not be definitively 
calculated, this study provided evidence that the correct complement o f genome 
segments can be obtained by randomly choosing a numerical excess of RNPs.
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1.8.9 Production of influenza A/B virus chimeras.
Using the same counterselectable WSN-HK helper reassortant described in section 
1.8.6 (Enami et al 1990) it was possible to introduce a NA segment containing non 
coding regions from an influenza B virus gene segment into the influenza A virus 
genome (Muster et al 1991). This produced an entirely novel influenza virus since 
natural reassortment between influenza A and B viruses does not normally occur 
(Murphy & Webster 1990). The resulting virus has normal coding regions from 
influenza A virus in all segments but the non coding region of the neuraminidase 
gene segment is derived from the inflenza B virus NS gene segment. Interestingly 
synthetic RNP containing the non coding region of the NA gene o f influenza B 
virus could not be rescued whereas if the non coding region of the influenza B 
virus NS segment was used to flank the wild type influenza A virus NA gene, the 
synthetic RNP could be rescued. The virus was found to be attenuated in mice and 
replication was restricted in the respiratory tract and partially so in the lungs 
(Muster et al 1990). Infection induced immunity to subsequent challenge with 
influenza virus. This work demonstrated the potential to produce new variants 
which are attenuated and show potential as live vaccines to protect against influenza 
virus infection.
1.8.10 Influenza virus engineering— concluding remarks.
Three years since the first report of in vivo replication, expression and packaging of 
synthetic influenza virus RNPs, influenza vims remains the only negative strand 
RNA virus for which stable genome alterations have been introduced by 
manipulating cDNA clones. Exploitation of this methodology has already furnished 
information about the replication cycle of influenza virus, such as those discussed 
here concerning the criteria for polyadenylation of mRNA and the mechanism of 
packaging RNPs into virus particles, which were not experimentally approachable 
prior to development of methods enabling the application of reverse genetics to 
influenza virus. The potential has also been demonstrated for producing novel 
strains of influenza virus which may prove useful as improved vaccines. This new  
technology has therefore paved the way for dissecting all aspects of the molecular 
biology of influenza virus and may find immense practical application to the 
development of new improved therapeutic agents.
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1.9 Bunyamwera virus.
1.9.1 Taxonomy
Bunyamwera virus is the prototype of both the B un ya v iru s  genus and the 
Bunyaviridae family (Table 1.9.1). The Bunyaviridae is subdivided into five genera 
which together contain more than 300 viruses (Karabatsos 1985). Four of the five 
genera, Bunyavirus , Hantavirus, Nairovirus, Phlebovirus (Calisher et al 1990), 
contain v i r u s e s  with the fifth, Tospovirus , containing a single
member. The Bunyavirus genus contains at least 18 serogroups (Beaty & Calisher 
1991) which together include over 160 viruses (Bishop 1990). The Bunyamwera 
serogroup, of the Bunyavirus genus, contains 25 viruses including Bunyamwera 
virus, Maguari virus and Germiston virus.
Genus Serogoups Viruses
Bunyavirus 18 groups -1 6 0  viruses 
Example groups:
Bunyam wera group 
California group  
Simhu group
25 viruses including Maguari, 
G erm iston and Bunyam w era viruses.
13 viruses including La C rosse  
virus
21 viruses including Akabane virus
Nairovirus 6 groups - 2 0  viruses 
Example groups:
CC1 IF
Dera Ghazi Khan
4 viruses including C rim ean-C ongo  
Haem orrhagic fever vir us.
5 vir uses
Phlebovirus 2 groups / 43 viruses 
Phlebotom us fever group
llukuniem i group
37 vir uses including N aples & 
Sicilian sand fly  fever and Rift 
V alley  fever viruses
6 viruses
Hantavirus One group— Hantaan 5 vir uses including Hantaan, 
Puuinala and Seou l viruses
Tospovirus One group one virus Tom ato spotted w ilt virus
Table 1.9.1 Classification of the Bunyaviridae.  (Table simplified from Beaty & 
Calisher 1991)
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1.9.2 Biology of the Bunyaviridae
The natural history of the Bunyaviridae has been well reviewed elsewhere (Beaty & 
Calisher 1991 and references there in) and will only be covered briefly here. With 
very few exceptions, members of the Bunyaviridae are arthropod-borne viruses of 
vertebrates (arboviruses). The exceptions are the five hantaviruses which are 
rodent-bome with no known arthropod host (Schmaljohn & Dalrymple 1983) and 
tomato spotted wilt virus which is transmitted between plants by plant feeding 
arthropods called thrips (Milne & FrancKi 1984; de Haan et al 1989).
Susceptible vertebrate hosts are infected by blood-feeding arthropod vectors which 
appear to suffer no ill effects from the infection which is persistent and can be 
passed from insect to insect by horizontal (venereal) and vertical (transovarial) 
transmission. The bunyaviruscs are transmitted principally by mosquitoes, 
nairoviruses by ticks and phleboviruses by sand flies (Phlebotomus group) or ticks 
(Uukuniemi group). Mammals and birds serve as the main animal reservoir hosts 
with different viruses principally infecting different species or groups of closely  
related species. Infected vertebrate hosts develop viraemia and serve to infect 
subsequent feeding arthropods and thus amplify the virus. Only rarely are humans 
or domestic animals amplifying hosts although the Bunyaviridae does contain a few  
members o f human and veterinary importance such as Crimean-Congo 
haemorrhagic fever, Rift Valley fever, La Crosse and Hantaan viruses (Karabatsos 
1985).
The human diseases include: several types of encephalitis (California group of 
bunyaviruses) which may be rare or endemic depending on the virus; epidemic 
fevers (Simbu bunyavirus, Rift Valley fever phlebovirus); endemic fevers (sand fly 
fever group o f phlebovirus) or haemorrhagic fevers (hantaviruses and 
nairoviruses). These and related animal diseases have been recently reviewed 
(Gonzalez-Scarano e ta l 1991).
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1.9.3 Bunyamwera virus genome structure.
Bunyamwera virus has a segmented genome consisting of three single stranded 
RNA molecules of negative polarity. Bunyamwera was the first member of the 
Bunyaviridae to be completely sequenced (Lees et al 1986; Elliott 1989a; Elliott 
1989b). The total genome size is 12.3kb, 95% of which encodes polypeptides. 
Similar efficient utilization of coding potential is observed for other negative 
stranded RNA viruses.
The three genome segments, L, M and S, are 6875, 4458 and 961 nucleotides in 
length respectively. The L segment has a single open reading frame coding the 
2238 amino acid L protein (Mr 259K) which is the virion associated transcriptase 
(Jin & Elliott 1991). The M segment encodes the two virion glycoproteins, G1 and 
G2, and a small non-siructural protein (NSm) of unknown function. The protein 
products of the M segment are co-translationally cleaved from a larger polyprotein. 
The S segment encodes the nueleocapsid (N) protein and a non structural protein 
(NSs) of unknown function. These two proteins are coded for in overlapping 
reading frames (Fuller et (d 1983) and are translated from a single type of mRNA 
(Bishop et al 1983; Elliott & McGregor 1989) by alternative translation initiation 
and not from separate RNAs as originally thought (Patterson et al 1983; Raju & 
Kolakofsky 1987b).
The terminal eleven nucleotides at each end of all three genomic RNAs are 
conserved for all members of the Bunyavirus genus. A further three or four 
adjacent nucleotides are also conserved for a given segment but with differences 
between segment types (Elliott 1990). These conserved regions are complementary 
between either end of the RNA molecule. Further complementary sequence, of non 
conserved sequence between different viruses and gene segments, is adjacent 
resulting in a fairly long region at both ends of each gene segment with potential to 
form a double stranded panhandle structure (see Figure 1.9.1).
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Figure 1.9.1 Complementary sequences at the termini of Bunyamwera virus S 
segment. The first eleven bases are conserved for all segments of all members of the bunyavirus 
genus. The next four bases (shaded box) are conserved for the S segment—  different short 
conserved regions exist for oilier segments. The remainder of die sequence is Bunyamwera virus S 
segment specific but such regions of complementarity exist for all bunyaviruses. The G/U base 
pair (double dots) becomes a miss-matched A/C pair in cRNA which would result in disruption of 
the helical duplex possibly enabling discrimination of vRNA from cRNA for packaging purposes. 
(Figure redrawn from Elliott 1990).
5' (-)  vRNA
JL. o h  3 ' (+ ) mRNA
(+ ) cRNA
Figure 1 .9 .2  Infected c e l l  R N A s  o f  bunyaviruses. Both vRNA and cR N A  are 
encapsidated in N protein mid me exactly complementary. mRNA contains additional 5' sequences 
derived from host cell capped mRNA. Bunyavirus mRNA differs from influenza virus mRNA in 
being shorter compared to die template and lacking a poly A tail. (See Figure 1.8.1 for influenza 
virus RNA). Bunyavirus mRNA also has sequences just upstream of its 3' terminus with 
potendal to form a stem-loop structure which may serve to stabilise die message (Kolakofsky & 
Hacker 1991).
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1.9.4 Bunyavirus mRNA.
The mRNA transcripts of bunyaviruses contain non templated heterologous 
sequences at their 5' ends which are capped (Bishop et al 1983; Patterson & 
Kolakofsky 1984). These arc also truncated 50-110 nucleotides compared to the 
full length cRNA (Patterson & Kolakofsky 1984; Bouloy e ta l  1990; Jin & Elliott 
1993). These features are shared with influenza virus mRNAs but unlike influenza 
virus, bunyavirus mRNA does not appear to be polyadenylated (see Figure 1.9.2). 
In vitro transcription studies using RNPs from purified La Crosse virus (Patterson 
e ta l  1984), demonstrated that transcription could be stimulated by dinucleotide 
ApG, A(n)G oligonucleotides and alfalfa mosaic virus mRNA. This study also 
showed methylated cap-dependent endonuclease activity which cuts the plant virus 
mRNA 13 or 14 nucleotides from its 5' end. Studies using anti-cap antibodies 
demonstrated that bunyavirus mRNAs are also capped in vivo (Hacker et al 1990).
1.9.4.1 Leader primed bunyavirus mRNA synthesis.
Recently the leader sequences of Bunyamwera virus S mRNA were cloned and 
several independent 5' sequences determined (Jin & Elliott 1993). mRNA was 
purified from infected cells by pelleting through CsCl gradients to remove 
encapsidated genome and antigenome RNP. v . The S mRNA 5' termini 
were then specifically amplified using a PCR-based procedure developed for 
cloning 5' ends of RNA (Dumas et al 1991). The strategy used is shown in Figure 
1.9.3.
Of twenty one clones sequenced, all were found to have heterologous 5' leader 
sequence. The length ranged from 12 to 17 nucleotides (average 14nt) and they had 
a combined base composition of 62% G/C. The striking feature of the non viral 
sequences was the occurence in all but one of the clones of a U residue at position 
-1  relative to the viral terminus. 90% of the clones had G at position -2 and half had 
an A residue at -3. Sequences further upstream did not show any marked base 
preference (see Figure 1.9.4). These findings were similar to those reported for 
snowshoe hare bunyavirus (Eshita et al 1985) and Germiston bunyavirus (Bouloy
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Host derived 
capped leader
5 ' ^
Viral mRNA
1 st strand cDNA PI
+ - 8 5 0
Purify ss cDNA
Ligate 3' blocked oligo
3
P2
_P3, PCR Amplify
P4
Clone & Sequence
PU
Figure 1.9.3 PCR c lo n in g  o f  B u n y a m w e r a  virus mRNA leader sequences. 
Reverse transcription was primed with oligo PI to make ss cDNA across the host derived leader 
RNA. After purification, oligo P2 was ligated to the 3' terminus o f the ss cDNA using T4 RNA 
ligase. P2 was 3' blocked to prevent mulliineric ligation. The cD N A  population was then 
amplified by PCR using oligonucleotides complementary to P2 and internal to Bunyamwera S 
segment sequence. After cloning individual RNA leaders could be sequenced off die Universal 
phagemid primer (PU). (Figure adapted from Jin & Elliott 1993; Mediod based on Dumas et al 
1991)
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et al 1990). Some evidence exists that these conserved nucleotides (A<G<U) are 
not present in the messages from which the leaders were cleaved (Jin & Elliott 
1993). It seems an unlikely coincidence that the three conserved nucleotides are the 
same as the first three nucleotides of viral RNA.
A similar arrangement exists for Uukuniemi uukuvirus. Instead of the double triplet 
5' AGUAGU-- found at the termini of bunyavirus segments, uukuviruses have a 
paired repeat 5' ACAC--. For eight out of eleven NSs mRNAs having all the viral 
terminal sequence intact, all had C at -1 and six of these also had A at -2, and five 
had C again at -3 (Simons & Petterson 1991). No information is available as to 
whether these repeated bases were present in the cellular mRNA (and were 
somehow specifically selected for priming) or whether the bases were added by the 
viral polymerase, perhaps by a slippage mechanism using the 3' end of the vRNA 
as template. It is interesting to note that all sequenced uukuvirus mRNAs having the 
C as the last leader base, had intact 5' ACAC-- starts to the viral sequence 
whereas 9 out of 10 clones with the viral A (at nucleotide +1) missing had a G 
residue— with potential to hydrogen bond to the template 3' terminal U residue, as 
the last base of the leader.
Clearly more data will be needed, particularly concerning the downstream 
sequences of the cleaved cellular mRNA, before meaningful hypotheses, 
concerning the mechanism of leader selection and priming, can be made.
Figure 1.9.4 Host derived leaders of Bunyamwera virus S segment mRNA 
showing the commonly occuring bases at positions - 1 ,- 2  and -3 relative to the start o f viral 
sequences. (Figure based on the results o f Jin & Elliott 1993) see text for details.
(mRNA capped leader) (Bunyamwera S segment cRNA)
- 1  + 1
(5') M7GpppXXXXXXXXXXXAGU AGUAGUGU/
50% 90% 95%
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1.9.5 Translational requirement for mRNA transcription
An unusual aspect of bunyavirus mRNA transcription is the requirement for 
ongoing U*anslation (Abraham & Pattnaik 1983; Pattnaik & Abraham 1983; Raju & 
Kolakofsky 1986; Gerbaud et a I 1987) for La Crosse virus. Although radiolabelled 
NTP incorporation in in vitro transcription reactions was unaffected by 
cycloheximide, it was found that the in vitro transcripts formed terminated after 
only extending 175 nucleotides. If a reticulocyte lysate translation mix was added to 
the in vitro transcription reaction, normal length mRNA transcripts could be made 
(B ellocq  et al 1987). Addition o f cycloh exim id e to the in v itro  
transcription/translation mix resulted in the reappearance of the prematurely 
terminated transcripts. mRNA transcripts which had terminated at nucleotide 175 
could also be detected in vivo if cyclohex/ mide was present (Raju & Kolakofsky 
1987a).
The sequence around nucleotide 175 where the truncated transcripts end, was 
shown to have homology to the region near the normal termination site for mRNA 
transcription at nucleotide 8 8 6  (Bellocq et al 1987). Incorporation o f inosine in 
place of guanosine in in vitro transcription reactions, which would weaken any 
secondary structure involving G-C hydrogen bonds, allowed read through of the nt 
175 termination site and revealed other termination sites before the genuine one at 
nucleotide 8 8 6  (Bellocq & Kolakofsky 1987). Conversely replacement o f uridine 
by bromo-uridine, to create stronger hydrogen bonds, resulted in more pronounced 
termination. These results together suggest that in the absence o f translation the 
nascent RNA forms secondary structure, probably with the template RNA, which 
causes premature termination of mRNA synthesis. For cRNA synthesis, co- 
transcriptional encapsidation with N protein would attenuate all premature 
termination sites and the genuine site at nucleotide 8 8 6 , allowing transcription of 
full length replicative intermediates to nucleotide 983 (see Figure 1.9.5; Kolakofsky 
e ta l 1987).
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In v i tr o  transcription
nt 1 75
A
T r u n c a t e d  t r a n s c r ip t
nt 175
Coupled transcription/translation 
nt 886
B
Normal length mRNA
Coupled transcription/encapsidation
3 1
nt 175y
nt 886 
T
nt 9 8 3  
▼
r i
c
Normal length cRNA (RNP)
Figure 1.9.5 Translational requirement for La Crosse virus mRNA transcription. 
During In vitro transcription, transcripts terminate at nucleotide 175 (A) unless transcription is 
performed in the presence of reticulocyte lysate (B) which attenuates the 175 stop site. Coupled 
encapsidation is thought to attenuate premature stop sites and the usual mRNA terminator (C) to 
allow production of full length amigcnoines. See text for details and references.
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1.9.6 mRNA termination
The mRNA termination sites lor several bunyavirus segments have been mapped. 
Bunyamwera virus S mRNA is predicted to terminate in or near a site 100 
nucleotides in from the 5' end of template at S'-UUGGGUGUUUU-S' (Jin & 
Elliott 1993). For Germiston virus S mRNA, 3'-GUUUGU-5' is present whereas 
for the M segment and the La Crosse virus S segment, 3'-GUUUUU-5' is present 
(reviewed in Kolakofsky & Hacker 1991). This last sequence is similar to that 
employed by influenza virus (see Section 1.8.7) although for influenza virus the 
site is also implicated in polyadenylation by slippage which is thought to result 
from hindrance to the polymerase by the double stranded pan handle which is 
immediately adjacent to the U-rich termination site (Luo et a l 1991). For 
bunyaviruses the pan handle lies much farther downstream of the termination signal 
than for influenza virus so polyadenylation would not be expected to occur.
Another U rich stretch, in the influenza virus vRNA promoter, has been suggested 
to result in weak interaction of the polymerase to its template and can be mutated to 
result in premature termination (Seong & Brownlee 1992b). In bunyaviruses the 
occurence of U residues may therefore facilitate termination by weakening the 
contacts o f the polymerase to its template which may be supplemented by the 
formation of secondary structures either with the nascent chain interacting with the 
template (Kolakofsky e ta l  1987) or within the new chain at sequences with 
potential to form a stem-loop structure just upstream of the 3' ends of mRNA 
(Kolakofsky & Hacker 1991). This picture is somewhat complicated by the 
occurence in snowshoe hare bunyavirus and Rift Valley fever phlebovirus of a C 
rich termination signal (Ihara e ta l 1985; Collett 1986). The termination consensus 
may thus depend on a short homopolymeric region, not necessarily on a run of U 
residues.
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1.9.7 Bunyavirus nucleocapsids.
As for all negative strand RNA viruses, genomes and complementary replicative 
intermediates are associated with viral proteins as ribonucleoprotein (RNP) 
structures or nucleocapsids. The RNP is the functional template for transcription.
Bunyavirus RNPs are stable in high salt concentrations and can be separated away 
from non-encapsidated viral or cellular mRNAs by centrifugation through 
preformed CsCl density gradients (Obijeski et al 1976). High salt stability is a 
property shared with all other negative strand RNA viruses except influenza virus 
where high salt concentrations dissociate the nucleocapsid protein from the genome 
segments (see Section 1.8.4).
In CsCl density gradients, bunyavirus RNPs band at a density of 1.31g/ml whereas 
naked RNA is found in the pellet (>1.35g/ml). The RNP density is the same as that 
found for paramyxoviruses and rhabdoviruses and tobacco mosaic virus. Applying 
stoichiometries of proteimRNA found for these other nucleocapsids, and taking 
account of the density and of the bunyavirus N protein, it has been estimated 
that one N protein monomer is present for each three nucleotides (Kolakofsky & 
Hacker 1991). However, estimation of protein ratios from SDS-PAGE compared 
to the chemical composition of purified virus, put this figure at one N protein 
molecule per six nucleotides (Obijeski eta l 1976).
Nucleocapsids can be found as circular forms in cells and virus (Samso et al 1975) 
as can deproteinised genomic RNA in vitro (Hewlett et al 1977). The obs^vation 
that genomic RNA had triphosphate at its 5' end (Gentsch et al 197^  and a free 
hydroxyl group at the 3' end (Obijeski et al 1976), suggested that the observed 
circular configuration of RNPs would not be due to covalent linkage and may 
therefore be due to hydrogen bonding. The conserved and complementary 
nucleotides found at the termini of bunyavirus gene segments (Elliott 1990), can 
indeed be found hydrogen bonded in nucleocapsides (Raju & Kolakofsky 1989).
N protein encapsidated bunyavirus RNA is moderately resistant to nuclease 
digestion (Pettersson et. al 1971) but not as resistant as for rhabdovirus or 
paramyxovirus RNPs (Obijeski et al 1976). Another difference is the hydrogen 
bonding potential of the encapsidated RNA. For bunyaviruses, encapsidated 
sequences are sufficiently exposed to base pair with complementary sequences, as 
judged by their sensitivity to RNAse H in the presence of added complementary
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oligonucleotide (Bellocq & K olakofsky 1987). Similar studies using 
paramyxovirus RNPs suggested that these encapsidated RNAs had a greatly 
diminished base pairing potential (Kolakofsky & Hacker 1991). The ability of the 
bunyavirus RNPs to form pan handle structures (Samso et al 1975; Obijeski e ta l  
1976) by complementary base pairing of segment termini (Obijeski e ta l  1980) is 
further evidence of the 'open' nature of the RNP. This latter property is shared with 
influenza virus RNPs as is relative nuclease sensitivity— both properties contrast to 
the non segmented negative strand RNA viruses.
1.9.7.1 Bunyavirus encapsidation signals.
Except in the case of persistent infection of mosquito cells (Hacker e ta l  1989) and 
for a small fraction in BHK cells (Raju & Kolakofsky 1987b), bunyavirus mRNA 
is not encapsidated nor are cellular mRNAs. Encapsidation must therefore 
specifically discriminate between mRNA and genome/antigenome RNA. mRNA is 
3' truncated relative to full length complementary RNA and so would not be 
capable of pan handle formation (Figure 1.9.2). This difference however would not 
account for the differential encapsidation since abnormal antigenomes of La Crosse 
bunyavirus occur which are truncated to the same point as mRNA, have a complete 
5' end but no host derived leader, but which are only found in RNP form (Raju & 
Kolakofsky 1987b). Another unusual transcript which has a capped leader but ends 
as a full length antigenome is mostly found not associated with N protein (see 
Figure 1.9.6).
These observations suggest that the 5' terminal nucleotides are the recognition 
signal for N protein binding and that to function correctly these nucleotides must be 
precisely located at the terminus and not preceeded by the capped leader as found in 
mRNA. As all segments and both polarities of full length RNA are found 
encapsidated, the encapsidation signal must be common to all 5' ends. This 
reasoning implicates at least some of the conserved 11 nucleotides as encapsidation 
signals (see Figure 1.9.1).
53
Chapter 1 RNA viruses and their genetic manipulation.
3 '  cRNA
||( g |( || 3* Unusual cRNA with . v 
mRNA truncation
► 3* Standard  mRNA
Unusual full length cRNA 
with capped leader
Figure 1.9.6 Clues to N protein encapsidation signals from La Crosse virus 
RNAs. In addition to the usual genome antigenome and mRNA, unusual transcripts can be found 
in La Crosse virus infected cells. Among others, two species give a clue to the encapsidation 
signals. One of these (a) is a uuncated cRNA which exists in RNP form and the other (b) is a full 
length cRNA with additional .*>' sequences, normally found only in truncated mRNA, which is 
mostly non encapsidatcd. See text for discussion ruid references.
1.9.8 Reassortment of bunyavirus gene segments.
Having a segmented genome, members of the Bunyaviridae would be expected to 
be able to reassort gene segments during dual infection. In the laboratory, 
coinfection of cells with closely related bunyaviruses can result in a high proportion 
of reassortants amoungst progeny virus (Bishop & Shope 1979; Iroegbu & Pringle 
1981a). The property of segment reassortment has been exploited to assign gene 
products to their segments by comparing the protein profiles of reassortant viruses 
to their gene segment complements (Bishop & Shope 1979). Reassortant viruses 
have also been used to define determinants of in vivo virulence and tissue tropism 
(Beaty et al 1982).
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1.9.8.1 Natural reassortment
For reassortment to occur in nature, dual infection of a single host would be 
necessary. Some examples of naturally occuijmg reassortants have been reported. 
An isolate of La Crosse virus from Minnesota was shown to have the expected 
RNase T1 fingerprints for the L and M segments but had a S segment of clearly 
different origin (Klimas et al 1981). Two distinct bunyaviruses, Shark river and 
Pahayokee viruses had similar L and S segments but had M segments with easily 
distiguishable RNA fingerprints suggesting a divergence by reassortment (Ushijima 
et al 1981). This ability to reassort gives the Bunyaviridae a great evolutionary 
potential as demonstrated by the large number of distinct viruses in the family 
(Karabatsos 1985).
1.9.8.2 Bunyavirus Temperature Sensitive mutants.
Over 200 ts mutants have been isolated, mostly from the Bunyamwera and 
California groups of the Bunyavirus genus (Pringle 1991). These have been useful 
tools to study reassortment and identify the limitations of genome segment 
exchange. Chemical mutagenesis using 5-flurouracil, 5-azacytidine or N-methyl- 
N'nitrosoguanidine has mostly been employed to generate ts mutants (Ozden & 
Hannoun 1978) although spontaneous mutants of La Crosse, snowshoe hare and 
Maguari bunyaviruses have been isolated at frequencies ranging from 1% to 2.7% 
(Gentsch et al 1 9 7 Iroegbu 1981).
Reassortment of gene segments between different ts mutants can result in progeny 
virus with non ts phenotype during dual infection provided that the ts lesions are in 
different segments for the two viruses. For example coinfection by two M segment 
ts mutants could not result in a non ts virus unless molecular recombination 
occuij^d, and no such recombination has been reported. This property has been 
exploited to assign ts mutants to reassortment groups with viruses capable o f  
reassorting with each other to lose their ts phenotype being placed into separate 
groups.
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Having three genome segments, bunyaviruses would be expected to form three 
reassortment groups representing lesions in each of the three segments. However, 
the vast majority of ts mutants fall into only two distinct reassortment groups 
(Pringle 1991). For the bunyavirus genus, of 197 ts mutants, all but ten belong to 
two reassortment groups. Eight of these are so far ungrouped. Of the remaining 
two, a Guaroa virus isolate has been tentatively assigned to a third group (Bishop 
1979) and a Maguari virus, r.vMAG23, is a genuine member of a third group based 
on its ability to reassort with all group I and II Maguari virus mutants and with two 
viruses thought to be double group I/II mutants (Pringle & Iroegbu 1982).
1.9.8.3 Heterologous reassortment in bunyaviruses
Reassortment only occurs between certain members of a serogroup, for example, 
Bunyamwera, Maguari and Germiston bunyaviruses can exchange gene segments 
with each other but not with Guaroa or Main Drain viruses which are also in the 
Bunyamwera serogroup (Pringle 1991). Reassortment does not occur between 
different serogroups such as between the California group of bunyaviruses (e.g. La 
Crosse and snowshoe hare viruses) and the Bunyamwera serogroup (e.g. 
Bunyamwera and Maguari viruses).
Because each virus has a distinguishable protein profile and RNA fingerprint, it has 
been possible to use heterologous reassortment to assign gene products to their 
segments. In general consistent assignments could be made. For some virus 
combinations, segment exchange was not reciprocal or was restricted. Co­
segregation of the L and S segments was often observed. Heterologous 
reassortment has been recently reviewed elsewhere (Pringle 1991) and therefore the 
complex crosses and their sometimes confusing outcomes will not be discussed 
further here except for the case of r.vMAG23 which will be discussed in Chapter 4.
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R easso r tm en t
groups
V'rus ts m u ta n ts  I II III
Bunyamwera
serogroup
Guaroa
Batai
Bunyamwera
Germiston
Maguari
5 1 4 0
8 5 3 0
8 2 6 0
46 12 31 1
13 5 7 1
California
se rog roup
La Crosse 
Lumbo
Snowshoe hare
Tahyna
Triv itta tus
20 6 14 0
17 3 14 0
48 26 20 0
20 1 17 0
12 4 6 0
Table 1.9.2 Temperature-sensitive bunyavirus m utants.T h e Table lists the number of 
ts mutants isolated for each virus and their assignments to each o f three possible reassortment 
groups. Heavily lined boxes group viruses capable of heterologous reassortment. Members of one 
box cannot reassort with those of another even within a serogroup (e.g. Guaroa virus cannot 
reassort with Bunyamwera virus). Temperature sensitive members o f one reassortant group (I,II or 
III) can reassort with members of other reassortant groups to produce non-te progeny by segment 
exchange. (Table modified from Pringle 1991).
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1.9.9 Recombinant Bunyamera virus L protein
Functional Bunyamwera virus L protein has been expressed from cloned cDNA  
(Jin 1991; Jin & Elliott 1991; Jin & Elliott 1992). Two recombinant vaccinia virus 
expression systems were investigated (Jin 1991). The first of these expresses the 
foreign protein constitu tively and to high levels from the vaccinia virus p7 .5  
promoter (Chakrabarti et a I 1985). The second system involves placing the foreign 
gene under control of a bacteriophage T7 promoter in the TK locus of vaccinia 
virus. Expression of the foreign protein is dependent on, and can therefore be 
controled by, coinfection with a second recombinant vaccinia virus, vTF7-3, which 
expresses T7 RNA polymerase (Fuerst e ta l 198^).
Both systems were successful at producing antigenically authentic L protein in vivo 
(Jin 1991; Jin & Elliott 1991). The functionality of the recombinant L protein was 
assessed in an in vivo transcription assay using transfected RNPs. Native 
Bunyamwera virus RNP was isolated from infected cells by CsCl gradient 
centrifugation and transfected into CV1 cells using calcium phosphate. Under these 
conditions, transfection of RNP alone resulted in only very weak signals by 
Northern blot analysis. In the presence of recombinant vaccinia virus expressing L 
protein, the RNPs served as templates for efficient amplification of S segment 
RNA. The use of strand specific probes revealed that both positive and negative 
strand RNA were produced from the RNP templates which were of mixed polarity. 
Metabolic labelling using 35S methionine showed that the transcribed RNA could 
be translated to produce N protein. RNP purified from virus, and therefore 
containing essentially only negative polarity RNA, was also transfected and used as 
transcription template by the recombinant L protein. Both polarities of RNA were 
detected demonstrating replication and implying that newly transcribed RNA could 
be encapsidated in newly synthesised N protein to form template-competent RNPs.
Characterisation of the RNA transcribed and replicated by the recombinant L 
protein demonstrated that the unencapsidated mRNA was primed by capped leaders 
scavenged from the intracellular pool of mRNA as occurs during normal infection. 
The chief difference in the host leaders was that they were unusually AU rich 
compared to those found during Bunyamwera virus infection. This anomaly was 
thought to be due to the abundance of AU rich vaccinia virus mRNAs in the 
cytoplasm. Sequence comparison of some of the leader sequences to the vaccinia 
virus genome suggested that this indeed may be the case (Jin & Elliott 1993). An
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unexplained difference was the heterogeneous tejjnination site of the mRNA 
transcribed by the recombinant L protein.
Expression of functional recombinant L protein was the first direct evidence that the 
L protein of bunyaviruses was the RNA polymerase, before this could only be 
assumed by deduction based on functional assignments to other segments (Elliott 
1990).
1.9.9.1 Mutational analysis of the L protein
The system for expressing functional L protein was modified to enable transient 
expression from plasmid constructs under control of the T7 promoter. The system 
involved U'ansfecting template RNP and L gene-containing plasmids (under control 
of a T7 promoter) into cells which had been infected with vTF7-3 to supply T7 
RNA polymerase (Jin & Elliott 1992). This system enabled mutations to be 
introduced into the L protein which could be tested for in vivo activity without the 
need to create recombinant vaccinia viruses for each mutant.
Four conserved motifs had been identified in RNA dependent RNA polymerases 
(Poch et al 1989) and were found to correspond to regions of similarity noted in the 
Bunyamwera virus L protein and the influenza virus PB1 protein (Elliott 1989b). 
The growing availability of more sequence data from L segments of other members 
of the Bunyaviridae, made sequence alignment of seven members possible and 
revealed highly conserved nucleotides in all four putative polymerase motifs (Jin & 
Elliott 1992). Some of these were mutated and tested for in vivo activity using the 
RNP transcription assay. In general highly conserved nucleotides were essential for 
L protein activity whereas poorly conserved ones were not. An amino acid triplet 
SDD, present in all available Bunyaviridae sequences was mutated to GDN, the 
invariant counterpart found in the RNA polymerases of non segmented negative 
strand RNA viruses. This change abolished activity of the L protein. No attempt to 
systematically mutate all bases of the conserved regions was undertaken but 
important deductions could be made. This report (Jin & Elliott 1992) was the first 
to investigate rationally introduced mutations in the RNA polymerase of any 
negative strand virus and establishes a system of great potential to investigate the 
transcription and replication of bunyaviruses.
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1.10 Aims of project.
The overall goal of the project was to attempt to define conditions under which 
RNA transcribed from cDNA could be replicated by Bunyamwera virus. Two 
approaches were devised to attempt to present the vims with synthetic RNA in a 
form in which it could be recognised as a transcription template. The first o f these 
involved transcribing Bunyamwera virus S segment RNA in vivo in the presence of  
a replicating helper virus. It was hoped that this approach might allow  
encapsidation of nascent RNA into the RNP form required for viral recognition. 
The second approach involved attempts to reconstitute RNP in vitro from synthetic 
RNA and N protein of viral origin. RNP reconstituted in vitro and transfected into 
Bunyamwera virus infected cells might be replicated by the vims.
For the in vivo transcription approach, the project set out to characterise suitable 
helper vims and in vivo transfection systems before attempting rescue of S segment 
RNA derived from cDNA. For the in vitro reconstitution, investigation was aimed 
at determining conditions under which synthetic RNA could associate with N  
protein to reconstitute RNP.
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2.1 M a ter ia ls .
2.1.1. Enzymes.
Restriction endonuclease enzymes, DNA polymerase I and T4 DNA ligase were 
purchased from Bethesda Research Labs (BRL) or Boehringer Mannheim; T7 
DNA polymerase from Pharmacia LKB Ltd; T7 RNA polymerase, RQ1 DNasel 
and RNasin ribonuclease inhibitor from Promega; Vent™ thermostable DNA  
polymerase, T4 polynucleotide kinase, MuLV reverse transcriptase and mung 
bean nuclease from New England Biolabs; calf intestinal phosphatase from 
Boehringer Mannheim; micrococcal nuclease and ribonucease A from Sigma and 
Taq DNA polymerase from Cetus.
2.1.2. Radiochemicals.
With the exception of 14C chloramphenicol which was supplied by DuPont, 
radiochemicals were supplied by Amersham International pic. at the following 
specific activities:
35S-L-methionine approximately 800 Ci/mmol (15pCi/|il)
a .32p_TTp 3 0 0 0  ci/mmol (lO^tCi/pl)
cx-32P-dATP 3,000 Ci/mmol (lO^iCi/pl)
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35S (aS)-dATP >1,000 Ci/mmol (lOpCi/pl)
35S (aS)-CTP >800 Ci/mmol (40pCi/pl)
a - 32P-CTP 400 Ci/mmol (10pCi/pl)
a - 32P-UTP 400 Ci/mmol (lOpCi/pl)
y-32P-ATP >5,000 Ci/mmol (10pCi/|il)
14C chloramphenicol 58.5 mCi/mmol (0.1|iCi/|il)
2.1.3. Synthetic oligonucleotides.
Synthetic oligonucleotides were either produced in house using a Biosearch model 
8600 DNA synthesiser or were gifts from C ruachem Ltd..
2.1.4. Plasmids.
Phagemid cloning vectors pUC118 /  pUC119 (Vieira and Messing, 1987) were 
supplied by Dr. R.M. Elliott. Recombinant plasmids containing full length 
Bunyamwera virus S segment in pUC9 and pUC18 (pUC9BunS+ and 
pUC18BunS-) and a T7 expression construct for synthesis of Bunyamwera virus 
N protein (pTF/BunN) were obtained from A. McGregor of this Institute.
2.1.5. Bacterial and bacteriophage strains.
E. coli strain XL-1 {supE44 h sdR l7 recAl endAl gryA46 thirelAl lac- F-; 
Bullock et al., 1987) was the usual host for the propagation o f recombinant 
plasmids and was also used for the growth o f phagemids. Bacteriophage 
M13K07 supplied by Dr. R. M. Elliott is a derivative of bacteriophage M13 that 
carries a mutated version of gene II, a plasmid origin of replication, and the 
kanamycin resistance gene from Tn903 (Vieira and Messing, 1987). M 13K 07  
was used to rescue single-stranded phagemids from XL-1 host bacterium.
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2.1.6. Bacterial culture media.
The following bacterial culture media were used:
LB-Broth (LB) 
LB-agar:
2 x YT broth:
lOg NaCl, lOg Bactopeptone, 15g yeast extract per litre. 
LB-Broth plus 1.5% (w/v) agar.
5g NaCl, 16g Bactopeptone, lOg yeast extract per litre.
Ampicillin was added at 75|ig/ml to the medium where appropriate.
2.1.7. Cells and tissue culture media.
BHK-21.C-13 cells, a continuous cell line derived from baby hamster kidneys 
(MacPherson and Stoker, 1962), were used for growing Bunyamwera virus in 
Glasgow modified Eagle's medium supplemented with 10% new bom calf serum 
(10% GMEM, Stoker and MacPherson, 1961). GMEM was supplied as a 10 x 
liquid concentrate. This was diluted in distilled water and supplemented with 
5mM L-glutamine, 2.75g/l NaHCC>3 , 100 unit/ml penicillin, 100^ig/ml 
streptomycin and 10% tryptose phosphate broth.
CV-1 monkey kidney cells were grown in Dulbecco's modified Eagle's medium 
(DMEM) containing 5% foetal calf serum.
293 cells, a human cell line transformed by DNA from human adenovirus type 5 
(Graham et al 1977), were grown in DMEM containing 5% foetal calf serum. 
Cells were grown at 37°C under 5% CO2 in a humidified incubator. Routine 
maintenance and ^  of cells was done by Joyce Mitchell of the cytology 
department of this Institute.
2.1.8. Viruses.
Bunyamwera virus, originally isolated from a suckling mouse brain homogenate, 
was obtained from Dr. N. Karabasos (Vector-borne Diseases Laboratory, Centre 
for Disease Control, Fort Collins, Colorado, USA.) and subsequently triple­
plaque purified in BSC-1 cells by Prof. C.R. Pringle in this Institute. The 
temperature sensitive mutants of Maguari vims (ts6, t s l l  and ts23) were isolated 
by C.U. Iroegbu (Iroegbu and Pringle, 1981a).
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vTF7-3, a recombinant vaccinia virus which expressed T7 RNA polymerase was 
obtained from Dr. B. Moss (Fuerst e ta l  1986). Vaccinia virus WR strain was 
obtained from Dr. A. Patel of this Institute.
2.1.9. Antiserum.
Anti-Bunyamwera virus antiserum (Watret, 1985) was obtained from Dr. R.M. 
Elliott.
2.1.10. Commonly used solutions.
Agarose gel loading buffer: 0.25% bromophenol blue, 0.25% xylene cyanol,
30% glycerol.
10 x EM buffer: 0.05M sodium borate, 0.1M sodium sulphate,
2 x RNA gel sample buffer: 20% glycerol, 0.05% bromophenol blue, 2 x EM
buffer.
0.01M EDTA, 0.15M boric acid.
Carrier DNA: lOmg/ml salmon sperm DNA, autoclaved and 
stored at -20°C.
50 x Denhart's solution: 1% polyvinylpyrrolidone, 1% BSA (Pentex
fraction V), 1% Ficoll.
Giemsa stain: 1.5% Giemsa in glycerol, heated to 50°C for 2 hr 
and diluted with an equal volume of methanol.
5% milk: 5% dried non-fat milk in water and stored at -20°C.
PBS: 170mM NaCl, 3.4mM KC1, lOmM H P04, 
1.8mM KH2P 0 4, pH 7.2, 6.8 mM CaCl2, 
4.9mM MgCl2
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Protein dissociation mix: lOOmM Tris-HCl pH 6.8, 4% SDS, 
200mM p-mercaptoethanol, 20% glycerol. 
0.2% bromophenol blue,
RNase A solution: lOmg/ml pancreatic RNase A in lOmM Tris-HCl, 
pH 7.5, 15mM NaCl, heated at 100°C for 15 min 
to inactivate DNases, cooled and stored at -20°C.
Sequencing gel mix: 6-12% acrylamide / bisacrylamide (57:3), 8M urea, 
1 x TBE.
20 x SSC: 
20 x SSPE:
3M NaCl, 3M trisodium citrate.
3M NaCl, 0.18M NaH2P 0 4, 20mM EDTA, pH 
7.4.
TAE:
TBS+ buffer:
40mM Tris-acetate, pH 8.0, 1 mM EDTA.
25mM Tris-HCl, pH 7.4, 135mM NaCl, 50mM 
KC1, 0.01% CaCl2, 0.01% MgCl2.
TBE: 90mM Tris-HCl, 90mM boric acid, ImM EDTA, 
pH 8.
TE: lOmM Tris-HCl, pH 8, ImM EDTA.
2.1.11 Miscellaneous materials.
Dialysis membrane (Medical International Ltd.).
Tissue culture disposable plasticware (Gibco Ltd.; Sterilin Ltd.). 
Hybond N nylon blotting membrane (Amersham).
Gene Clean DNA purification kit (Bio 101).
Qiaex DNA purification kit (Qiagen).
RNaid RNA purification kit (Bio 101).
X-omat S film for autoradiography (Kodak Ltd.).
Disposable plastic reaction vials & pipette tips (Scotlab).
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2.2 DNA cloning procedures.
2.2.1 Large scale preparation and purification o f plasmid DNA.
Single colonies of the appropriate E. coli strain were picked from agar plates and 
inoculated into 10ml aliquots of 2 x YT broth, containing 75pg/ml ampicillin, and 
incubated overnight at 37 °C in a shaking incubator.
Supercoiled plasmid DNA was purified on caesium chloride /  ethidium bromide 
gradients as described by Maniatis et al. (1982). A 5ml overnight culture was 
inoculated into 300ml of LB-broth in a 2-litre flask (containing 75pg/m l of  
ampicillin where appropriate) and shaken for 20 hours at 37°C. Following 
centrifugation of the cultures at 3,000 rpm (Sorval GS3 rotor) for 10 minutes at 
4°C, the bacterial pellet was by washed by resuspending it in 10ml o f TE buffer 
and repelleting in the SS34 rotor at 3,000 rpm for 10 minutes at 4°C. The pellet 
was resuspended in 8ml of 50mM glucose, 250mM Tris-HCl pH 8 and 12mM 
EDTA containing 5pg/ml lysozyme, and was incubated for 5 minutes at room 
temperature before lysing the cells by the addition o f 16ml o f 0.2N NaOH/1% 
SDS (freshly made). The mixture was incubated for 10 minutes on ice followed 
by addition of 12ml of ice-cold 5M potassium acetate pH 4.8, and a futher 10 
minute incubation on ice. Following centrifugation at 8,000 rpm (Sorval SS34 
rotor) for 15 minutes at 4°C, the supernatant was transferred to Corex tubes and 
the plasmid DNA precipitated by the addition of 0.6 volumes of isopropanol for 
15 minutes at room temperature followed by centrifugation at 8,000 rpm for 15 
minutes at 15°C. The DNA pellet was washed with 70% ethanol, air-dried and 
resuspended in 10ml TE pH 8.0. lOg of caesium chloride and 1ml of a 10 mg/ml 
solution of ethidium bromide was added to the DNA solution giving a final 
density of 1.55 to 1.60 g/ml. The solution was then transferred to a Ti 50 heat- 
sealable centrifuge tube and centrifuged at 40,000 rpm (Beckman Ti 65 or 50 
rotor) for 36 hours at 15°C. The plasmid DNA appeared as a red band (due to the 
intercalated ethidium bromide) and was removed from the gradient using a needle 
and syringe through the side of the tube.
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Up to seven extractions with an equal volume o f isoamyl alcohol (equilibrated 
with 5M NaCl) were carried out to remove the ethidium bromide. Following 
dilution of the solution with 3 volumes of water to prevent precipitation of CsCl, 
the DNA was precipitated by adding 2 volumes o f ethanol. Following 
centrifugation at 6,000 rpm (SS34 rotor) for 10 minutes, the DNA pellet was air- 
dried, dissolved in water and stored at -20°C. The concentration of the plasmid 
DNA preparation was determined by measuring the absorbance o f the solution at 
260nm and assuming 1 A26o= 50(ig/ml for a 1cm light pathlength cuvette.
2.2.2. Small scale preparation of plasmid DNA.
Single colonies o f transformed E. co li strain XL1 were picked from 
transformation plates using a cocktail stick and inoculated into 2ml aliquots of 2 x 
YT broth containing 75pg/ml of ampicillin and cultures were grown overnight at 
37°C with shaking. The bacterial cells from ~ 1.4ml o f culture were pelleted (in 
1.5 ml Eppendorf tubes) for 1 minute and the supernatant removed by aspiration. 
The pellet was resuspended in lOOfil o f an ice-cold solution containing 50mM 
glucose, 25mM Tris-HCl pH 8, lOmM EDTA and incubated on ice for five 
minutes. The bacterial cells were then lysed by the addition o f 200pl of 0.2N  
NaOH/1% SDS. After 5 minutes at room temperature, 150pl o f 5M potassium 
acetate (pH 4.8) was added to the tubes and incubation continued for a further 5 
minutes. The supernatant produced following centrifugation for 5 minutes at
13,000 rpm in a microfuge, was extracted with phenol /  chloroform and ethanol 
precipitated to yield a pellet containing plasmid DNA. This was washed with 70% 
ethanol, dried briefly under vacuum and dissolved in 40pl of water.
2.2.3 Restriction enzyme digestion of DNA.
Appropriate restriction enzymes were used at 1 unit per pg DNA in buffers 
supplied by the manufacturers (BRL or Boehringer Mannheim). Restriction digest 
analysis of small scale DNA preparations used 5fil of DNA, digested in a 10pl 
reaction volume containing 20p.g/ml RNase A. Digestions were for 1-4 hours at 
37°C after which DNA fragments were separared by electrophoresis on agarose 
gels.
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2.2.4. Agarose gel electrophoresis of DNA.
Electrophoresis of DNA was performed on horizontal slab gels (14 x 11 x 0.5 cm, 
BRL gel electrophoresis apparatus Model H5, of 5.7 x 8.3 x 0.3 cm, BRL gel 
electrophoresis apparatus Horizon 58). 1% (w/v) agarose in 1 x TBE or 1 x TAE 
containing 0.5 pg/ml ethidium bromide was used. DNA samples were loaded to 
the gel in 5% (v/v) glycerol, 0.05% (w/v) bromophenol blue, 0.05% (w/v) xylene 
cyanol. Electrophoresis was carried out at 50-100 V in 1 x TBE or 1 x TAE 
containing 0.5 pg/ml ethidium bromide.
2.2.5. DNA purification from agarose gels by silica  matrix 
adsorption.
DNA fragments produced by restriction enzyme digests and PCR reactions were 
separated by electrophoresis through 1% agarose TAE gels containing 0.5|ig/ml 
ethidium bromide. Long wave UV illumination allowed visualization of the DNA  
bands. Two commercial kits, Geneclean (BIO 101 Inc, La Jolla, CA) and Qiaex 
(Qiagen Inc, Chatsworth, CA), were used for retrieval o f DNA from agarose 
blocks excised from the gels. Both kits contain a silica matrix that binds DNA in 
the presence of high concentrations of sodium iodide (Vogelstein & Gillespie, 
1979). Blocks containing the required DNA fragments were excised from 1 x 
TAE agarose gels and mixed with 3 volumes o f saturated Nal solution and 
incubated for 5 minutes at 55°C until the agarose had completely dissolved. Silica 
matrix was added (5jil for up to 5pg of DNA) and the mixture incubated for 5 
minutes on ice to allow the DNA to bind to the matrix. Following a 5 second 
microcentrifuge spin, the pellet (containing DNA bound to silica particles) was 
washed with buffers supplied with the kits. For Geneclean three washes were 
performed by repeated resuspension / centrifugation cycles using ’NEW' wash (a 
Tris-buffered mixture of NaCl, ethanol and water). For Qiaex, two washes in 8M 
NaC1 0 4  followed by two washes in buffer QX3 (70% ethanol, lOOmM NaCl, 
lOmM Tris/HCl, ImM EDTA, pH7.5) were used. For both kits, the DNA was 
eluted from the silica matrix by resuspending the pellet in 2 0 |i l water and 
incubating for 2 minutes at 55°C. After a short centrifugation, the DNA solution 
was removed and stored at -20°C.
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In general the Qiaex kit was used for fragments <500bp which were not efficiently 
recovered using the Geneclean kit. For larger fragments Geneclean was used as it 
involved slightly simpler wash steps.
Both kits were also used to purify DNA away from enzymes, oligonucleotides 
and other unwanted buffer components. For this application electrophoresis was 
not required.
2.2.6. End repair and DNA ligation.
DNA fragments (0.1 |ig) and vector DNA (0.01-0.05 jig), which had been 
digested previously with the appropriate restriction enzyme(s), were ligated 
together in a 20pl mixture containing 0.1M Tris-HCl pH 7.4, 50mM MgCl2, 
ImM spermidine, ImM ATP, 100|ig/ml BSA and 1 unit of T4 DNA ligase for 16 
to 24 hours at room temperature.
For blunt end DNA ligations, DNA fragments with sticky ends were converted to 
blunt ends by incubating the DNA fragment (up to lfig) in a reaction buffer 
containing 33mM Tris. OAc pH 7.9, 6 6 mM KOAc, lOmM MgCh, 0.5mM DTT, 
0.1 mg/ml BSA, 0.2mM of each dNTP, O.lmM ATP and 3 units of T4 DNA  
polymerase for 30 minutes at 37°C. Following phenol /  chloroform extraction, the 
DNA was resuspended in 20|il of NT buffer with 0.2mM dNTPs, and incubated 
with 1 unit of Klenow fragment of DNA polymerase I for 30 minutes at 20°C. 
The DNA was again phenol /  chloroform extracted before ethanol precipitation 
and resuspension in 20pl of water. Ligation was carried out as above except that 
the ATP concentration was reduced to 0.05mM.
2.2.7. Preparation of competent bacterial cells.
0.5ml of an overnight E. coli culture was diluted into 50ml of 2 x YT broth in a 
250ml flask and shaken for approximately 2  hours at 37°C until the culture OD550 
reached 0.2. The bacterial cells were harvested by centrifugation at 3,000 rpm for 
10 minutes, the pellet was gently resuspended in 10ml of 0.1M CaCl2 and placed 
on ice for at least 20 minutes. The suspension was centrifuged at 3,000 rpm for 5 
minutes and the pellet resuspended in 3ml o f 0 . 1M CaCh. The resulting 
competent bacterial cells were either used directly for transformation or were 
stored for up to 48 hours at 4°C.
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2.2.8. Transformation.
200|il of competent cells were incubated with half of a ligation reaction (10|il) for 
60 minutes on ice, followed by a 1 minute 42°C heat shock to allow uptake of the 
ligated DNA by the E. coli cells. The reaction tube was returned to the ice bath, 
0.5ml of 2 x YT broth added and the cells incubated for a further 60 minutes at 
37°C. The cells were then plated onto LB agar, containing 75|ig/ml ampicillin, 
and incubated for 12 to 20 hours at 37°C to allow single colonies to form. For 
vectors containing the LacZ gene, 20pl of lOOmM IPTG and 20|il of 2mg/ml X- 
Gal was added to the cells before plating out to allow blue/white colour selection 
of recombinants.
2.2.9 Purification of synthetic oligonucleotides.
Synthetic oligonucleotides were produced by the phosphoramidite method and 
supplied in ammonium hydroxide; heat treatment for 5 hours at 55°C removed the 
base protecting groups and the ammonia was removed by lyophylisation. The 
oligonucleotide pellet was dissolved in 0.2ml of water and loaded in 95% 
formamide onto an 8% or 12% polyacrylamide gel containing 8M urea. The gels 
were viewed under UV light following electrophoresis and oligonucleotide bands 
were visualized as dark shadows against a fluorescent thin-layer chromatography 
plate. Gel slices containing the full length oligonucleotide species were excised 
with a scalpel blade and eluted in 1-2 ml of water at 42°C overnight with shaking. 
Supernatants were transferred to Spin-X centrifuge units (COSTAR) which 
contain a 0.45|im cellulose acetate filter in a microfuge tube. Centrifugation for 2 
minutes in a microcentrifuge removed the acrylamide gel pieces, the 
oligonucleotides in the filtrate were then precipitated with 3 volumes o f ethanol in 
the presence of 0.2M NaCl overnight at -20°C. The oligonucleotide pellets were 
washed with 70% ethanol, dried under vacuum and dissolved in water. 
Spectrophotometry was used to quantify the concentration of the oligonucleotide 
solutions, assuming that an 1 A26o= 20pg/ml for a 1cm pathlength cuvette.
An alternative rapid deprotection/purification method (Cruachem technical bulletin 
no. 41; Sawadago & Van Dyke 1991) was employed for oligonucleotides to be 
used for PCR primers. 50|il of triethylamine was added to 1ml oligonucleotide in
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ammonia (as supplied). Deprotection could then be achieved by heating to 80°C 
for 30 minutes instead of 5 hours at 55°C. Instead of lyophilisation, ammonia was 
removed by precipitating the oligonucleotide by the addition of 9 volumes of dry 
butan-2-ol followed by centrifugation at 13,000 rpm for 1 minute in a microfuge. 
The oligonucleotide pellet was resuspended in lOOpl o f water and butanol- 
precipitated a further three times to remove the last traces of ammonia. The final 
oligonucleotide pellet was resuspended in water and diluted appropriately for use 
in PCR reactions without further treatment. In general -1 /5 ,000th of a complete 
0.2 pinole column synthesis was used per PCR reaction giving between 40  
picomoles (theoretical 100% recovery) and 10 picomoles (25% recovery). If 
problem s were encountered, concentrations were re-determ ined  
spectrophotometrically.
2.2.10 Polymerase chain reaction (PCR) amplification of DNA.
PCR primers were typically 15-30 nucleotides long. 10-50 picomoles of each 
primer were used in reaction volumes rang mg from lOjil to 50pl. When plasmid 
DNA was used as template, triplicate reactions were set up containing -1 0 ,1  and 
0.1 ng of template. Further replicates allowed reactions to be halted after different 
numbers of cycles to minimise the number of copying steps and so reduce the 
possibility of accumulating point mutations. Standard reactions (Innis et al 1990) 
contained, in addition to primers and templates (above): 50mM KC1,20mM Tris- 
HCl pH 8.4 at 25°C, 2.5mM MgCl2, 1 mg/ml BSA, 200pM dNTPs and 1 unit of 
Taq thermostable DNA polymerase. Reactions were overlaid with 1 drop of 
mineral oil and cycled for between 10 and 30 PCR rounds. Typical cycling 
parameters were duplex melting at 94°C for 30 seconds, primer annealing at 54°C 
for 30 seconds and primer elongation by Taq polymerase at 72°C for 1 minute. 
These conditions were altered empirically where improvement was required. 
Reactions were performed either in the Cambio Intelligent Heating Block or the 
Perkin-Elmer DNA Thermal cycler 460.
2.2.11 Coupled reverse transcription/PCR for cDNA amplification 
starting from RNA.
The following protocol for coupled reverse transcription/PCR was devised by 
combining methods based on Kawasaki and Wang (1989). Template RNA was 
purified from pelleted virus by two phenol extractions. Following ethanol
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precipitation and resuspension in water, the RNA was added to the standard PCR 
mix (above) along with 20 units of placental ribonuclease inhibitor ('RNasin'—  
Promega), and 100 units MuLV reverse transcriptase (NEB). For bunyavirus S 
segment amplification two 15mer primers were used which anneal to the 3' ends 
of positive and negative strand S segment RNA (5' AGTAGTGTACTCCAC and 
5’ AGTAGTGTGCTCCAC) The reaction was overlaid with mineral oil and 
incubated at 42°C for 45 minutes before being cycled (30 rounds 94°C for 30 
seconds, 54°C for 30 seconds and 72°C for 1 minute). The products o f the 
amplification were separated by 1% TAE agarose gel electrophoresis.
2.2.12 Cloning of PCR-generated DNA fragments.
DNA fragments were retrieved from agarose gels as described in Section 2.2.5. 
Prior to ligation into suitably cleaved vector DNA, the fragments were treated to 
ensure the ends were flush and to add a phosphate group to the 5' ends in order to 
allow ligation. The end-repair/kinasing steps were combined into a single 
reaction. The DNA fragment was added to a reaction mix containing 50mM Tris- 
acetate pH7.8, 50mM KOAc, lOmM MgCl2 , ImM DTT, 200mM each dNTP, 
ImM ATP, 1 unit of T4 DNA polymerase and 5 units of polynucleotide kinase. 
After incubation at 37°C for 30 minutes the DNA was purified by binding to silica 
matrix and ligated to Smal cut vector, transformed to XL1 E. coli cells and plated 
onto LB-agar plates containing 75|ig/ml ampicillin.
2.3 DNA sequence determination.
2.3.1 Preparation of ssDNA templates from phagemid vectors
10ml cultures of E. coli strain XL1 harbouring phagemid vectors (pUC118 or 
pUCl 19) containing cloned inserts were grown in 2 x YT broth for two hours at 
37°C in the presence of 75pg/ml ampicillin to maintain the vector. Helper phage 
M 13K07 was then inoculated into each universal and shaken for lhr at 37°C 
before addition of Kanamycin to select cells infected with M 13K07. Incubation 
was continued at 37°C with shaking, overnight. After growth, the cultures were 
transferred to 1 2 ml reaction tubes and centrifuged for 5 minutes at 3,000 rpm 
(Sorval SM24 rotor) at 4°C. The supernatant was removed to a fresh tube and
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1.5ml of 20% PEG / 2.5 M NaCl solution added, mixed and incubated for 15 
minutes on ice. After centrifugation for 10 minutes at 8,000 rpm, the supernatant 
was removed by aspiration using a drawn-out Pasteur pipette; followed by 
removal of any remaining traces of PEG by centrifugation and aspiration. The 
visible pellet, containing single stranded phagemid vector packaged into M l 3-like 
particles by M 13K07, was resuspended in 500|il of water and twice extracted 
with 500|il of TE-saturated phenol followed by a single chloroform extraction. 
The upper phase was transferred to a fresh tube and the DNA was ethanol 
precipitated and dissolved in 1 0 0  p.1 of water.
The procedure could be scaled down to use microcentifuge tubes. This produced 
sufficient template for 1 or 2 sequencing reactions. The use of the SM24 rotor 
method provided sufficient template for at least 10  sequencing reactions and 
allowed processing of 24 tubes per spin instead o f 12 for the microcentrifuge 
based method.
2.3.2. Dideoxynucleotide sequencing reactions.
The dideoxynucleotide chain termination sequencing method (Sanger et al., 
1977), according to the protocol of Pharmacia LKB, was used to determine DNA  
sequence from single stranded phagemid vector DNA templates.
10(il of single stranded DNA (approx 2-10 |ig), was mixed with 2\i\ of 
sequencing oligonucleotide primer (0.8jxM) and 2|il of annealing buffer (200mM 
Tris-HCl, lOOmM MgCl2 , 250mM NaCl, pH 7.5). Annealing reactions were 
carried out for 10 minutes at 60°C followed by incubation for 10 minutes at room 
temperature. For labelling, 6 pl of enzyme premix (5 |xCi of a -32P-dATP at 3,000 
Ci/mmol, or a - 35S-dATP at >1,000 Ci/mmol, 0.57|iM  each dGTP, dCTP and 
TIP, and 3 units of T7 DNA polymerase) was added to the annealed DNA/primer 
and incubated for 5 minutes at room temperature. Each reaction was divided into 
four wells of a prewarmed (37°C) 96 well reaction plate (Nunc) for the four chain 
termination reactions. For each 1/4 reaction, 2.5p.l of termination mix (150|iM  
each of the 4 dNTPs, 15|iM of the required ddNTP chain terminator) was pipetted 
into the relevant well, mixing was achieved by centrifugation at 1 ,0 0 0  rpm for 10  
seconds. The plate was incubated for 5 minutes at 37°C, 5 |il o f stop solution 
(95% formamide, 20 mM EDTA, 0.05% bromophenol blue, 0.05% Xylene 
cyanol) was added to each well, and the plate was heated for 2 minutes at 80°C 
immediately before loading onto a 6 % sequencing gel.
73
Chapter 2: Materials and Methods.
2.3.3 End-labelling of sequencing primers
When sequence close to the primer binding site was to be determined, the 
sequencing primer was labelled at the 5' end to allow terminations immediately 
following the primer to be detected. The labelling reaction was omitted if end 
labelled sequencing primer was used. End labelling was achieved by incubating 
lOpmole of primer in a 20|il reaction containing lOpmole y-32P ATP (5|il at 
lOmCi/ml, 5,000Ci/mmole) and 5 units o f polynucleotide kinase in lx  kinase 
buffer (50mM Tris pH 7.5, lOmM MgCl2, 5mM DTT and ImM spermidine) The 
reaction was incubated at 37°C for 10 minutes before being heated to 90°C for 2 
minutes to inactivate the enzyme. The reaction was used without further treatment 
(2|il containing 1 picomole of end labelled primer, per template). Excess labelled 
primer was stored for up to 2 weeks at -20°C. Annealing was performed as for 
the standard sequencing reaction but the labelling step was omitted. Annealed 
template/end labelled primer was then used directly in the termination reactions.
2.3 .4  Denaturing electrophoresis o f the products o f  DNA  
sequencing reactions.
6 % acrylamide sequencing gel mix was made by dissolving 480g urea, 57g 
acrylamide and 3g bisacrylamide in 800ml of distilled water. The solution was 
deionised by stirring with Amberlite ion exchange resin for 30 minutes and then 
filtering through Whatman 3MM filter paper. 100ml of 10 x TBE was then added 
and the volume adjusted to 1 litre with water.
The BRL model S2 electrophoresis apparatus (44.5 x 42.2 x 21.6 cm) was used 
to run sequencing gels. One pair o f glass plates (one is 2 cm shorter) were 
siliconized and assembled with one spacer (0.4 mm thick) on each side. 70ml of 
6 % sequencing gel mix was used for one gel and poured between the sealed plates 
immediately after having added the ammonium persulfate and TEMED to 0.1%. 
The smooth interface was formed by inserting the flat edge o f the sharkstooth 
comb between the plates to a depth o f 2-3 mm below the short plate. The gel 
sandwich was assembled in the gel apparatus and the comb inserted between the 
plates until it just made contact with the surface o f the gel. Sequencing reactions 
(2 -2 .5 |il) were loaded using a 'crystal tip' fitted to a 10|il Eppendorf pipette.
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Electrophoresis was performed at 60-80 watts for 2—4 hours and the smaller 
plate was carefully removed from the gel. The gel was transferred to a sheet of 
Whatman 3MM paper, covered with 'cling film' and dried on a vacuum gel drier. 
The cling film was removed and the gel exposed to X-ray film for several hours 
for 32P labelled DNA, and 1-3 days for 35S labelled DNA.
2.4 Virus Culture.
2.4.1. Bunyamwera virus growth and titration.
BHK-21, clone 13, cells (MacPherson and Stoker, 1962) were used for growing 
Bunyamwera virus stocks. Confluent BHK-21 cells grown in 10% GMEM in 
80oz roller bottles were infected with Bunyamwera virus at multiplicity of 0.01 
pfu/cell and incubated at 31°C for 2-3 days. The culture fluids were harvested and 
clarified by centrifugation at 3,000 rpm for 15 minutes (Sorval GS3 rotor). The 
clarified fluids were aliquoted and stored at -70°C and used virus stocks without 
further purification.
Virus was titrated by plaque assay (Iroegbu and Pringle, 1981a). Ten-fold serial 
dilutions of virus stocks were made in PBS/2% serum. The growth medium was 
removed from confluent BHK monolayers in 50 mm dishes and 0.1ml of diluted 
virus was added to each dish. The dishes were incubated at 31°C or 37°C for 1 
hour to allow the virus to adsorb to the cells. The inoculum was removed and the 
cells overlaid with Eagle's medium supplemented with 2% calf serum containing 
0.6% agarose. The dishes were incubated at 31°C for 3 -5  days. The cell 
monolayers were fixed with 1% glutaraldehyde in PBS for 2 hours and plaques 
were counted after Giemsa staining.
2.4.2 Growth and titration of vaccinia viruses
Crude stocks of vaccinia viruses were grown as described by Macket e ta l  (1985). 
A single plaque was picked and used to inoculate an almost confluent monolayer 
of CV-1 cells grown in a small (25cm2) flask. After growth for 48 hours at 37°C 
the supernatant was harvested and used as seed stock to grow working stocks.
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Large flasks (150cm2) containing almost confluent monolayers were infected with 
seed stock using 1/16 of the supernatant from a 25cm2 infected monolayer per 
large flask. After virus adsorption for 1 hour, DMEM containing 5% foetal calf 
serum was added and the flasks incubated at 37 °C for 48 hours. The infected cells 
were then scraped into the tissue culture medium and pelleted by centrifugation
3,000 rpm for 5 minutes (Sorval SS34 rotor). The pellet was resuspended in 
lOmM Tris-HCl pH9 at a rate of 2ml per large flask. The cell associated virus was 
released by three cycles of freeze/thawing and the nuclei removed by centrifuging 
at 1,000 rpm for 5 minutes. The supernatants were titrated by plaque assay on 
CV-1 cell monolayers and stored at -20°C for use as working stocks of vaccinia 
virus.
2.5 Bunyamwera virus RNP purification and analysis.
2.5.1. Preparation of Bunyamwera virus nucleocapsids (RNP).
The method was based on Leppert et al. (1979). Bunyamwera virus infected cells 
were scraped into the medium and pelleted by centrifugation at 3,000 rpm for 30 
minutes in a 50ml Falcon tube. The cell pellet was suspended in cold lysis buffer 
(0.15M NaCl, 0.05M Tris-HCl pH 7.5, 0.6% NP-40) using 2ml per roller bottle 
of infected cells. The suspension was incubated on ice for 5 minutes before being 
vortexed for 2 minutes to break open the cells. Nuclei and cell debris were 
pelleted by centrifugation at 4,000 rpm (Sorval SS34 rotor) for 10 minutes at 4°C. 
EDTA was added to the supernatant to give a final concentration of 6 mM. Up to 
5ml of extract was loaded onto each CsCl gradient.
The preformed continuous CsCl gradient contained 6  ml of 20-40% (w/w) CsCl 
overlaid with 2ml of 5% (w/v) sucrose in 50mM NaCl, 25mM Tris-HCl pH 7.5, 
in a TST41 centrifuge tube. Nucleocapsids were separated by centrifugation at
32,000 rpm (TST41 rotor) overnight at 12°. After centrifugation, the nucleocapsid 
band was visible in the middle of the gradient and was harvested with a needle 
and syringe through the side of the tube. CsCl was removed by dialysis against 
three llitre volumes of 50mM NaCl, 25mM Tris pH7.5 and ImM EDTA allowing 
1 hour between changes. RNP preparations were stored at -20°C.
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2.5.2 Micrococcal nuclease treatment o f Bunyamwera virus RNP.
This method was used by Seong and Brownlee (1992a) for production of 
influenza virus proteins capable of transcribing synthetic influenza virus-like RNA 
in vitro. Bunyamwera virus RNP was dialysed against 50mM Tris-HCl pH8 , 
50mM NaCl and ImM CaCl2. RNP (50pg protein content) was added to a 
reaction containing 25mM Tris HC1 pH8 , 25mM NaCl, ImM CaCl2 and 5 units 
of micrococcal nuclease (Sigma). Digestion was for 5 hours at room temperature 
after which time the nuclease was inhibited by addition o f EGTA to 5mM 
(Cautrecasas et al 1967; Pelham & Jackson 1976). For each batch, degradation of 
the RNA to smaller fragments was confirmed by Northern analysis using S 
segment specific probes. The nuclease treated RNP preparations were 
supplemented with 20% glycerol and stored at -20°C prior to use in in vitro 
reconstitution studies.
2.5.3 In vitro Bunyamwera virus RNP reconstitution.
Micrococcal nuclease treated Bunyamwera virus RNP was mixed with RNA  
transcribed in vitro from the relevant plasmid constructs using T7 RNA  
polymerase. l|ig  (protein content) digested RNP was incubated with 50-100ng of 
RNA at 30°C for 1 hour followed by incubation on ice for a further 1 hour 
(method based on Seong & Brownlee (1992a)). Reconstituted RNP was then 
either transfected into cells for expression studies or analysed by CsCl gradient 
centrifugation.
2.5.4 Fractionation of CsCl gradients.
To monitor reconstitution of synthetic RNP containing radiolabelled RNA, 
reactions were centrifuged through preformed 20-40%  CsCl gradients as 
described in Section 2.5.1, fractionated and the radioactivity o f each fraction 
determined by liquid scintillation counting. After centrifugation, a capillary tube 
with flexible tubing attached, was inserted through the gradient from the top of the 
tube until its open end was just above the base of the tube. The capillary was held 
firmly in this position using modelling clay. The tubing attached to the glass 
capillary was fed through a peristaltic pump which was then used to remove the
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gradient from the bottom upwards. Fractions were collected into Eppendorf tubes. 
Typically each fraction contained ~150pl (6-10 drops). A  portion of each fraction 
(20-50^1) was removed to scintillation vials containing 5ml Ecoscint water- 
compatible scintillation fluid and the radioactivity of the sample determined using 
the appropriate channel of the scintillation counter.
The density of each fraction was determined by refractometry. 20|il samples were 
pipetted onto the glass stage of a refractometer and the edge o f the refraction 
shadow aligned with the graticule before reading the refractive index from the 
scale. This figure was converted to density for CsCl solutions by consulting the 
appropriate data tables (Dawson e ta l  1986).
2.6 Introduction of nucleic acid into mammalian cells.
2.6.1 Liposome mediated transfection
A commercially available liposome preparation, Transfectace™ (BRL), was used 
for transfection of DNA, RNA and the products o f in vitro  reconstitution 
reactions, into cells. Confluent monolayers of cells were washed once with Opti- 
MEM™ (Gibco) low serum medium prior to application of the transfection mix. 
Nucleic acid (0.5-5p,g) was diluted to 250|il in Opti-MEM and combined with 
separately diluted Transfectace (10-50|ig  diluted to 250pl opti-MEM). The 
mixture was incubated at room temperature for 15 minutes before addition to the 
cell monolayers (0.5ml per 35mm dish). After 4 hours, 2ml DMEM containing 
5% serum was added and incubation continued for a further 20-48 hours before 
harvesting the cells for analysis.
2.6.2 DEAE dextran mediated transfection.
For transfection of the products of in vitro RNP-reconstitution reactions the 
DEAE dextran transfection method, as used for transfection o f influenza virus 
synthetic RNP (Luytjes et al 1989), was used. 35mm dishes containing semi­
confluent cell monolayers (-5X105 cells) were washed with PBS and treated for 
30 minutes at room temperature with 1ml of a solution containing 300pg/ml 
DEAE dextran, 0.5% DMSO and O.lmg/ml gelatin in PBS. Reconstituted RNP
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was diluted to 200|il in PBS containing O.lmg/ml gelatin and 80 units RNasin 
(promega). This mixture was added to the cell monolayer after removal of the 
dextran/DMSO solution. Following incubation at 37°C for 1 hour, the solution 
was removed and DMEM containing 5% serum added. Incubation was continued 
at 37°C for 20-48 hours until the cells were harvested.
2.6.3 Calcium phosphate mediated transfection.
Transfection of in vitro reconstituted RNP was also attempted by the calcium 
phosphate method used by Jin and Elliott (1991) for transfection of Bunyamwera 
virus nucleocapsids. Almost confluent cell monolayers (~106 cells per 35mm 
dish) were washed with TBS+ (25mM Tris-HCl pH 7.4, 135mM NaCl, 50mM 
KC1, 0.01% CaCh, 0.01% MgCl2). In vitro RNP reconstitution reactions (up to 
50|il) were diluted to 250|il in transfection solution containing 140mM NaCl, 
5mM KC1, 0.75mM Na2HPC>4 • 2 H2O, 6 mM dextrose, 25mM HEPES buffer pH 
7.05, and 125mM CaCl2. This mixture was applied to the cell monolayers and 
incubated at room temperature for 30 minutes. 2ml of DMEM containing 5% 
foetal calf serum was then added and incubation continued a further 4 hours at 
37°C. The supernatant was then removed and the cells were shocked with 10% 
glycerol (in TBS+) for 1 minute. After two washes with TBS+, 2ml of DMEM 
containing 5% serum was added and the cells incubated at 37°C until they were 
harvested.
2.7 RNA manipulations.
2.7.1 T7 RNA polymerase in vitro  transcription.
For synthesis of jig quantities of RNA for RNP reconstitution experiments ~ l|ig  
of linearised plasmid DNA was mixed with the following components in a final 
volume of 50|il: ImM each ATP, GTP, CTP and UTP, 20 units placental 
ribonuclease inhibitor (RNasin), 50 units of T7 RNA polymerase (Promega) and 
a buffer containing lOmM DTT, 6 mM MgC^, 2mM spermidine, lOmM NaCl and 
40mM Tris-HCl pH 7.5. Trace quantities of a 32P CTP, a 32P UTP or 35S (aS) 
CTP (~0.5|iCi) were included to enable quantification o f RNA (by % NTP
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incorporation calculated according to the ratio of TCA precipitatable/total counts) 
and for analysis of reconstituted RNP by CsCl gradient fractionation (see section
2.5.4). The transcription reaction was incubated for 1-2 hours at 37°C before 1 
unit of DNasel (Promega) was added and incubation continued for a further 15 
minutes to degrade the DNA template. The reaction was phenol extracted and 
chloroform extracted once to remove enzymes. 0.5 volumes of 7.5M ammonium 
acetate was added to the supernatant followed by 2.5 volumes o f ethanol. The 
RNA was precipitated on dry ice for 15 minutes and pelleted by centrifuging at
13,000 rpm in a microfuge for 10 minutes. The RNA pellet was rinsed with 70% 
ethanol, air dried and resuspended in water. In vitro transcribed RNA was used 
immediately or stored at -70°C.
2.7.2. Extraction of total cellular RNA.
RNA was extracted from virus infected or uninfected cell monolayers by the 
method described by Chomczynski and Sacchi (1987). Cell monolayers in 35mm 
dishes were washed with PBS and lysed in 0.5ml GSCN solution (4.2M  
guanidinium thiocyanate, 0.5% sarcosine, lOOmM p-mercaptoethanol, 0.33% 
Antifoam A emulsion, 50mM Tris-HCl pH 7.5 and 2mM EDTA). The lysate was 
transferred to a microfuge tube and 50pl of 2M NaOAc pH 4.0, 500|il of water- 
saturated phenol, and 100|il chloroform/ isoamylalcohol (49:1) were added. After 
vortexing for 10 seconds the tubes were incubated on ice for 15 minutes before 
centrifuging for 10 minutes at 13,000 rpm in a microcentrifuge. The aqueous 
phase was mixed with an equal volume of isopropanol and the RNA precipitated 
at -20°C for lhour followed by centrifugation for 10 minutes at room temperature. 
The RNA pellet was resuspended in 300|ll of GSCN solution, mixed with 300pl 
isopropanol and reprecipitated. After centrifugation for 10 minutes, the pellet was 
dissolved in 200pl of water by heating for 5 minutes at 60°C and extracted with 
an equal volume of a 4:1 mixture of chloroform:butan-2 -ol. The RNA was 
precipitated with 3 volumes of ethanol in the presence o f 0.3M NaOAc and 
pelleted by centrifugation for 10 minutes at 13,000 rpm in a microcentrifuge. The 
RNA pellet was washed with 70% ethanol, briefly vacuum dried and dissolved in 
water before use or storage at -70°C.
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2.7.3. Electrophoresis of RNA
Two methods were used for denaturing electrophoresis of RNA through agarose. 
The use of methylmercury hydroxide as a denaturant was initially used but was 
later supers eded by the glyoxal/DMSO method principally to avoid the handling 
of the volatile and highly toxic mercury compound.
2.7.3.1 Methylmercury hydroxide method.
RNA samples were separated on an agarose gel containing 5mM methylmercuric 
hydroxide, as described by Perbal (1988). Electrophoresis was performed on a 
1% or 1.2% agarose horizontal slab gel (14 x 11 x 0.5 cm) containing 1 x EM 
buffer (5mM sodium borate, lOmM sodium sulphate, ImM EDTA, 15mM boric 
acid) and 5mM methylmercuric hydroxide as denaturant. Agarose was melted in 1 
x EM buffer and cooled to 60°C prior to the addition o f methylmercuric 
hydroxide. RNA samples were mixed with an equal volume of 2x sample buffer 
(20% glycerol, 0.05% bromophenol blue, 2 x EM buffer) and loaded onto the 
gel. Electrophoresis was carried out in 1 x EM buffer at 75 volts for 4 hours until 
the bromophenol blue had migrated to the bottom of the gel. All manipulations 
involving methylmercuric hydroxide were performed under a fume hood.
2.7.3.2 Glyoxal method.
RNA was denatured in glyoxal/DMSO according to Sambrook et al (1989). RNA 
was added to a mixture containing 5.4|il deionised glyoxal, 16jnl DMSO and 
0.1M sodium phosphate pH7 in a total volume of 30pl and heated at 50°C for 1 
hour. Agarose gels (1-1.4%) were prepared in lOmM sodium phosphate pH7 
which was also used as running buffer. 0.1 volumes o f loading buffer (50% 
glycerol, lOmM sodium phosphate pH7, 0.25% bromophenol blue and 0.25% 
xylene cyanol) was added to the heated RNA/glyoxal/DMSO mixture before 
loading the samples to the gel. Electrophoresis was at 3 -4  volts/cm with the 
buffer being circulated between the two buffer tanks to maintain the pH within 
acceptable limits and so prevent the glyoxal dissociating from the R N A  When the 
bromophenol blue dye front had migrated -4 /5  the length o f the gel, 
electrophoresis was halted and the gel removed for Northern transfer.
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2.7.4 RNA purification by silica matrix adsorption.
RNA fragments were located in agarose gels by ethidium bromide staining and 
retrieved from excised gel blocks using a commercial Kit RNaid™ (BIO 101 Inc, 
La Jolla, CA). RNaid™ works on the same principle, binding nucleic acid to 
silica particles in the presence of high salt concentrations, as the Geneclean and 
Qiaex kits used for DNA purification (section 2.2.5 ). Agarose blocks containing 
the required RNA fragments were solubifclised in concentrated RNase-free 
NaC1 0 4  solution ('RNA binding salt1) before adding 5pl of the binding matrix 
and allowing adsorption for 5 minutes on ice. Following three washes in RNase- 
free ethanolic RNA wash (resuspension/centrifugation cycles), RNA was eluted 
into 30pl distilled water.
RNaid™ was also used to purify RNA from solutions containing enzymes or 
radiolabel.
2.7.5. Northern transfer of RNA.
RNA samples separared by denaturing agarose gel electrophoresis were 
transferred to a charged nylon membrane (Hybond N, Amersham Pic.) by a 
standard method (Sambrook et al. 1989). Two strips of Whatman 3MM paper 
were wrapped around a glass plate which was put on a rack in a tray containing 
20 x SSC. The gel was placed upside down on the Whatman 3MM paper and 
covered with a sheet of nylon membrane which had been prewetted with 2 0  x 
SSC. The nylon membrane was then covered by a stack of blotting pads (BRL) 
about 10 cm high and a weight (~0.5Kg). Transfer was performed overnight. The 
nylon membrane was then air-dried and the transferred RNA cross-linked to it by 
ultraviolet radiation (150 mJ/cm2) in a Stratalinker™ uv cross-linking apparatus, 
prior to hybridisation.
2.7.6 Radiolabelling of nucleic acid for use as hybridisation probes 
2.7.6.1. Nick translation labelling of DNA
Plasmid DNA was labelled in vitro with 32P by nick translation as described by 
Maniatis et al. (1982). 0.2-0.5pg of plasmid DNA was added to a 50pl reaction,
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containing NT buffer (lOOmM Tris-HCl pH 7.5, lOmM MgSC>4 , ImM DTT, 
0.05mg/ml BSA), lOpCi of a -32P-dATP or lOpCi of a -32P-TTP, 20pM each of 
the four unlabelled dNTPs, 1 unit of E. coli DNA polymerase I and 10~3pg/ml 
DNase I. This reaction was incubated for lhour at room temperature. The 
radiolabelled plasmid DNA was separated from unincorporated label by gel 
filtration chromatography through a Sephadex G-50 column. The Sephadex G-50 
beads were equilibrated in TE buffer and the column prepared in a 1ml plastic 
syringe with a siliconised glass wool plug. Orange G dye was added to the 
reaction as a small-solute mobility marker. The DNA was applied to the column 
and fed through with water. The eluted DNA was collected before the orange G, 
and therefore unincorporated radiolabel, had reached the bottom of the column. 
The probes were heated at 90-100°C for 2 minutes before hybridisation.
2.7.6.2 Riboprobes from in vitro transcription.
Recombinant plasmid DNA with cDNA insert under the control of a T7 promoter 
was linearised with an appropriate restriction enzyme and the DNA used as 
template for in vitro transcription by T7 RNA polymerase (Promega) as described 
by Nielsen and Shapiro (1986). 0 .5 -lp g  of linearized DNA template was added 
to an in vitro transcription reaction containing 40mM Tris-HCl pH 8.0, 25mM 
NaCl, 8 mM MgCh, 2mM spermidine.HCl, 5mM DTT, 0.5mM ATP, GTP, 
UTP, 1.2pM CTP, 50 pCi/ml oc-32P-CTP (400 Ci/mmol), 40 units o f RNasin 
and 25 units of T7 RNA polymerase in a total volume of 20pl. The reaction was 
incubated for 1 hour at 37°C followed by the addition of 1 unit o f RQ1 DNase I 
(Promega) to degrade the DNA template. After 15 minutes at 37°C the reaction 
mix was extracted with phenol / chloroform. The RNA was precipitated from the 
aqueous phase by adding 3 volumes of ethanol in the presence of 1M ammonium 
acetate and pelleted in a microcentrifuge.The labelled RNA pellet was dried briefly 
under vacuum before being dissolved in 50p l o f water and either used 
immediately or stored at -70°C.
2.7.7. Hybridisation of radiolabelled probes to nucleic acids 
immobilized on nylon membranes.
When 32P-labelled cDNA was used as a probe, the nylon membrane with 
transferred nucleic acid was prehybridised in a heat-sealed polythene bag 
containing 5 x SSPE, 0.5% non-fat milk, 0.2pg/ml salmon sperm DNA, and 
50% formamide. Prehybridisation was continued for 2 -4  hours at 42°C. The
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prehybridisation solution was then replaced by hybridisation solution containing 5 
x SSPE, 0.1% milk. 0.2% carrier DNA, and 50% formamide. 32P labelled cDNA  
probes were denatured by heating for 5 minutes at 100°C, quick-chilled on ice and 
added to the hybridisation bag which was then sealed and submerged in a water 
bath at 42°C and incubated with agitation for 12-18 hours.
When 32P labelled riboprobes were used, the prehybridisation solution was 6  x 
SSPE, 5 x Denhardt's reagent (0.02% each o f Ficoll, polyvinylpyrrolidone and 
bovine serum albumin) (Maniatis et al. 1982), 0.2mg/ml carrier DNA, 0.1% 
SDS, 50% formamide. The hybridisation solution contained 6  x SSPE, 1 x 
Denhardt's solution, O.lmg/ml carrier DNA, O.lmg/ml yeast tRNA and 50% 
formamide. Hybridisation was performed at 42°C as described above.
After hybridisation, the membrane was removed from the bag and immediately 
submerged in a tray containing 200ml of 2 x SSC and 1% SDS. The filter was 
washed for 30 minutes at room temperature with constant agitation with one 
change of the wash solution. The filter was then further washed with 0.1% SSC 
and 1% SDS for 30 minutes at 42°C. The filter was then placed on a pad of paper 
towels to remove most of the liquid, wrapped with 'cling film' and exposed to X- 
ray film at -70°C with an intensifying screen.
2.8 Protein analysis.
2.8.1. Protein concentration determination.
The protein concentrations of RNP preparations and cell extracts to be used in 
CAT assays were determined using the method of Bradford (1976). Protein 
samples and solutions of BSA for use as standards were adjusted to lOOpl 
volumes using distilled water (BSA standards contained between 0.5 and 15(ig of 
protein). 900pl of Bradford reagent (lOOjig/ml Coomassie brilliant blue, 8.5% 
phosphoric acid, 50% ethanol, filtered and stored at room temperature) was added 
and mixed. After 5 minutes the absorbances at 595nm were determined in a 
spectrophotometer. The A595 values for the BSA standards were plotted against 
protein concentration to give a standard curve from which the absorbances of the 
test samples could be applied to determine the unknown protein concentrations.
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2.8.2. Metabolic labelling of intracellular proteins.
Monolayers of cells in 35 mm dishes were radiolabelled with 35S-methionine in 
lm l of PBS (30pCi/ml) for 2 hours at 37°C. The radioactive solution was then 
removed, the monolayers washed with PBS and the cells lysed in 200pl of 
protein dissociation mix (0.125M Tris-HCl pH 6 .8 , 4% SDS, 10% p -  
mercaptoethanol, 20% glycerol and 0.1% bromophenol blue). Cell lysates were 
heated at 100°C for 5 minutes before loading onto polyacrylamide gel containing 
SDS (see Section 2.8.4).
2.8.3. Immunoprecipitation of radiolabelled proteins.
Cell monolayers were radiolabelled with 35S-methionine (30 pCi/ml) in 1 ml 
methionine free minimal essential medium for 2 to 16 hours. The cells were 
washed with PBS and lml of RIPA buffer (50mM Tris-HCl pH 8.0, 150mM 
NaCl, 1% NP-40, 0.5% sodium deoxycholate and 0.02% SDS) was added to 
each dish to lyse the cells. The dishes were incubated on ice for 30 minutes and 
the solution transferred to microcentrifuge tubes. Nuclei and cellular debris were 
removed by centrifugation for 5 minutes at 13,000 rpm and the lysate precleared 
by incubation with 10|il of preimmune serum for 30 minutes at 4°C followed by a 
second 30 minute incubation at 4°C after adding 50|il of a 10% suspension of 
formalin fixed Staphylococcus aureus cells. The S. aureus cells and bound 
antibody from the preimmune serum, were removed by centrifugation. The 
cleared supernatant was then reacted with 5|il of antiserum for 4-16  hours at 4°C 
on a rotating mixer. Immune complexes were collected by incubation with 50pl of 
S. aureus cells for 30 minutes at 4°C and pelleted by centrifugation for 30 
seconds. The pellet was washed three times with 0.5M LiCl /  0.1M Tris-HCl pH 
8 , resuspended in 50pl of protein dissociation mix and boiled for 5 minutes prior 
to electrophoresis on SDS-polyacrylamide gels.
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2.8.4 SDS polyacrylamide gel electrophoresis (SDS PAGE) of  
proteins
Denatured proteins were fractionated by electrophoresis through polyacrylamide 
gels containing SDS (Laemmli 1970). The resolving gel contained 10% or 12% 
polyacrylamide in which the acrylamide was crosslinked with N, N'-methylene 
bisacrylamide in a ratio of 75:1 (w/w) in resolving gel buffer (0.375M Tris-HCl 
pH 8 .8 ,0 . 1% SDS). Ammonium persulphate and TEMED were added to a final 
concentration of 0.1% (v/v) immediately prior to pouring the gel. The gel was 
overlaid with butan-2 -ol to leave a smooth interface after polymerisation. The 
butanol was removed when the gel had polymerised and the interface rinsed once 
with unpolymerised stacking gel solution. The stacking gel (3.8%  
polyacrylamide, 62.5mM Tris-HCl pH 6 .8 , 0.1% SDS 0.1% ammonium 
persulfate and TEMED) was layered on top of the resolving gel and the required 
comb inserted to form wells. The stacking gel was allowed to polymerise for 1 
hour before being assembled in the electrophoresis tank which was then filled 
with running buffer (53mM Tris, 53mM glycine, 0.1% SDS). Samples in protein 
dissociation mix were heated at 100°C prior to loading to the gel. Electrophoresis 
was carried out at 40 mA until the bromophenol blue had reached the bottom of 
the resolving gel.
The gel was removed from the glass plates after electrophoresis and either stained 
with 0.2% Coomassie brilliant blue for 30 minutes followed by destaining with 
several changes of gel fix (7% acetic acid, 20% methanol) or dried under vacuum 
and placed in contact with Kodak X-Omat S film for autoradiography 
(flourography was not used).
2.8.5 Chloramphenicol acetyl transferase (CAT) assays.
CAT assays were adapted from Gorman et al (1982). Cell monolayers were 
washed once with, and scraped into, PBS. Cells were pelleted by low speed 
centrifugation (500 rpm for 5 minutes) and resuspended in 75|il o f 250mM Tris- 
HCl pH 7.5. Three freeze-thaw cycles were performed (dry ice/ethanol bath -  
37°C water bath) to disrupt the cells. Nuclei were removed by centrifugation at
86
Chapter 2: Materials and Methods.
13,000 rpm for 1 minute in a microcentrifuge. The supernatant was then heated to 
60°C for 10 minutes to inactivate any deacetylase enzymes present. Extracts were 
then stored at -20°C or assayed immediately.
The CAT assays were performed for between 2 and 20 hours at 37°C in a total 
volume of 75p.l. The reaction contained up to 50p,l cell extract (equivalent to 
approximately half a cell monolayer from a 35mm dish), 2pl o f 50mM acetyl 
coenzyme A and l|J.l of 14C chloramphenicol (0.1 |iCi/|il; 58.5 mCi/mmole) in 
250mM Tris-HCl pH 7.5.
After incubation the reactions were extracted with 200|il o f ethyl acetate. 
Following centrifugation at 13,000 rpm for 1 minute in a microfuge, the upper 
organic phase was removed and dried under vacuum in a 'speedi-vac' centrifuge. 
The residue of chloramphenicol was redissolved in 20|il ethyl acetate and applied 
as a spot near the base o f a thin layer chromatography plate. Ascending 
chromatography was performed using 95% chloroform/ 5% methanol until the 
solvent front had reached the top of the plate. The chromatographs were then 
removed from the tank, dried in a fume hood for 5 minutes and placed directly 
against Kodak X-omat S film for exposure (12 hours to 5 days).
For quantitation, the regions of the TLC plate containing acetylated chloramphenicol 
were located by autoradiography, cut out and scintillation counted. Based on the 
specific activity of the 14C chloramphenicol used and the amount of protein in each 
assay (judged by Bradford assay) CAT activity was expressed as pico moles 
chloramphenicol acetylated per mg protein per minute.
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by a ReassortantVirus.
3.1 Strategy.
The original strategy for rescuing plasmid derived RNA into a bunyavirus was to 
exploit the property of genome segment reassortment to replace a segment from a 
natural virus with a distinguishable segment derived from cDNA. The S segment 
was chosen since full length cDNA clones were available for Bunyamwera virus S 
segment (see Figure 3.1) and a reassortant virus, with an easily distinguishable N  
protein, was available which would be suitable as a helper virus to replicate and 
package the synthetic RNA. The reassortant virus (Bun/Bun/Mag) contained the L 
and M segments of Bunyamwera virus and the S segment o f Maguari virus. 
Although the N proteins of Bunyamwera virus and Maguari virus contain the same 
number of amino acids, they have different electrophoretic mobilities when 
analysed by SDS PAGE. This difference, and the fact that N protein is abundant in 
infected cells compared to other viral products, would allow screening of genotype 
and make the S segment the ideal target for segment replacement. Another possible 
advantage was that using the Bun/Bun/Mag reassortant as a helper virus to rescue a 
synthetic Bunyamwera virus S segment would result in wild type Bunyamwera 
vims, which would not be expected to suffer any growth disadvantage compared 
with the helper virus.The plan involved transcribing the synthetic Bunyamwera 
virus RNA in vivo from transfected cDNA in the presence of the replicating helper 
reassortant vims. This was felt to increase the chances of the plasmid derived RNA 
being encapsidated and replicated since encapsidation is thought to occur co- 
transcriptionally during the normal life cycle o f bunyaviruses. In vivo DNA- 
templated transcription was to be achieved by co-infecting the cells with the 
recombinant vaccinia vims vTF7-3 (Fuerst et al 1986), which expresses T7 RNA  
polymerase, which could transcribe from an appropriately positioned T7 promoter 
in the plasmid. The overall strategy is depicted in Figure 3.2.
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A pUC9/BunS+
piiro17 ATG TAA
B pUC 18/BunS-
Smal
pU C 18
— — ATG TAA 17
C pTF/BunN
pTF
17 ATG TAA 1
Figure 3.1 Bunyamwera virus S segment cDNA constructs. Vector D N A  is shown as 
a thick black line, inserts as boxes. The start and stop codons of the N protein open reading frame 
are indicated. Transcription st art sites from the T7 promoters are indicated by arrows. pUC/BunS+ 
(A) contains the complete S segment cDNA. Xba I digestion followed by mungbean nuclease 
digestion of the resultant 5' overhang, results in a template for run-off transcription to produce a 
positive stranded RNA terminated at exactly the last viral base. The 5' end o f the transcript is 
determined by T7 promoter position and for this plasmid adds one additional nucleotide (G) to the 
5' end of the transcript. The inclusion o f the extra G molecule was to improve transcription yield 
since T7 polymerase prefers to initiate on a G residue. pUC18/BunS- (B) contains the complete S 
segment cDNA. Transcription following Smal digestion results in a negative stranded complete S 
RNA widi Three additional C residues at its 3' end and the one additional G residue at the 5' end. 
pTF/BunN (C) is an expression construct containing the N protein open reading frame and a 
portion o f 3' and 5' S segment untranslated regions flanked by bacteriophage T7 sequences (shaded 
boxes) including a transcription termination signal. All three constructs were designed and built 
and generously provided by A. McGregor o f this Institute. The pTF/BunN plasmid is usually 
referred to as pTF/BunS, tliis term is avoided here to distinguish this construct from those that 
contain complete S segment sequences.
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vTF7-3
T7 RNA polymerase
eaooomaoo(HMQoooooQ
Bun/Bun/Mag 
(L) (M) (S)
Transfected linear 
iBun S cDNA
Bun S synthetic RNA
Replication o f synthetic RNA  
by helper virus proteins
Bun/Bun/Mag
Plaque progeny 
virus
Bun/Bun/Bun \
Screen plaques by metabolic 
labelling to determine N  
protein origin
Mas N
Bun N
Figure 3.2 Strategy for attempted rescue of synthetic Bunyamwera virus S RNA 
transcribed in vivo. vTF7-3 is a recombinant vaccinia virus which expresses T7 RNA  
polymerase. The transfected linear cDNA produces Bun S RNA by T7 run-off transcription (see 
Figure 3.1). The replicating helper virus supplies proteins to encapsidate, replicate and package the 
synthetic RNA. Progeny viruses are screened to identify any carrying Bunyamwera virus N  
protein, which is distinguishable from the Maguari virus N protein encoded by the reassortant 
rescue virus.
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3.2 Protein synthesis during dual infection.
Of key importance to the design of this rescue strategy is the ability of bunyaviruses 
to replicate in cells which are infected with vaccinia virus. This property was 
assessed by examining protein production in dually infected cells (see Figure 3.3). 
This method was also applicable to assessing whether any growth advantage was 
apparent between the parent or reassortant viruses.
Bunyamwera virus N and G1 proteins are clearly distinguished from their Maguari 
virus counterparts by their slightly faster electrophoretic mobility (Figure 3.3, lanes 
11 and 10). Both were expressed to higher levels in the absence o f co-infecting 
vaccinia virus vTF7-3 (compare lanes 9, 10, 11 with lanes 2, 3, 4 respectively). 
The difference seen for the the Bun/Bun/Mag reassortant is due to the slightly lower 
multiplicity (2-5 pfu/cell) used for infection compared with the parent viruses (10 
pfu/cell).
Co-infection of cells with Bunyamwera and Maguari viruses resulted in the 
Maguari virus G1 and N proteins predominating over the Bunyamwera proteins 
(compare lane 8 to 10 and 11). Maguari virus G1 protein also predominated over 
Bunyamwera G1 protein coded for by the Bun/Bun/Mag reassortant virus (lane 6 ). 
The former result is unlikely to be due to errors in titration of the viruses since in 
single infections, using the same volume of stock viruses as used for the dual 
infections, Bunyamwera virus produces at least as strong a signal as Maguari virus 
(lanes 11 and 10). Advantage by Maguari virus over Bunyamwera virus during 
dual infection has been reported by Pringle (1991). Regardless of any growth 
advantage Maguari virus may have over Bunyamwera virus during dual infection, 
Bunyamwera virus N protein is efficiently produced when Bunyamwera virus is 
replicating in the presence of the Maguari virus S segment supplied by the 
Bun/Bun/Mag reassortant virus (lane 7). This observation is evidence that if  
encapsidated, the plasmid transcribed Bunyamwera virus S segment would not be 
dissadvantaged in the reassortant virus infected cell.
The co-infection experiments were carried out at a multiplicity of infection of 10 
pfu/cell for each virus to increase the proportion of cells co-infected. Although it is 
formally possible that in individual cells one or other o f the viruses predominates, 
the ability to isolate reassortant viruses following dual infection with Bunyamwera 
and Maguari viruses demonstrates that both viruses can multiply in the same cell. 
Therefore this experiment is felt to genuinely reflect the expression o f co-replicating 
viruses.
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Figure 3.3 Protein profiles of bunyavirus and vaccinia virus infected cells. BHK cell 
monolayers were infected at lOpfu/cell for each virus, except for the Bun/Bun/Mag reassortant virus which 
was used at 2 -5  pfu/cell. 24hrs post-infection cells were labelled with 15jiCi 35S methionine for 2hrs 
before being washed and harvested. Cell lysates were denatured by heating in SD S/p-m ercaptoethanol 
before being analysed by SDS PAGE. Gels were dried and autoradiographed overnight. L a n e  1: Mock  
infected. L a n e  2:Vaccinia virus vTF7-3 coinfected with the Bun/Bun/Mag reassortant virus (BBM ). L a n e  
3 : vTF7-3 plus Maguari virus. L a n e  4: vTF7-3 plus Bunyamwera virus. L a n e  5: vTF7-3 alone. L a n e  
6: Maguari plus reassortant virus. L a n e  7: Bunyamwera plus reassortant virus. L a n e  8: Bunyamwera 
plus Maguari virus. L a n e s  9  Reassortant virus, 1 0  Maguari virus and 11 Bunyamwera virus alone. 
Bunyamwera virus N and G1 proteins migrate faster than the corresponding Maguari virus proteins.
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Efficient shut-off of host cell protein synthesis by bunyavirus infection is observed 
(Figure 3.3 lanes 6-11 compared to lane 1)— the partial exception being for the 
Bun/Bun/Mag reassortant (lane 9) which is accountable by a lower multiplicity of 
infection being employed for this virus. Similar shut o ff is also observed for 
vaccinia virus proteins— several strong vaccinia virus specific proteins occur 
(compare lane 7 to lane 1) but signals for these are reduced to varying extents by 
co-infection with one or other of the bunyaviruses (lanes 2, 3, 4). T7 RNA  
polymerase production from the vaccinia virus to adequate levels in the presence of 
co-infecting bunyavirus is not addressed by this experiment.
This experiment appears to confirm that protein production by the bunyaviruses 
used is not significantly affected by co-infection with the recombinant vaccinia 
virus. Moreover, at least for the relevant Bun/Bun/Mag rescue virus, efficient 
expression of the N protein from Bunyamwera vims S segment, in the presence of 
the Maguari S segment, could be achieved. This experiment also demonstrates that 
the two N proteins can easily be distinguished and therefore screening by metabolic 
labelling would be able to discriminate between the rescue reassortant and any 
progeny virus carrying the plasmid derived Bunyamwera vims S segment.
3.3 Rescue attempt
BHK cell monolayers were infected with the Bun/Bun/Mag reassortant and the T7 
polymerase expressing vTF7-3 recombinant vaccinia virus at 10 pfu/cell each and 
then transfected with lin^rised pUC9/BunS+ DNA. After 24 hours supernatant 
fluid was harvested and used to infect fresh monolayers. Plaques were allowcl to 
develop for five days under overlays containing phosphonoacetic acid at 300  
pg/ml. This reagent had been previously shown to inhibit plaque formation by 
vaccinia vims while allowing bunyaviruses to form plaques (Jin 1991). Plaques 
were visualised by staining with neutral red and were transferred individually to 
BHK monolayers in 24-well limbro plates. Conditions were determined under 
which N  protein could be detected by metabolic labelling using 35S methionine 
followed by SDS PAGE and autoradiography. Where host shut-off had not 
occurred sufficiently for identification of N protein, fresh infections were made 
using the supernatants from the first infection and rescreened. Gels included 
labelled extracts from cells infected with either Bunyamwera virus or Maguari virus 
to provide appropriate N protein markers. Of 200 plaques screened, all displayed N  
protein mobilities consistent with those expected for Maguari vims and were 
therefore judged to be formed by the amplified input Bun/Bun/Mag reassortant 
virus. It was decided to further characterise the expression system before 
continuing.
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3.4 RNA analysis
RNA accumulation in infected and transfected cells was examined by Northern 
analysis, using nick-translated Bunyamwera S segment cDNA as a probe (Figure
3.4). The RNA extraction method employed did not exclude carry over of plasmid 
DNA. The probe detects S RNA of both Bunyamwera and Maguari virus and the 
mobilities of each are indistinguishable in this gel system (Lanes 6 & 4).
For both Bunyamwera and Maguari viruses, co-infection with the recombinant 
vaccinia virus appeared to slightly reduce accumulation of S segment RNA  
(compare lane 6 with 5 and lane 4 with 3 for Bunyamwera and Maguari viruses 
respectively). The reduction in signal is thought to be due to different harvesting 
efficiencies— the cell sheets infected with vaccinia virus detached more readily than 
those without and so more losses occured during washing.
Transfection of cells with linearised or circular plasmids containing the 
Bunyamwera vims S segment cDNA resulted in detection o f a major, slow  
migrating band of similar mobility in both cases (lanes 8 &10). These signals most 
likely represent DNA not RNA since no vTF7-3, and therefore no T7 RNA- 
polymerase was present. The occurence of bands of similar mobility was not as 
expected since under the denaturing conditions employed, linear DNA would 
migrate as two (possibly co-migrating) single stranded molecules while circular 
DNA would be in the form of two covalently inter-linked single stranded circular 
molecules. Nicks in the circular plasmid DNA may account for the similar mobility. 
The marked difference in signal strength for linear versus circular DNA (lanes 8 -  
10) could reflect differential transfection or harvesting efficiencies or differences in 
degradation rates for the two species.
When linearised DNA was transfected in the presence of recombinant vaccinia vims 
vTF7-3, no convincing S segment-sized RNA was detected (lane 7 )  (a slight 
shadow was present around the position for S segment sized RNA on the original 
autoradiograph but a stronger equivalent signal is also present in lane 9 where 
circular plasmid was transfected).
This experiment therfore raised concern about the transcription system employed 
but did confirm the expectation from the protein labelling study of co-infected cells 
that the vaccinia vTF7-3 recombinant does not significantly interfere with RNA  
production from at least the S segments of the bunyavimses tested.
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Figure 3.4 RNA profiles of infected and transfected cells. Infections were performed 
at lOpfu/cell. For transfections, 5pg o f circular or Xbal/M ung bean nuclease digested  
pUC9/BunS+ DNA was lipofected into BHK monolayers lhr after virus infection. RNA was 
extracted from washed monolayers 24 hours later by the acid-guanidinium method without DNAse 
treatment. RNA was electrophoresed through 1% agarose gels containing methylmercury hydroxide 
as denaturant, transfered to nylon membranes and probed using 32P-dNTP labelled nick translated 
Bunyamwera virus S segment cDNA. Single infections with Bunyamwera, Maguari or the 
Bun/Bun/Mag reassortant— lanes 6, 4 and 2 respectively. The same bunyaviruses in dual infection 
with vaccinia virus vTF7-3 (T7)— lanes 5, 3 and 1 respectively. Note the reduction o f S RNA  
signal when vTF7-3 is present, most noted for Bunyamwera and Maguari viruses (Lanes 3 through 
to 6). Transfection o f  linear (lanes 7 and 8) or circular (lanes 9 and 10) pUC9/BunS+ in the 
presence (7 and 9) or absence (8 and 10) vTF7-3. The low mobility band and smear for lanes 7 
through to 10, is carry over DNA as it occurs independently of vTF7-3.
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3.5 Protein production from transfected plasmids.
The inability to detect S segment RNA transcribed from transfected plasmids could 
have been due to a number of causes including correct transcription simply not 
occuring (e.g. promoter or run-off restriction site incorrectly placed, vaccinia virus 
vTF7-3 not functioning properly) or to degradation of the RNA. While most o f the 
former possibilities were excluded by in vitro  analysis of the construct, further 
investigation was performed to help clarify the situation. Metabolic labelling was 
performed to see if N protein could be detected from transfected plasmids. This 
would demonstrate that RNA was transcribed in the system and that some other 
property of the system was responsible for the inability to detect RNA.
As controls, lysates from mock, Bunyamwera virus, Maguari virus and vaccinia 
virus infected cells were immune-precipitated using anti-Bunyamwera virus 
antiserum (Figure 3.5, lanes 1 to 4). Bands of the expected different mobilities for 
Bunyamwera and Maguari viruses N proteins were detected. No equivalent signals 
were observed in the vaccinia virus- or mock-infected cell lysates.
In a separate experiment protein expression from transfected cDNA was assessed. 
Maguari virus infection was used as a control for N protein detection to avoid 
possible cross contamination to the transfected cells as Maguari virus N protein is 
of different mobility to Bunyamwera virus N protein. In addition to the 
pUC9/BunS+ construct which produces a full-length S segment o f positive 
polarity, a second expression construct was included. pTF/BunN contains an 
incomplete S segment under T7 promoter control followed by a downstream T7 
RNA polymerase terminator sequence (see Figure 3.1). This construct, when 
transfected into cells infected with vTF7-3 to supply T7 RNA polymerase, 
produces RNA easily detectable by Northern blot and Bunyamwera virus N protein 
(A. McGregor & R.M. Elliott, personal communication). The ability to produce N  
protein from these two plasmids was assessed ( Figure 3.5 lanes 5 to 8 ).
Transfection of pUC9/BunS+ construct, which contains the complete Bun S 
segment, gave similar levels of N protein to those observed for pTF/BunN  
transfection and infection with the Bun/Bun/Mag reassortant virus. This experiment 
demonstrates that transcription from pUC9/BunS+ must occur even though no 
unique RNA species could be detected by Northern analysis.
96
Chapter 3: Reassortant rescue v iru s /in  vivo transcribed RNA
Figure 3.5 N protein production from bunyaviruses and transfected cDNAs. 
Infections, transfections and labelling were as described for Figure 3.4. Cell lysates were reacted 
with anti-Bunyamwera virus antiserum to immune-precipitate Bunyamwera and Maguari virus N  
proteins. SDS PAGE followed by autoradiography o f dried gels revealed signals for N  protein. 
Virus and mock infected cells demonstrate the specificity of the IP procedure (lanes 1 to 4). N o N  
protein signal is seen in lysates from vTF7-3 infected or mock infected cells (lanes 1 and 4  
respectively). Maguari and Bunyamwera viruses produce N  protein o f  distinguishable mobility 
(lanes 2 and 3 respectively). Lane 5: marker for N protein (Maguari virus N). Lanes 6 to 8, 
transfections of cDNA into vTF7-3 infected cells: Lane 6—  pUC9/BunS+; lane 7—  pTF/BunN; 
lane 8—  cotransfecdon of both plasmids. (See Figure 3.1 for plasmid maps).
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3.6 Transcription of S RNA in the presence of N protein.
Because N protein could be detected in cells transfected with cDNA clones, 
degradation of the RNA immediately following translation may have been the cause 
of the inability to detect RNA. A further experiment attempted to protect newly 
transcribed RNA by transcribing it in the presence of an intracellular pool o f N  
protein. pTF/BunN has already been shown to produce levels of N protein similar 
to those found in virus infected cells (Figure 3.5) and the mRNA produced would 
not be expected to bind N protein since it lacks S segment terminal sequences and is 
flanked by heterologous RNA. This construct was used to provide an intracellular 
pool of N protein in which a Bunyamwera virus S segment could be transcribed 
from cDNA and possibly encapsidated. To facilitate specific detection of the S 
segment RNA without interference from the N protein mRNA from pTF/BunN, a 
second S segment cDNA construct, pUC 18/BunS- (see Figure 3.1), was used in 
which the T7 promoter is oriented such that negative stranded S segments would be 
produced. This would allow strand specific riboprobes to discriminate between the 
two species.
When probed to detect positive stranded S RNA (Figure 3.6, panel A) a strong 
signal was detected in Bun/Bun/Mag infected cell RNA (lane 2). For pTF/BunN 
and pUCl 8/BunS- dually transfected cells, a faint doublet band could be detected in 
the absence o f vTF7-3 (lane 3). The origin’ o f the polymerase responsible for 
transcription here is unknown but it may recognise promoter and termination 
signals at or very close to those for T7 RNA polymerase as judged by the similar 
mobilities to T7 transcripts from pTF/BunN (lane 4). This doublet was many times 
stronger when the transfected cells were also infected with vTF7-3 to supply T7 
RNA polymerase. The occurence of a doublet signal from this construct is 
reproducible (A. MacGregor personal communication) although the origin of the 
two species is unknown. The strength of the signal diminished again when the full 
length cDNA in pUC 18/BunS- was co-transfected (lane 5). Why co-transfection 
should diminish this signal is not clear—competition for T7 RNA polymerase 
would be expected to be greatest from the pTF construct which has more efficient 
translation initiation nucleotides (5'-GGG...) for T7 transcription than the full 
length cDNA (5'-GAGU...). Any hybrids formed between the mRNA and full 
length genome RNA would not be expected to interfere with probe hybridisation on 
the blot since the gel was ran under strong denaturing conditions.
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When probed to detect negative strands (Figure 3.6, panel B), apart from a weak 
aberrant signal in the mock infected track (lane 1) and the strong signal expected 
from virus infected cells (lane 2), no negative stranded S segment RNA could be 
detected either in the presence or absence of co-transfected pTF/BunN plasmid as a 
source of N protein (Lanes 5 & 6).
A. B.
Positive Strands Detected Negative Strands Detected
1 2 3 4 5 6  1 2 3 4 5 6
Figure 3.6 Attempted in vivo transcription in the presence of N protein. 
Transfections and infections were carried out at 5fig and lOpfu per cell respectively. 
Electrophoresis and blotting was as described for Figure 3.4 except filters were probed with strand 
specific 32P-labelled riboprobes to specifically detect positive (panel A) or negative (panel B) S 
segment RNA. For both panels, lane assignment is as follows. L a n e  1: Mock infected; L a n e  2:  
Infected with Bun/Bun/Mag reassortant virus.(BBM) L a n e  3: Transfected with pUC18/BunS- (S-) 
and pTF/BunN (N) without vTF7-3 infection. L a n e  4: Transfected with pTF/BunN and infected 
with vTF7-3 (T7). L a n e  5: Transfected with both pUC18/BunS- and pTF/BunN and infected with 
vTF7-3. L a n e  6: Transfected with pUC18/BunS- and infected with vTF7-3.
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3.7 Why no RNA?
The inability to detect S segment RNA even though its gene product N protein 
could be detected suggested either rapid degradation of the RNA or the existence of 
heterogeneous length transcripts which were sufficiently variable to be undetectable 
by Northern analysis. A possible explanation for the observation, which might 
indeed produce a wide range of transcript sizes, is that the potent ligase activity 
encoded by vaccinia virus could recircularise the transfected plasmids. In the 
absence o f any T7 terminator sequence, the resultant loss o f the run-off end of the 
transfected DNA would cause transcription to continue until the polymerase fell off 
the template. If termination was random, a whole range of RNAs of very variable 
length would be produced which would be too diffuse to detect on Northern blots 
but which could still be translated to give N protein. The observation of similar 
mobilities for plasmid DNA isolated from cells transfected with either linear or 
circular plasmids is consistent with this hypothesis. However, the vaccinia virus 
alone could not be implicated since the mobilities were still similar when the cells 
had not been infected with vaccinia virus, (lanes 7 -10  Figure 3.4). In more recent 
work (Pattnaik et al 1992) the difjiculties of making run-off transcripts in vivo using 
this sytem were commented on and overcome by incoiporating ribozyme sequences 
to tailor a larger transcript to the required length.This approach may be applicable to 
the present problem and this is discussed further in Chapter 7.
To help discourage recircularisation of transfected linearised plasmids treatment 
with alkaline phosphatase could be performed prior to transfection. Even when this 
precaution was taken, no S segment sized transcript could be detected (data not 
shown). Other workers (D. Kolakofsky personal communication) have found 
recircularisation of linearised plasmids transfected into vaccinia virus infected cells, 
even when the ends of the linear molecule were cut with different restriction 
enzymes such that opposing single stranded extensions were generated (i.e. a 5 1 
single strand extension at one end and a 3' single strand extension at the other). In 
principle such treatment should make it exceedingly difficult for the two ends to be 
arranged in a position suitable for ligation. Other effects may occur such as 
degradation of single strand extensions, which might allow ligation. For blunt- 
ended, dephosphorylated termini, phosphorylation would be required for ligation 
either as a direct enzyme activity or by cleavage o f terminal bases to expose a 
phosphate.
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Clearly production of RNA from templates which were circular would not produce 
transcripts which mimicked natural S segments and so the rescue o f  such 
transcripts into vims would be most unlikely.
With the system as it stands, if any plasmid derived RNA transcripts are packaged 
into virus, the frequency at which this occurs (< 1  per 2 0 0  progeny virus) is 
sufficiently low to make screening of individual isolates by metabolic labelling 
impractical. Screening pooled samples by PCR was considered as was screening 
plaques by hybridisation to filter lifts. Preliminary studies indicated that both these 
approaches would prove difficult due to the extremely similar nucleotide sequences 
of Bunyamwera and Maguari viruses which made production o f discriminatory 
oligonucleotides very difficult. Efforts were instead directed towards modifying the 
strategy to allow counter-selection of a rescue virus and so aid detection o f any, 
rare, viruses carrying the S segment derived from cDNA. The most obvious 
counter-selectable helper vims would be one carrying a temperature sensitive lesion 
in its S segment. Since unambigous assignment of lesions to the S segment had not 
yet been made, this approach required some preliminary characterisation o f  
available ts mutants. Such work and rescue attempts using a likely S segment ts 
mutant are discussed in the next chapter.
3.8 Conclusions.
Protein and RNA profiles of co-infected cells suggested that the vaccinia vims 
vTF7-3 slightly reduced bunyavirus expression levels although the reductions were 
not thought to be significant. Maguari vims appeared to have a slight growth 
advantage compared with Bunyamwera virus as judged by N protein synthesis in 
co-infected cells. However, similar experiments using Bunyamwera vims and the 
Bun/Bun/Mag reassortant vims suggested that the Bunyamwera vims S segment 
would not be dissadvantaged in the presence of co-expressed Maguari vim s S 
segment supplied by the reassortant vims. These results suggested the general 
strategy of rescuing a Bunyamwera vims S segment RNA, transcribed in vivo  by 
vTF7-3, using the Bun/Bun/Mag reassortant virus, was feasible with regard to 
interactions of the component viruses.
It was not possible to detect RNA transcribed in vivo from transfected linearised 
plasmids using recombinant vaccinia virus vTF7-3 as a source of T7 RNA  
polymerase. Transcription did occur since N protein could be detected in 
transfected cells. Attempts to stabilise transcripts by co-expressing N protein still 
did not allow detection of a unique RNA species. Signals present on Northern blots 
representing transfected DNA, suggested that the transfected linearised plasmids
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were religated to form a circular template which would not be expected to yield a 
discrete transcript but which would be expected to be translatable.
In an attempt to rescue plasmid derived Bunyamwera virus S RNA into a 
Bun/Bun/Mag reassortant virus, 200 plaqued progeny virus were screened by 
metabolic labelling to determine the origin o f their N protein. No Bun/Bun/Bun 
virus was recovered indicating that if  rescue occured, it did so at a frequency of 
<1/200. This makes screening o f individual plaques impractical and preliminary 
attempts to detect packaged S segm ent in pooled virus progeny, using 
oligonucleotides as PCR primers or probes, suggested the high degree of 
conservation between Bunyamwera and Maguari virus S segments would prevent 
such an approach. An alternative, selectable rescue virus was felt more likely to 
allow detection of rescued RNA if it occured using the present system. The use of a 
temperature sensitive rescue virus is discussed in Chapter 4.
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As discussed in Section 1.9.8 .2, bunyavirus ts mutants can be assigned to 
reassortment groups based on their ability to reassort only with members of a 
different group, producing viruses with a non-ts phenotype. Three such 
reassortment groups would be expected for bunyaviruses, representing lesions in 
each o f the three gene segments. Contrary to this expectation, almost all mutants 
can be placed into two reassortment groups with only one isolate, Maguari virus 
ts23, definitely belonging to group III (see Table 1.9.2). Since ts mutants are 
available for closely related bunyaviruses, heterologous crosses could be used to 
assign each group to a segment in which the lesion is present for that group. This 
would involve selecting non-ts progeny from heterologous crosses between for 
example, a Bunyamwera virus ts mutant and a Maguari virus ts mutant and 
determining the parental origin of each of the non ts gene segments by RNA or 
protein profiles. Alternatively, the phenotype of non-selected reassortants from 
heterologous crosses between wild-type and ts viruses can be compared to their 
genotype and ts status. Such studies have clearly demonstrated that the Maguari 
virus group II ts mutants contain lesions in the M segment (Murphy & Pringle 
198^). The segment assignment for group I Maguari virus mutants (the other well 
represented group) could not be unequivocally determined. Most available evidence 
pointed to the group I mutants having lesions in the S segment For example when 
group I Maguari mutants were crossed with Bunyamwera virus, reassortants 
displaying a ts phenotype were found to include a Mag/Bun/Mag genotype while a
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non-to Mag/Bun/Bun virus was also isolated (Murphy and Pringle 1987). This 
finding is not as expected for the well represented group I since the relative 
proportion of mutants isolated for each o f a given set of target sequences is 
expected to reflect the relative sizes of those target sequences. This expectation is 
largely fulfilled for other virus systems (Pringle 1987; Pringle 1990). More 
convincing contrary evidence comes from the extremely thorough crosses 
performed with ts mutants of California group bunyaviruses (Gentsch e ta l  1979). 
The observed progeny reassortants from these crosses unambiguously suggest that 
the two common reassortant groups of California group viruses represent lesions in 
the L and M segments.
Since a ts S segment mutant would be an ideal helper virus to rescue a cDNA- 
derived S RNA, further characterisation of the Maguari virus ts  mutants was 
undertaken to try to resolve the actual assignment for the group I and group III 
Maguari vims mutants. Identification of a potential S segment mutant would enable 
it to be used as a rescue vims in the same strategy discussed in Chapter 3 but with 
an additional step involving temperature selection to supress growth of the helper 
virus and so increase the chance o f identifying rare reassortants carrying the 
synthetic S segment.
4.1 Progeny virus titre and plaque formation
Plaque purified virus stock for each of the ts mutants was used to infect BHK cell 
monolayers in large flasks and grown at 31°C or 38*5°C for five days before 
harvesting the viral supernatants. Titrations were performed on the resultant stocks 
by plaquing onto BHK cells. Incubation was at 31°C for five days before staining 
and counting plaques. The three ts mutants were all found to be restricted at 38-5°C 
compared to 31°C and all grew to lower titres at 31°C than similarly inoculated wild 
type vims (see Table 4.1).
The group I and II viruses gave slightly smaller plaques than wild type vims (2-3  
mm) while the plaques of the group III mutant were barely visible after five days 
incubation (<0-5mm). Subsequent attempts to improve yields or plaque size by 
longer incubations failed and the low titres available for the mutant made useful 
studies very difficult.
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Virus Reassortment
group
p fu /m l 
31°C 3 8 - 5 ^
Maguari virus (w t ) - 1-2 x 1 0 6 1-15 x I O 6
Maguari virus ts6 I 3-5 x 1 0 5 <1 x I d 2
Maguari virus ts 1 7 I I 2-8 x 1 0 5 <1 x 102
Maguari virus ts23 I I I 2-5 x 1 0 3 <1 x 1C2
T a b le  4 .1  Wild type and ts Maguari virus titrations. Stocks were grown for five days at either
31°C or 38-5°C before being titrated on BHK monolayers at 31°C. Cell sheets were fixed in 
glutaraldehyde and stained with Giemsa stain to visualise the plaques.
4.2 Protein and RNA synthesis by Maguari virus ts mutants
Members of each of the three Maguari virus ts reassortant groups were investigated 
to see if any differences in protein or RNA synthesis were apparent which might 
provide evidence as to which segment was mutant for each. Profiles were 
compared for each virus following growth at 3 PC or 38-5°C.
Lysates from cells radiolabelled with 35S methionine were reacted with anti 
Bunyamwera virus serum and analysed by SDS PAGE. Wild type Maguari virus 
infection gave a clear strong band for N protein at both temperatures (Figure 4.1; 
lanes 4 & 9). Other proteins are cellular, remaining from the low-stringency IP 
washes, as shown by their presence in uninfected cells (lanes 5 & 10). Slightly less 
labelled N protein was precipitated from virus cultured at 38-5°C (lane 9) than at 
31°C (lane 4) although the difference is minimal.
The apparent partial restriction of N protein synthesis seen for all three ts mutants at 
the permissive temperature (compare lanes 1, 2, 3 with lane 4), is partly artefactual 
due to different multiplicities of infection used for the viruses. This was caused by 
difficulties in growing high titre stocks of the ts mutants (see Section 4.1). The 
group II mutant (lane 2) is probably genuinely partially restricted at the permissive 
temperature since it was infected at the same multiplicity as the group I mutant (lane 
1). The multiplicity used for the group III mutant ts23 was only -0-01 pfu/cell due
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to the extremely low titres obtained for stocks grown at 31°C. This resulted in the 
N protein for this mutant being undetectable even at the permissive temperature.
For the group I mutant, complete shut-off of N protein synthesis is observed when 
grown at 38.5°C (compare lane 1 to lane 6 ). Temperature dependent shut-off is 
consistent with the group I mutant being ts in either the L or S segments since the 
products of both segments are required for amplified gene expression and the low 
multiplicities used would not allow detection of primary transcripts.
For the group II mutant, a small amount of N protein is still detected at the raised 
temperature (lane 7). Group II mutations are known to map to the M segment 
which encodes the glycoproteins. A lesion in the glycoproteins would not be 
expected to interfere with gene expression. The apparent restriction in N  protein 
synthesis is probably therefore due to the mutant being unable to establish 
secondary infections in neighbouring cells due to the glycoprotein defect. At low  
multiplicity infection, this effectively reduces the number of cells infected and 
would account for the observed lower level of N protein. If increasing multiplicities 
were used the effect would be predicted to be less marked.
RNA accumulation was asseled by Northern analysis using S segment 32P labelled 
cDNA as a probe. The results obtained following growth o f the mutants at 
permissive and non-permissive temperatures (Figure 4.2) largely mirror those 
found for protein synthesis. Maguari virus ts22> S segment RNA could not be 
detected at either temperature (lanes 3 & 8 )— again presumably due to the low  
multiplicity used to infect. The group II mutant produced RNA at both temperatures 
(compare lane 2 to lane 7) while the group I mutant showed 
levels of RNA at 38-5°C (lane 1 compared to lane 6 ).
Since the L protein is the viral RNA polymerase (Jin & Elliott 1991), L segment 
mutants would be expected to display reduced RNA, and consequently reduced 
protein, levels when grown at the non-permissive temperature. N  protein, encoded 
by the S segment would not be required for primary transcription but is required for 
amplification of transcription templates since it forms an essential component of the 
viral RNP. If the multiplicity of infection were high enough to allow detection, S 
segment mutants might allow production of mRNA by primary transcription of 
input genomes (providing that the preformed template did not alter conformation at 
the non permissive temperature) but would result in reduced genome replication and 
therefore little secondary mRNA production. This investigation was severly 
compromised by the inability to grow sufficient seed stocks o f mutant for 
meaningful study— in the case of w23, no RNA or protein could be detected even at
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the permissive temperature. Depending on how leaky the phenotype of the mutants 
are, it might be possible to specifically detect primary transcrips in the S segment 
mutant by PCR using a reverse transcription primer directed against positive 
stranded RNA. For the L segment mutant this approach should result in the absence 
of a signal if primary transcription is completely abolished and if the inoculum does 
not contain detectable quantities of positive stranded RNA. This approach would 
only yield informative results if a) the L segment mutant was completely restricted 
for transcription at 38.5°C and b) if RNP of the S segment mutant formed at the 
permissive temperature was still a functional transcription template at 38.5°C.
31"C 38.5°C
1 2 3 4 5 6 7 8  9 10
Figure 4.1 Protein synthesis by Maguari virus and t s  mutants. BHK monolayers were 
infected at lOpfu/cell (wild type Maguari virus), lpfu/cell (ts6 and ts \7 )  and O.Olpfu/cell (ts23). 
Different multiplicities were used because o f die difficulty o f growing high titre stocks for the 
mutants. For ts23 (lanes 3 and 8) insufficient virus was present to detect N  protein even at the 
perm issive temperature. For wild type virus, a strong N protein band is present at both 
temperatures (lanes 4 and 9). A faint band is seen for die group II mutant even at 38-5°C (lane 7). 
A slightly stronger band is visible at the lower temperature (lane 2). The group I mutant (lanes 1 
and 6) shows marked shut off at die higher temperature.
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31°C 38.5°C
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m
s
Figure 4.2 RNA profiles of wild type and ts  mutant Maguari virus infected cells. 
BHK monolayers were infected at the same multiplicities described for Figure 4.1. At 24Hrs post 
infection, RNA was purified from cells and separated on 1% agarose gels under denaturing 
conditions. Northern blots were probed using negative strand riboprobes transcribed in vitro from 
S segment cDNA to detect positive sense RNA. S RNA could be separated into full length 
(antigenome) and shorter (mRNA) species resulting in a doublet band. For ts23,  the low  
multiplicity prevented detection o f RNA at both temperatures (lanes 3 and 8). For wild type virus 
similar levels o f RNA accumulated at both temperatures (lanes 4 and 9). The group II mutant 
produced RNA at both temperatures (lanes 2 and 7) with a strong signal seen for full length anti 
genome RNA at 38.5°C (upper band lane 7). No RNA could be detected for the group I mutant 
grown at 38.5°C (lane 6 compared to lane 1).
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4.3 S segment sequencing.
The RNA and protein analysis of cells infected with the Maguari virus ts mutants 
were not helpful in assigning the group I and group III mutants to their segments. 
Further characterisation was required and it was decided to attempt to identify 
sequence differences between the S segments in the hope that any lesion would be 
unique to one group and would therefore likely be the cause of the ts phenotype.
Various methods could have been employed to identify which S segments 
contained mutations. One potential approach would be to anneal S RNA from each 
of the mutants to wt cDNA and treat with RNase to nick at mismatched nucleotides. 
Such nicks could then be identified by electrophoresis to separate the resultant 
fragments (Sambrook e ta l  1989). Another approach, which has been succelfully 
used to discriminate sequences containing single point differences, is denaturing 
gradient gel electrophoresis (Fischer & Lerman 1979) where hybrids of the two 
sequences being compared are electrophoresed through a two-dimensional system 
which employs a denaturing gradient which at some point (depending on the degree 
of difference between the two strands o f the hybrid), will separate the duplex into 
two single strands. While both techniques would in principle have been applicable 
to the present problem, and might be extremely useful if many mutants were to be 
screened, a potential draw back would be that since the mutants had been generated 
by chemical mutagenesis, inconsequential mutations may occur in S segments 
which were not ts. It was therefore decided to clone and sequence the S segments 
from each of the three mutants and wild type vims. The ideal outcome would be to 
find no mutations in any but one segment— the genuine ts segment. Even if  this 
ideal were not attained, the availability o f sequence data might enable probable 
assignment based on the degree of conservation of the affected nucleotide with 
other bunyaviruses.
A rapid coupled reverse transcription/PCR procedure was developed which allowed 
production of full-length S segment cDNAs starting with crude vims preparations. 
Vims from infected cell supernatant fluid was pelleted by high speed centrifugation 
and RNA purified by double phenol extraction. Sufficient vims was present in the 
5ml supernatant of an infected BHK cell monolayer grown in one 50mm petri dish 
to allow S segment cDNA amplification from even the poorly growing ts23 mutant 
Following ethanol precipitation and resuspension in water, the viral RNA was 
added to a 50jil reaction mix (50mM KC1, 20mM Tris.HCl — pH 8.4 at room 
temperature, 2.5mM MgCl2, 1 mg/ml BSA and 10 units RNasin). 100 units o f 
MuLV reverse transcriptase (BRL) and 1 unit of Taq thermostable DNA
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polymerase (Cetus) was added along with 30 pmole o f each o f two synthetic 
oligonucleotides for cDNA and PCR priming. The oligonucleotides used were 
complementary to the 15 terminal nucleotides at the 3' ends o f genome and anti 
genome Maguari virus S segment RNA ( 5' AGTAGTGTACTCCAC and 5' 
AGTAGTGTGCTCCAC respectively). These primers are specific for S segments 
of all members of the B u n ya v iru s  genus (Elliott 1990). Although the 
oligonucleotides differ from each other by only one nucleotide (position 9 ) they 
correctly primed their specific ends when used in combination. If used alone, either 
primer was able to prime amplification by annealing to both ends of the segment 
and introducing a point mutation nine nucleotides in from one end. The assembled 
reaction mixture was incubated at 42°C for 45 minutes to allow first strand cDNA  
synthesis. This was followed by 30 rounds of temperature cycling (94°C for 30 
seconds, 54°C for 30 seconds and 72°C for 1 minute) during which duplex 
melting, primer annealing and elongation could occur.
The reaction products were electrophoresed through 1% agarose and S segment 
cDNA isolated and cloned to pUCl 18 for sequencing. This procedure enabled even 
the low abundance ts 23 RNA to be cloned (see Figure 4.3). Several clones were 
isolated from three independent RT/PCR amplifications and were sequenced using 
primers spanning the S segment. For wild type and and ts mutants 6  and 17 (the 
group I and II mutants), no mutations were found. For ts23 (the group in  mutant) 
a point mutation was found in each of three independent clones. The mutation was 
also found when uncloned PCR amplified DNA was used as sequencing template 
and no alternate base was present at that position as might be expected if  the 
mutation had arisen during PCR amplification (see Figure 4.4).
The mutation, a U to C transition, found in Maguari vims ts 23 occurs at nucleotide 
327 and therefore affects the amino acid sequence of both the N  and NSs proteins 
resulting in a valine to alanine change in the former and a phenylalanine to leucine 
change in the latter. In thirteen available S segment cDNA sequences, nucleotide 
327 is invariant with the ts23 mutant being the only exception. Table 4.2 shows 
nucleotide and amino acid sequence comparisons for different bunyaviruses at this 
region o f the S segment. The alanine introduced into the N protein of ts23 is not 
present in any of the other viruses which have a conserved valine except for three 
California group viruses which have isoleucine— an amino acid of similar size and 
hydrophobicity as valine. For NSs the relevant amino acid is less conserved and the 
leucine present in ts23 is also present in the three California group viruses. Based 
on these comparisons it is possible that the alteration found in the N protein would 
be of more significance to phenotype than the NSs change.
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Figure 4 .3cD N A  amplified from wild-type and temperature sensitive mutant 
Maguari viruses. RNA was purified from pelleted virus and cD N A  amplified in a coupled 
reverse transcription / PCR reaction. 15mer primers, complementary to the 3' termini o f genome 
and antigenome RNA, were annealed to RNA, mixed with reverse transcriptase, Taq D N A  
polymerase and dNTPs. The reaction was incubated at 42°C for 45 minutes to allow reverse 
transcription to occur. This was follow ed by 30 cycles o f denaturing (94°C for 30 seconds), 
annealing (54°C for 30 seconds) and extension (72°C for 1 minute). The cDNA produced was 
separated on 1% agarose gels and visualised by staining with ethidium bromide. DNA was purified 
from gels by adsorption to silica, end-repaired, kinased and cloned to phagemid pUC118 for 
sequencing. PCR populations were also sequenced directly by boiling in the presence o f excess 
sequencing primer and cooling to room temperature before standard di-deoxy termination reactions 
were performed. CDNA size marker is Haelll digested q>x 174).
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wt ts23
S P V P D  ( N)  S P A P D  
V Q F Q T <NSs) V Q L Q T
GTCCAGITCCAGA GTCCAG£TCCAGA
Figure 4.4. Sequence o f  M agu ari virus t s 23 S segment mutation. Left panel shows 
sequence o f cloned wild type Maguari vir us S segment cDNA determined by the Sanger di-deoxy 
chain termination method. Right panel shows ts23  sequenced using uncloned PCR product as 
template. The T to C transition at nucleotide 327 (cDNA  sense strand) is shown in bold type. The 
deduced effect o f the mutation on the primary sequence for N and N Ss proteins is shown. See 
abbreviations section for amino acid symbols.
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nucleotides virus N protein  NSs p ro te in
GTCCAC CTCCAGAC t s 2
GTCCAG TTCCAGAC MAG
GTCCAG TTCCAGAC NOR
GTCCAG TTCCAGAC CV
GTCCAG I TCCAGAC MD
ACCCAG 7 TCCTGAC BUN
GTCCAG 7 TCCAGAC BAT
ATGCAG I GCCTGAC GER
TGTCAG I TCCAGAT KRI
GTCCAG 7 CCTCGAT GRO
ACCCAA 1 TGGTAAC LAC
ATCCAA 7 TAACAGC SSH
ACCCAA 7 TGATAAC LUM
ATCCTG 7 GCCAGAC AIO
NSP
NSP
NSP
NSP
NSP
NNP
NSP
NNA
NMS
NSP
NNP
NNP
NNP
ANP
APDD
7PDD
7PDD
^PDD
7PDD
VPDD
VPDD
7PDY
VPDD
VLDD
SNN
USD
DNN
VPDT
V£L
V£ 
VC 
VC 
VC 
TC 
VC FI
QT 
Q T 
QT 
QT 
FLT
C£
VC
TC
IQ
TC
IL
QT
■QT 
MdCLT
QM
SM
VT
TA
IT
QT
Table 4.2 Sequence alignment o f  ts23 mutation with other bunyavirus S 
segments. Numbered for Maguari virus S segment sense strand cDNA, nucleotide 327 (boxed) is 
invariant in all S segments o f the bunyavirus genus so far sequenced except for the T to C 
transition found in die Mag ts23 S segment cDNA. The deduced effect on N and N Ss amino acid 
sequences are shown and compared to the sequences present in other viruses. At the relevant 
position in N protein, valine occurs in all bunyaviruses except those o f the California serogroup 
(La Crosse, snowshoe-hare and Lumbo viruses) which have isoleucine. The ts23 mutant has 
alanine at tliis residue. For NSs the amino acids at this position are more variable and the leucine 
found in ts23 is also present in the California group viruses although in a different context. See 
abbreviations section for amino acid and virus symbols. (Data compiled by, and includes the 
unpublished results of, E. Dunn and R.M. Elliott).
Since the terminal 15nt at both ends of the clones are formed by the primers used 
for PCR, it is formally possible that a mutation could exist in this region which 
might affect promoter or packaging functions of the segment. Direct RNA 
sequencing to confirm the absence of such mutations in this region was not 
undertaken due to the small amounts of RNA obtainable from the poorly growing 
mutants. Using the PCR based method recently applied to sequence the 5’ terminal 
sequences of Bunyamwera virus mRNA (Jin & Elliott 1993; see Section 1.9.4.1), 
it should now prove possible to check the terminal sequences exactly as depicted in 
Figure 1.9.3 using CsCl banded RNP as a source of RNA. However, although a ts 
mutant carrying a lesion in a non-coding region has been reported for poliovirus 
(Racaniello & Meriam 1986), mutations resulting in a ts phenotype almost always 
occur in protein coding regions of a genome.
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The finding here of a point mutation in the S segment of ta23, with no mutations 
being found in the S segment of other mutant virus groups compared to wild type, 
is evidence that the group III Maguari virus mutants, for which ts23 is the only 
available member, do indeed represent lesions in the S segment. As discussed 
earlier this suggestion contradicts the results o f reassortment studies (Murphy & 
Pringle 1986) but is in agreement with the assignment expected based on target 
sequence size and the unambiguous findings for the California group bunyaviruses 
(Gentsch et al 197?). Further sequencing studies to identify lesions in the L 
segments of group I mutants would be useful additional evidence for group 
assignment as would complete sequence determination of the L and M segments of 
ts23. Complementation with a wild type segment would provide the strongest 
evidence of which segment contains the ts lesion.
During growth of ts23 no revertants were observed. This prevented investigation of 
nucleotide 327 in a revertant which should have demonstrated that the mutation 
identified was no longer present. Ts23 produces only very small plaques at the 
permissive temperature. It is not known whether the small plaque phenotype is a 
result of the same mutation as the ts phenotype or whether another mutation is 
responsible. Revertants of a small plaque mutant would have been easy to spot had 
they occured and their absence is puzzling considering the growth advantage they 
would be expected to have especially as a single point mutation is all that would be 
required for reversion if the identified lesion was the cause of the small plaque 
phenotype.
4.4 Rescue experiments
Several attempts were made to rescue the Maguari vjrrus ts23 mutant using plasmid 
derived RNA. As described in Chapter 3, linearised cDNA designed to produce T7 
transcripts corresponding to B unyamwera virus S RNA, w<xs transfected into cells 
infected with vTF7-3, to supply T7 RNA polymerase, and the ts mutant. Cells 
were then incubated at 31°C or 38-5°C for 24 or 48 hours before supernatants were 
harvested and inoculated onto BHK monolayers and then grown at either 
temperature for plaques to form. Phosphonoacetic acid was included in overlays to 
selectively inhibit vaccinia virus replication (Jin 1991). Any plaques forming at 
38-5°C would be expected to be formed by a reassortant virus, Mag/Mag/Bun, with 
the S segment being derived from the plasmid transcribed RNA (see Figure 4.5).
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vTF7-3
T7 RNA- 
polymerase 
Transcription off,—^
transfected linear 
Bun S cDNA
ts helper virus
Am plify
Plaque at non-permissive 
temperature
• o o Replication of synthetic 
%j t  • RNA by helper virus 
proteins at permissive 
temperature
Any plaques forming should have Bunyamwera virus S 
segment derived from cDNA. Check by protein profiles.
G l—►
Mag N s ^  
Bun
Figure 4.5 Rescue strategy using Maguari virus te23 as a counter-selectable helper.
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No plaques were obtained at either temperature. The ts23 mutant is severely 
restricted even at 31°C and in coinfection with vaccinia virus was not able to form 
plaques in this study. Plaquing of non ts control virus was achieved in the presence 
of vTF7-3 and so if rescue of ts23 had occured, the resultant virus should have 
been able to form plaques. Although the Maguari virus ts23 appears not to be 
suitable for a rescue strategy involving vaccinia virus it may still prove useful for 
rescue of S segment RNP assembled in vitro since the only competing virus present 
would be the non-ts virus which replication of the synthetic S segment would 
produce.
Establishment of a rescue system involving Maguari virus ts23 would enable some 
interesting studies to be conducted. With the identified lesion causing alteration of 
two proteins, it would be expected that one lesion may be more important than the 
other. For example if, the Val to Ala mutation in the N protein were more damaging 
than the Phe to Leu change in the NSs protein, it might be possible to rescue a less 
restricted virus by supplying just the N protein in a synthetic S segment. Such 
separate expression of proteins usually encoded by overlapping reading frames was 
successfully achieved for influenza vims and resulted in a vims which packaged an 
additional segment (Luo et al 1991; see Section 1.8.8.2). The success of such an 
experiment would not only demonstrate that bunyaviruses can package more than 
three segments but might provide useful information concerning the function of N  
or NSs by comparing phenotypes of viruses known to be mutant only in one or 
other o f the proteins, with that of wild type vims.
4.5 Why so few S segment mutants?
In addition to the smaller target size for mutagenesis already discussed, the 
overlapping coding strategy employed by the S segment might place tight 
constraints on sequence variation. This is because a significant proportion of S 
segment mutations would be expected to affect two genes, those coding for the N  
and NSs proteins, and this might result in a higher proportion o f mutations being 
lethal. The validity of this argument could be assesed by isolating a reasonable 
number of ts mutants for a representative o f another genus other than the 
Bunyavirus genus which is the only group to employ overlapping reading frames 
for N and NSs. If the presence of overlapping genes did limit the proportion of S 
segment bunyavirus mutants, analagous limitation would not be expected for these 
other groups of viruses since their S segment coding sequences do not overlap. 
Five ts mutants of Uukiniemi vims have been assigned to one o f two reassortant
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groups . Such a small number might not be expected to contain any S segment 
mutants due to the smaller target size and therefore more mutants would need to be 
characterised for this suggestion to be investigated.
For influenza virus, direct evidence exists that more than the usual eight segments 
can be packaged (see Section 1.8). Some evidence exists that this may also be the 
case for bunyaviruses. In preparations of purified bunyaviruses it is rarely possible 
to achieve recovery of each of the three gene segments in equimolar amounts 
(Elliott 1990). For Germiston bunyavirus, a ratio of 1:1:2-5 for the L, M and S 
segments has been measured from labelled RNP separated by sucrose gradient 
centrifugation (J. Szilagyi personal communication). Also electron microscopy of 
vitrified virus has demonstrated variation in virion size which might reflect variable 
packaging (Talmon et al 1987). While these observations are consistent with an 
'overpacking* hypothesis, they are also the results expected if  a proportion of  
virions contained less than the complete genetic complement of a viable virus.
More compelling evidence comes from the isolation of several reassortant viruses 
which appear to be heterozygous for the S segment (Iroegbu & Pringle 1981a and 
1981b). Protein analysis o f end point dilution infections provides evidence that 
such viruses are genuine heterozygotes and not merely the result of contamination 
with a reassortant virus (C.R. Pringle personal communication). Heterozygosity 
requires packaging of at least two segments of the same type. Assuming random 
segregation of two distinguishable S segments in a heterozygote, estimation of S 
segment copy number might be possible by analysing plaqued progeny and
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determining the proportion of each genotype present. For example, if  two S 
segments are packaged and can freely segregate to progeny from a heterozygote, 
50% of plaques would be expected to remain heterozygous (SI and S2 or S2 and  
SI being the possible choices leading to heterozygosity) with 25% o f each 
homozygote also occuring (SI and SI and S2 and S2 being pakaged for each). The 
more segments packaged the lower the expected frequency o f homozygous 
progeny. Also for multi segment packaging, any bias of segment frequency in the 
parent would be reflected by the proportion of each homozygote found in progeny 
virus.
The absence of revertants of ts23 may be explicable if the mutant protein had a 
dominant interfering effect. This is feasible for a protein such as the N protein 
which has to polymerise onto viral RNA to form a functional transcription template. 
A defect might enable N protein to bind RNA or an existing N protein nucleation 
centte already formed on the RNA, but prevent further binding of N  protein even of 
the correct conformation. By acting as a terminator of coordinate binding, a very 
small dose of mutant to wildtype protein could effectively block replication at the 
stage of transcription template assembly and so when revertant genomes occured 
they would be unable to complement the defect. If the small plaque and ts 
phenotypes are caused by the same lesion, any dominant-interfering affect o f the 
ts23 gene products could be investigated by assessing the plaque forming ability of  
wild type virus in a cell sheet which had previously been infected with ts23. A  
dominant interfering effect would restrict formation of plaques by wild type virus.
4.6 Exploitation of S segment amplification for other bunyaviruses.
The ease and apparent lack of error with which the S segments of the Maguari virus 
ts mutants were cloned led to the technique being applied to isolate full length 
cDNA clones for the S segments of other viruses. Since for all available sequences, 
the bunyaviruses share common 5' and 3' nucleotides at the termini o f the S 
segments for fifteen nucleotides, it was possible to use the technique without 
modification. RNA was purified from crude virus preparations o f Northway, 
Cache Valley, Main Drain, Batai, Kairi, Guaroa and Lumbo viruses and cDNA  
obtained by the coupled RT/PCR used for the Maguari virus mutants. For all but 
Guaroa virus, single DNA bands o f the expected size for the S segment were 
obtained (see Figure 4.6) and cloned in phagemid vectors for sequencing. Guaroa 
virus S segment cDNA was later amplified and cloned using fresh RNA and 
slightly shorter primers (R.M. Elliott personal communication). Sequencing 
(performed by E. Dunn) confirmed the clones for different viruses to be different
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from each other and demonstrated the usefulness of the technique which doubled 
the number of complete S segment cDNAs available. The sequence data and 
comparisons with existing data will be discussed elsewhere (E. Dunn, D. Pritlove 
and R.M. Elliott.; Manuscript in preparation).
(bp’s)
1,353
1,078
872
603
310
Figure 4.6 Bunyavirus S segment cDNAs. A 1% agarose gel stained with ethidium 
bromide was used to visualise S segment cDNAs amplified by coupled-reverse transcription /PCR 
(DNA size marker is Haelll digested 0X174). See text for details.
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4.7 Chapter 4 summary.
In an attempt to identify a counter-selectable virus for rescue of plasmid derived S 
segment RNA, representatives of each of the three ts reassortment groups o f  
Maguari virus (Pringle 1990) were examined to identify a ts virus with an S 
segment lesion. Previous characterisation had assigned group II mutations to the M 
segment, suggested that the group I mutants earned S segment mutations and that 
the single group III mutant, ts23, resulted from a lesion in the L segment (Murphy 
and Pringle 1987). Because of the relative frequencies with which mutants 
belonging to each of the three groups could be generated in random mutagenesis 
studies, this assignment was not as expected based on the assumption that genes of 
larger target size would produce more mutants in such experiments than those of 
smaller size (Pringle 1990). Conversely, thorough studies o f ts mutants of 
California group bunyaviruses (Gentsch et al 1979) demonstrated that the two well 
represented reassortment groups earned lesions in the L and M segments not the M 
and S segments as suggested for Maguari virus mutants.
Attempts to compare the levels of RNA and protein synthesised in cells infected 
with mutants at the permissive (31°C) or non-permissive (38.5°C) temperatures 
were hampered by difficulties in growing stocks of sufficiently high titre to enable 
infections to be established at high multiplicity.
To enable the S segments of mutants from each of the three reassortment groups to 
be sequenced, a rapid PCR-based procedure was developed which allowed full- 
length S segment cDNA to be amplified in a single step from RNA isolated from 
crude preparations of vims. Using this method, full-length S segment cDNAs were 
amplified and cloned from three ts mutants (ts6, t s l l  and ts23; representing 
reassortment groups I, II and III respectively) and from wild type Maguari vims. 
Three cDNA clones of each segment were sequenced by the Sanger di-deoxy chain 
termination method. No mutations were found in the ts6 or t s l l  S segment cDNAs 
compared to wild type. A single point mutation was found in the S segment cDNA  
of ts23 which was also apparent when the non-cloned PCR population was 
sequenced directly. The mutation was at nucleotide 327 (sense strand cDNA) and 
altered a thymidine (invariant in all bunyavirus S segment cDNAs so far sequenced) 
to a cytosine. This mutation is expected to alter the primary amino acid sequences 
of both the N and NSs proteins which overlap this region o f the S segment. The
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predicted change in the N protein alters a valine residue (invariant in all sequenced 
members of the Bunyamwera group viruses) to an alanine residue. For NSs this 
region is slightly less conserved for different bunyaviruses. Phenylalanine is 
replaced by leucine which is also found in the equivalent position in the NSs 
proteins of three California group bunyaviruses.
Maguari virus ts23 was used as a helper virus in attempt to replicate RNA  
transcribed in vivo from a Bunyamwera virus cDNA by the vTF7-3 T7 polymerase 
expression system. Progeny virus were amplified and grown at 38.5°C to suppress 
the ts helper virus. Any plaques forming were expected to contain a reassortant 
virus containing a Bunyamwera virus S segment (derived from cDN A) and 
Maguari virus L and M segments (derived from ts23). No plaques formed even at 
the non permissive temperature indicating that the poorly growing ts23 mutant may 
not be suitable for this type of experiment.
The PCR based method developed for amplification of S segment cDNAs from the 
Maguari virus ts mutants was exploited to clone several previously uncloned S 
segments from other bunyaviruses.
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The inability to detect rescue of synthetic RNA corresponding to a distinguishable 
but bone-fida. bunyavirus S segment could have been due to the low efficiency of 
the system. Bunyavirus-like RNA containing a reporter gene might increase the 
level of detection of rescued RNA and so enable conditions to be optimised to an 
efficiency which would allow rescue and detection of virus-like RNA.
Two reporter gene containing constructs were made, both employing T7 RNA- 
polymerase promoter and a run-off transcription site to produce RNA with 
authentic bunyavirus termini flanking the reporter gene. The first construct makes 
positive stranded RNA containing message-sense reporter gene RNA flanked by 
Bunyamwera virus S segment cRNA termini, while the second makes a vRNA- 
like transcript containing antisense reporter gene RNA.
No measure of the proportion of cells in a monolayer which were transfected or 
infected was made in the studies reported in this thesis. Immunofluorescence could be 
employed to help optimise infection/transfection conditions to maximise the number 
of cells receiving both virus and nucleic acid.
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5.1 Construction o f pUC118/T7BunS(+)30/29CAT.
Two synthetic oligonucleotides were used to create a 102bp fragment containing 
the terminal 30 (5') and 29 (3') nucleotides of the Bunyamwera virus S segment 
cRNA, separated by a restriction site into which a reporter gene could be cloned. 
The overall cloning strategy is shown in Figure 5.1. The cDNA was flanked by a 
T7 promoter at one end and a Xbal restriction site at the other to allow run-off 
trascripts to be made (Figure 5.2). A 15mer (5' CCTGCAGCCT CTAGA) was 
annealed to the 3' end o f a 102mer (5' CGAATTCTAATACGA  
CTCACTATAAGTAGTGTACTCCACACTACAAACTTGCTAAGCTTATTTTA 
AGTTTTAGGTGGAGCACACTACTCTAGAGGCTGCAGG) and extended 
using T7 DNA polymerase to make a double stranded fragment 102 base pairs 
long. This fragment was digested with EcoRI and 5' phosphorylated resulting in a 
blunt/EcoRI phosphorylated fragment. This was ligated to pUC118 which had 
been cut with Hindm and end-filled (destroying the HindM site and generating a 
blunt end) followed by EcoRI digestion and dephosphorylation. The ligation 
reaction was transformed into E.coli strain XL1 and recombinants selected by 
ampicillin resistance and white colony phenotype in the presence of X-gal. Single­
stranded DNA generated from XL1 cells harbouring the plasmid, by infection with 
helper phage M13K07, was sequenced to confirm the presence of correct insert 
(Figure 5.3).
A plasmid containing the correct insert was cleaved with Hindm at the unique site 
between the Bun S terminal sequences and ligated to a H indlll fragment 
containing the CAT coding sequence and some Tn9 flanking sequence. 
Sequencing was used to identify clones containing the CAT gene in the correct 
orientation. The final construct map is shown in Figure 5.4. For brevity, 
pUC118/T7BunS(+)30/29CAT is abbreviated to pBunS(+)CAT.
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dephosphory la ted  vector,  
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Figure 5.1. Construction of pUCl 18/T7BunS(+)30/29 CAT. A 102mer DNA  
fragment was assembled from two overlapping oligonucleotides (a 102mer and a complementary 
15mer ). This fragment contains (5’ to 3’ for die ss 102mer): an EcoRI restriction site followed  
by T7 promoter followed by 30nt Bunyamwera virus S segment sequence (cRNA 5' terminus) 
followed by a Hindlll cloning site followed by 29nt Bun S sequence (cRNA 3' terminus) 
followed by Xbal and Psd restriction sites. When cloned into pUCl 18 (in which the Hindlll site 
had been destroyed) die insert was cleaved at the H indlll site between die Bun termini and a 
fragment of Tn9 containing die CAT coding sequence was ligated. Clones were sequenced to 
idendfy those containing die CAT open reading frame in die correct orientahon. The Map and 
partial sequence of die construct is shown in Figure 5.4.
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UACACUACUoh 3 '  (Bunyamwera virus
S se g m e n t  cRNA
term inus)
Bun S Xbal
BunS cDNA co n s t ru c t  
with Xbal site.
. TACACTAC T CTAGA
. ATGTGATG AGATCA
Xbal
digestion
TACACTACT
ATGTGATGAGATC— • • • UACACUACUCUA£ oh 3
T7 RNA-
polymerase (4 extra bases)
Mung bean 
nuclese 
digestion
TACACTACT
ATGTGATGA
.UACACUACUoh 3
I? RNA_ (Correct terminus)
polymerase
Figure 5.2 Xbal run-off transcription end for Bunyamwera virus cRNA 3' 
terminus. DNA construct sequences are shown on the left as double strands with the top strand 
written 5'-3'. Single stranded RNA 3' run o ff transcription termini are shown to the right of 
their relevant DNA templates. This Xbal run o ff site is used for pUC9/BunS+ (Chapter 3) and 
the pBunS(+)CAT construct of this chapter.
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EcoRI 
T7 promoter
B un S 5 ’ 
(30  nt)
Hind m
Bun S 3' 
(29  nt)
■
I
■
X bal
End-filled
H indlH
(vector) —
Primer —
Figure 5.3. D N A  sequence o f  cloned 1 0 2 m e r  oligonucleotide. Three clones are 
shown each with the Hindlll site o f the vector end-filled to a different base. 32P end-labelled  
universal primer and a doubled ratio o f dideoxy:deoxy NTP were used to allow sequence close to 
the primer to be read. The first base after the primer is easily read here (see Figure 5.4 for the 
relationship o f vector to insert and position o f universal primer binding). Clone 1 above was 
digested with Hindlll (between die Bun S termini) to allow ligation o f a H indlll fragment 
containing the CAT open reading frame resulting in pUC118/T7BunS(+)30/29CAT (see Figures 
5.1 and 5.4).
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Figure 5.4 Map of pUCl 18/T7BunS(+)30/29 CAT. Construct map (top— not to 
scale) shows the components o f pBunS(+)CAT including sites for common restriction enzymes 
and transcription start site from the T7 promoter (arrow). Under the map is sequence detail o f 
various junctions including flanking vector sequence (lower case letters). Bracketed sequence at 
the start o f B and D are repeated from A and C respectively. T7 run o ff transcription would 
produce a transcript 863 nt long with Bunyamwera virus S segment cRNA termini.
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5.2 Transfection and infection conditions.
Optimisation o f  transfection and vaccinia virus infection conditions was 
performed using pBunS(+)CAT and assaying cell lysates for CAT activity. Two 
transfection methods were investigated: Calcium phosphate mediated transfection 
(using two batches of calcium chloride) and lipofection using commercially 
available Transfectace™. Initially, cells were infected with recombinant vaccinia 
virus vTF7-3, at 2 or 20 pfu/cell and transfected with 5jig uncut pBunS(+)CAT. 
As a control for DNA transfection and CAT detection, plasmid pRR55, which 
constitutively expresses CAT under control o f a cytomegalovirus promoter and 
enhancer (M. McFarlane personal communication), was included. 24 hours post 
transfection, cell sheets were harvested and used to make extracts which were 
then assayed for CAT activity as described in Chapter 2. Because of the varying 
harvesting efficiencies, caused by different degrees of cell losses for the different 
infection and transfection conditions, CAT activity was standardised by correcting 
for protein content of the samples (determined by Bradford assay) and expressing 
CAT activity as picomoles chloramphenicol acetylated/ min/ milligram protein.
Figure 5.5 shows the variable activities obtained for the two batches of calcium 
chloride used. In both cases infection with vTF7-3 at 20pfu/cell resulted in greater 
CAT activity than infection at 2 pfu/cell. Expression from pBunS(+)CAT by 
vTF7-3 at either multiplicity resulted in greater CAT activity than that obtained 
from the constitutively expressing plasmid pRR55 when calcium phosphate was 
used as transfection facilitator. Lipofection greatly increased CAT levels from 
pRR55 and pBunS+CAT at the higher vTF7-3 multiplicity while with vTF7-3 at 
2 pfu/cell one o f the batches of calcium chloride produced a higher level than 
obtained with Transfectace™. Tranfection of pBunS(+)CAT in the absence of 
vTF7-3 gave no detectable CAT activity as expected. Similarly, vTF7-3 infection 
alone failed to produce any CAT activity. Based on these results lipofection was 
adopted to investigate optimum vTF7-3 infection conditions since a difference in 
levels of CAT activity was observable for the two multiplicities used.
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C hloram ­
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2v 20v (+) I 2v 20v (+) I 2v 20v (+) (-)
Ca batch 1 Ca batch 2 Transfectace
Key:
2 v- pBunS(+)CAT with vTF7-3 at 2 pfu/cell 
2 0 v -  pBunS(+)CAT with vTF7-3 at 20 pfu/ccll 
(+ )-  pRR55 (positve control)
( - ) -  No DNA (negative control)
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Ca batch 1 Ca batch 2 Transfectace
Figure 5.5 Transfection conditions for expression of pBunS(+)CAT. BHK 
monolayers were transfected using either of two batches o f calcium chloride or Transfectace™ as 
described in die text. CAT assays were performed on cell extracts (top) and activity expressed, 
after correcting for protein concentrations o f samples determined by Bradford assay, as picomoles 
chloramphenicol acetylated/min/mg protein (graph). (The autoradiograph o f the TLC plate (top) 
was cut up and rearranged for photography to simplify interpretation— die results presented were 
obtained under identical conditions at die same time)
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5fig circular pBunS(+)CAT DNA was lipofected into BHK cells infected with 
vTF7-3 at 0, 1, 3, 5, 7.5 or 10 pfu/cell. In addition, 10 or 3|ig of linearised and 
dephosphorylated plasmid was transfected into cells infected with vTF7-3 at 10 
pfu/cell. CAT activity was detected in all cases except in the absence of vTF7-3 
(Figure 5.6). In general the linearised plasmid DNA produced lower levels o f  
CAT than circular plasmid. This may be due to less efficient uptake of linear 
DNA, compared to supercoiled plasmids, by cells. Another possibility was that 
the circular plasmids produced concatameric RNA transcripts by the T7 
polymerase (known to be a highly processive enzyme) repeatedly transcribing 
around the plasmid. This would effectively increase the copy number o f the 
transcript. To result in the higher CAT levels observed, the concatameric 
transcript would have to be capable of being translated by internal initiation. An 
alternative explanation is that the shorter transcripts derived from linearised 
template were more rapidly degraded from their 3’ ends than longer transcripts 
produced from the circular templates.
For vTF7-3 infections, a slight increase followed by a slight decrease of activity 
was observed with increasing multiplicity used (Figure 5.6). From these results, 
5 pfu/cell was adopted for use in further experiments. Any increased expression 
at higher multiplicities was felt to be outweighed by the increased cpe observed.
5.3 Expression o f pBunS(+)CAT in bunyavirus infected cells.
The 30 and 29 terminal 5' and 3' nucleotides of the transcript expected from 
pBunS(+)CAT are identical to the respective termini of the Bunyamwera virus S 
segment cRNA. Although the genuine S segment has much longer non-coding 
regions (87 and 185 nt respectively for the 5' and 3' ends of cRNA), the 30 and 
29 terminal nucleotides include at least the sequences which are conserved 
between all segments o f all bunyaviruses (see Figure 1.9.1) and so would be 
expected to include the promoter and packaging signals. Under the correct 
conditions, the RNA transcribed from pBunS(+)CAT, might be recognised and 
replicated by Bunyamwera virus proteins.
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Figure 5.6 vTF7-3 dependent CAT expression. BHK cells were transfected with 3pg 
pBunS(+)CAT after infection o f vTF7-3 at varying multiplicities to determine the optimum  
conditions for expression o f the CAT transcript by T7 RNA polymerase encoded by the 
recombinant vaccinia virus. 3 or lOpg o f linearised and dephosphorylated pBunS(+)CAT was 
transfected into cells infected with vTF7-3 at lOpfu/cell. These show reduced CAT activity 
compared with the transfection of circular plasmids.
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This possibility was investigated by transfecting linearised pBunS(+)CAT into 
cells infected with both vTF7-3 and Bunyamwera virus. To increase the chances 
of the Bunyamwera vims infection being at the correct stage for recognition of the 
synthetic RNA, the Bunyamwera virus was added to cells either immediately 
preceding (-1 hour), or 12 hours before, transfection and infection with vTF7-3. 
Supernatants were harvested at 24, 48 or 72 hours post transfection and examined 
to see if  any of the synthetic RNA had being packaged by progeny virions.
The levels of CAT activity in the transfected/infected cell sheets are shown 
graphically in Figure 5.7. Infection of cells with Bunyamwera virus clearly 
reduces the level of CAT activity (compare the second and third lanes to the first 
lane for each of the four panels o f the graph). This reduction might have been 
due to encapsidation of the CAT RNA by N protein or to a non-specific reduction 
of non-bunyavirus expression (Figure 3.3 demonstrates the marked shut off of 
host cell and vaccinia virus gene expression in the presence of Bunyamwera 
virus). When supernatants from these transfections were used to infect fresh 
BHK cells, which were then assayed for CAT activity (to see if  RNP containing 
CAT RNA had been packaged into virions), there was no evidence of 
Bunyamwera virus specific CAT activity. In fact, carry over o f plasmid DNA, 
vTF7-3 and (presumably) transfection reagent, resulted in higher detectable CAT 
activity than those also infected with Bunyamwera virus (see Figure 5.7). Similar 
inhibition of CAT activity was observed when Bunyamwera virus infected cells 
were transfected with control plasmid pRR55 which contains no bunyavirus 
sequence— suggesting a non-specific shut o ff by Bunyamwera virus. It is 
assumed that if the synthetic RNA were recognised and encapsidated by N protein 
that it would then be recognised as a 'bunyavirus gene' and not be down 
regulated. This proposal could only be confirmed by achieving rescue of the 
RNA. No evidence of rescue occui£d here and efforts were directed to the second 
reporter constuct which is designed to produce CAT activity only if replicated by 
a bunyavirus. However, the use of the positive stranded CAT construct had at 
least allowed assessment of suitable transfection and vTF7-3 infection conditions.
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Figure 5.7 Expression of pBunS(+)CAT in the presence of replicating 
Bunyamwera virus. Transfections (top graph): BHK cells were infected with vTF7-3 at 5 
pfu/cell to supply T7 RNA polymerase. In addition some cells were infected with Bunyamwera 
virus (10 pfu/cell) either immediately (-lhr) or 12 hours prior to transfection o f all cells with 
3pg linearised and dephosphorylated pBunS(+)CAT. After 24, 48 or 72 hours, cell sheets were 
harvested and assayed for CAT activity. In all cases Bunyamwera virus infection appeared to 
significandy reduce the level o f CAT detected. Supernatants were retained and used to infect fresh 
cells (bottom graph). Activity was observed following addition o f supernatant fluids from the 
transfected cells, to fresh cells which were then harvested 48 hr later. The activity for vTF7-3 
infection alone was strongest and could be due only to carry over from transfection. Samples 
also infected with Bunyamwera virus showed markedly reduced activity.
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5.4 Negative stranded Bunyamwera virus S segment /  CAT RNA.
The initial breakthrough in negative strand RNA virus engineering was facilitated 
by a simple reporter system for detecting influenza virus dependent replication 
(Luytjes e ta l  1989; see Section 1.8.5). A chimeric RNA containing an anti-sense 
copy o f the CAT open reading frame flanked by negative stranded (vRNA) 
influenza virus termini was constructed. Being of negative polarity, the plasmid 
derived RNA could not be translated to give CAT enzyme unless it was first 
copied to give a positive stranded (mRNA) transcript. Since RNA templated 
transcription does not normally occur in eukaryote cells, this copying step could 
only occur if the chimeric RNA was recognised by influenza virus proteins. 
Having a sensitive and absolute reporter system for the influenza virus dependent 
copying step (i.e. assaying for the presence o f CAT enzyme), it was possible to 
define conditions for associating viral proteins with the chimeric RNA, to 
reconstitute a synthetic RNP and replicate it using a wild type influenza helper 
virus.
To apply the reporter system to Bunyamwera virus, assuming the transcription 
and translation signals lie in the non-coding regions of viral segments, it was 
decided to base the construct on the most highly expressed segment (the S 
segment) to increase the levels of reporter gene expression.
5.4.1 Design of pBunS(-)CAT
The precise design for the chimeric construct was based on the following criteria:
i) Transcription by T7 RNA polymerase should give a negative stranded (vRNA) 
transcript containing an antisense copy of CAT such that translation competent 
mRNA can only be made if  the transcript was copied by bunyavirus proteins. T7 
RNA polymerase was chosen as it would permit both in vitro  and in vivo  (by 
vTF7-3 infection) transcription from a defined and stringent promoter.
ii) The termini of the chimeric RNA should contain the same sequences as the 
Bunyamwera virus S segment with terminal bases exactly mimicking viral 
segments. This would require precise initiation and termination of the T7 
transcript.
iii) Since the cis signals required for bunyavirus transcription, translation, 
encapsidation by N protein and packaging into virions are not clearly defined, as
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much as possible of the non-coding S segment sequence should be pesent. The 
ideal would be an exact replacement of the N protein open reading frame with 
CAT coding sequence.
5.4.2 Transcript 5' end tailoring
At the transcription start site, T7 RNA polymerase usually initiates (+1) on a 
guanosine residue immediately  ^ the tightly conserved 17bp promoter. In 
bacteriophage T7 the next two transcribed nucleotides are also G (Dunn & Studier 
1983; Hamm et al 1990). For all bunyavirus segments, the 5' terminal nucleotide 
is an adenine residue followed by guanosine then uridine. Influenza virus cRNA 
transcripts, which have the same First five 5' nucleotides as bunyavirus RNA, had 
been generated by other workers using T7 RNA polymerase. Two groups 
assessed initiation on an A residue by demonstrating incorporation of 32P 
supplied as gamma labelled ATP (Luytjes et al 1989; Seong and Brownlee 
1992a). The required sequences were therefore expected to be obtainable by 
replacing the usual G triplet with viral sequence (see Figure 5.8). Since the first 
four nucleotides are identical to those used by influenza virus and since T7 
influenza vims transcripts had been successfully replicated by viral proteins, no 
attempt was made to map the 5' end of the transcripts produced from the 
Bunyamwera virus construct.
5.4.3 Transcript 3' end tailoring.
For the Bunyamwera virus S segment plasmid constructs described in Chapter 3, 
the 3' end had been defined by run off transcription from a linearised plasmid. 
The blunt-ended run-off DNA end was generated by using mung bean nuclease to 
remove the 5' single-stranded extension remaining after Xbal digestion of an 
appropriately positioned site (Figure 5.2). While this approach is adequate in 
principle, the precise conditions for nuclease digestion were difficult to control 
and monitor, and it was felt preferable to simplify this step in the new construct. 
For T7 RNA polymerase, a run-off end which is blunt or 3’ recessed is preferable 
to reduce the possibility of the enzyme transferring template strands and extending 
the transcript with complementary bases (Promega 1991). This limited the means 
of producing template with correct end sequence since for a 3' recessed cutting 
restriction enzyme, most of the enzyme recognition sequence would remain in the 
5' overhang and would be transcribed by the polymerase. A search of available 
restriction enzyme recognition sites ruled out a fortuitous match of an enzyme site
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to the terminal sequences required and so a different approach was sought. 
Attention was turned to restriction enzymes which have separated cleavage and 
recognition sites. Bbsl was chosen as it does not cut the vector nor planned insert 
and its non-paundromic recognition site could be inverted and placed down 
stream of the insert to cleave a 5' overhang ending at the precise final template 
base required (see Figure 5.9)
. . . . TAATACGACTCACTATAAGTAGTGTA (Bunyamwera virus 
requirement)
Figure 5.8 T 7 promoter initiation and bunyavirus cDNA requirements. The 17nt 
core promoter is written 5 -3 ' top strand. Sequences transcribed into RNA are in bold type with 
the 1st transcript base shown labelled +1. A shows the optimum initiation nucleotides— three G 
residues, as found in bacteriophage T7 (Dunn & Studier 1983; Hamm et al 1990). B shows the 
alternative bases required for transcription of bunyavirus or influenza vims-like transcripts. These 
are common for die first five nucleotides and influenza virus transcripts produced in this way 
have been successfully replicated by influenza virus (Luytjes et al 1989 suggesting that the 
arrangement should function to produce bunyavirus transcripts initiating on the correct 
nucleotide.
+1
. . . . TAATACGACTCACTATAGGG (<j> T7 genes)
T7 promoter
+1
+1
 T AAT ACG ACT C ACT AT A AGT AG (Influenza virus 
requirement)
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3 1 . . .CTTCTGNNNNNNN. . . K S SUe)
▲
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. ATGTGATGP
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CG
GTCT TC TAGA
CAGAAGATCT
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CG.
Bun S cDNA Inverted 
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\
Xbal site for 
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T 7 tra n sc rip tio n  o f 
Bbsl c u t tem p la te
v
.TACAC
ATGTGATGA
(Bbsl cut template)
UACACUACUoh (Transcript)
Figure 5.9 Bbsl restriction site for run off transcription. Because the recognition 
site is separated from the sequence-independent cleavage site, the non-palindromic site of Bbsl 
could be positioned to produce die required cD N A  terminus with a 5' overhang. Transcription 
from a template prepared by a single cleavage reaction gives a transcript with the exact 3' end 
sequence required for bunyavirus vRNA. The sequence shown, including the Xbal site for 
fragment cloning were used for die pBunS(-)CAT construct described in this chapter.
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5.5 Construction of pBunS(-)CAT
The negative stranded CAT/Bun S construct was synthesised using existing DNA 
constructs and four oligonucleotides. Two oligonucleotides were used to 
recombine the CAT open reading frame into the S segment at the start and stop 
codons for N protein, thereby replacing it. The other two oligonucleotides 
introduced the T7 promoter and Bbsl restriction site for run off transcription. A 
multi step PCR procedure was employed for the in vitro recombination of the 
component fragments at the precise positions required (see Figure 5.10). To 
lessen the likelihood of accumulating mutations during repeated amplification 
cycles, two precautions were taken:
i) Taq DNA polymerase was replaced with Vent™ thermostable polymerase (New 
England Biolabs) as this enzyme has a higher fidelity due to its 3 —5* exonuclease 
'proof-reading' activity which Taq lacks (Gelfand 1989; Mattila et al 1991).
ii) For each step, several template concentrations were employed and each 
amplified for different numbers of cycles. The reaction which had undergone the 
fewest rounds of amplification, while still giving a clean product on gels, was 
used for subsequent steps. In this way the total number of cycles employed, and 
therefore the number of opportunities for mutation to arise, was kept to a 
minimum.
The first step was to amplify the CAT open reading frame with oligonucleotides to 
tail the CAT sequence with short regions identical to those flanking the N protein 
open reading frame in the S segment. This step also removed the Tn9 flanking 
sequence. This stage was achieved by only eight cycles o f PCR (Figure 5.11). 
Next, in separate reactions, each terminus of the S segment was recombined with 
the Bun-tailed CAT fragment using the relevant terminal primer (which included 
T7 promoter or Bbsl site) together with the distal CAT primer. This generated two 
overlapping fragments both containing the CAT coding sequence recombined with 
either the 3' or 5' non coding S segment sequences together with the relevant 
terminal modifications (Figure 5.12). These fragments were recombined by 
mixing and amplifying with the segment terminal primers (Figure 5.13). The 
whole fragment was digested with Xbal (one site, adjacent to the Bbsl site) and 
ligated as a blunt ended/Xbal fragment into Xbal and Smal digested pUC118. The 
final fragment had under gone a maximium of 40 PCR rounds with the S segment 
regions only being subjected to 32 rounds. Sequencing of the termini into the CAT 
open reading frame, showed that the recombination was correct and that no point 
mutations had occured.
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Bun 5'(+) Bun 3'(+)
CAT T7Bun 3'(+)Bun 5'(+)
Tn9 DNA
Bun S cDNA
BunS(-)CAT
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Figure 5.10 Templates an d  primers for construction o f  pBunS(-)CAT.The 
relationship between the primers used (PI to P4) and the DNA templates is shown. Primers are 
drawn as lines widi half arrow heads at dieir 3' ends. PI and P2 are designed to amplify the CAT 
open reading frame from a fragment o f transposon Tn9 and tail it with short regions o f  
Bunyamwera virus S segment immediately adjacent to the N protein coding region. The 
sequences o f the primers are as follows: PI: 5' G G T C A T T A A A G G C T C T T T A A T G G A  
GAAAAAAATCACTGG — underlined sequence is Bunyamwera virus S segm ent cDNA  
nucleotides 67-85 which immediately preceed the N protein open reading frame. The remainder of 
die sequence is die first 20 nucleotides of die CAT open reading frame starting with the ATG 
initiation codon. P2: 5 'GCCCGATTAAAAATGCATCCCTG CTTACGCCCCGCCCTGCC  
ACT — underlined sequence is die complement o f Bunyamwera virus S segm ent cDNA  
nucleotides 787-811 which immediately follow die N protein open reading frame. The remainder 
of the sequence is die complement of die last 20 nucleotides o f die CAT open reading frame 
starting widi die complement of die stop codon. P3: 5' GCTCTAGAAGACGCAGTAGTGT  
A C T C CA C A C  — Underlined sequence is the first 17 nucleotides of Bunyamwera virus S 
segment cDNA. The remainder of die sequence codes for a Xbal cloning site and an inverted Bbsl 
site to allow cleavage at die viral cDNA terminus for run-off transcription (see Figure 5.9). P4: 
5' CGGAATTCTAATACGACTCACTATAAGTAGTGTGCTCCACCT — Underlined sequence 
is the complement of die last 17 nucleoddes o f the Bunyamwera virus S segment cDNA. This is 
immediately preceeded by a T7 promoter (17 nucleotides ending TATA) and an EcoRI restricdon 
site. See Figures 5.11 to 5.13 for construcdon steps.
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Figure 5.11 Construction o f  pBunS(-)CAT. Figure shows the generation o f three 
DNA fragments used in the construction of pBunS(-)CAT. A fragment containing the CAT gene 
tailed with short Bunyamwera virus S segment sequences which usually lie immediately adjacent 
to die N protein open reading frame, was generated from Tn9 DNA by PCR using primers PI 
and P2 (see Figure 5.10 for primer sequences). The left gel shows the D NA after eight 
amplification cycles starting widi 1 or O.lng Tn9 DNA. Bunyamwera virus S segment cDNA  
termini containing bodi complete non-coding regions and a few codons at either end o f the N  
protein open reading frame, were generated by restriction digest (right gel) o f pBunS300, an 
engineered cDNA in which most of die N protein coding region has been deleted but the start and 
stop transladon codons remain (A. McGregor & R.M. Elliott personal communicadon). Figures 
5.12 and 5.13 show die use o f diese diree fragments to produce pBunS(-)CAT.
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CAT
CAT
Bun 5'(+) CAT
N Bun 3'(+)
'  P4 \
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CAT Bun 3'(+) T7
Figure 5.12 7n vitro recombination of CAT gene DNA with Bunyamwera virus 
S segment cDNA termini. The Bun-tailed CAT fragment from Figure 5.11 was recombined 
with the Bunyamwera virus S segment non-coding regions in separate PCR reactions to give 
two over lapping fragments. The primers used also introduced T7 promoter or Bbsl restriction 
site into the relevant fragment (see Figure 5.10 for primer sequences). The gel shows 
recombination and amplification o f the two fragments after 12 PCR rounds. Figure 5.13 shows 
final recombination of die two fragments generated here to give pBunS(-)CAT.
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P3
CATBun 5'(+)
ca
CAT Bun 3'(+) T7
P4
EcoRI
Figure 5.13 Final recombination to produce pBunS(-)CAT. The overlapping 
fragments generated in figure 5.12 were mixed and recombined by PCR using primers P3 and 
P4. The gel shows the final PCR product and EcoRI digestion pattern EcoRI digestion was done 
to ensure, prior to cloning, that the correct fragment was amplified since any contaminating 
Bunyamwera virus S segment cDNA would be efficiently amplified by the primers used and the 
expected size would be very similar— no EcoRI site is present in BunS cDNA. The intact 
fragment was purified from the gel digested with Xbal (site adjacent to BbSI site for cloning 
purposes), 5’ phosphorylated and cloned to Smal and Xbal cut pUC l 18.
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5.6 Attempt to demonstrate bunyavirus-dependent replication o f  
pBunS(-)CAT RNA
Bbsl cleaved template DNA was transfected into BHK cells infected with vTF7-3 
and Bunyamwera virus to see if the negative stranded RNA transcribed by T7 
RNA polymerase could be used as template for bunyavirus-dependent 
transcription. In the absence of coinfecting Bunyamwera virus, vTF7-3 should 
produce negative stranded transcripts incapable of being translated to give CAT 
activity. Only if Bunyamwera virus recognised and replicated the transcript would 
CAT activity be detected. As a positive control, pBunS/CAT(+)DNA was 
transfected into vTF7-3-infected cells. The results o f the transfections/infections 
are shown in Figure 5.14.
It was immediately apparent that the pBunS(-)CAT was not behaving as expected 
since CAT activity was observed when the construct was transfected into cells 
infected with vTF7-3 alone. In this situation, only negative stranded transcripts 
would be expected from the T7 promoter. The 'no DNA' and 'no virus' controls 
were negative indicating that the activity was dependent on the presence of both 
pBunS(-)CAT and vTF7-3. To investigate whether the activity was dependent on 
the expression of T7 RNA polymerase, by vTF7-3, or of some other activity of 
vaccinia vims, pBunS(-)CAT was transfected into cells infected with either vTF7- 
3 or non-recombinant vaccinia virus (WR strain). pBunS(+)CAT, which is 
expected to produce CAT activity dependent on T7 RNA polymerase, was also 
included as a control. Figure 5.15 shows that for pBunS(+)CAT, activity is 
dependent on vTF7-3 with only very low level acetylation occuring in the 
presence of only the WR strain of vaccinia vims. In contrast, strong activity was 
detected on transfection of pBunS(-) CAT into cells infected with either vTF7-3 
or vaccinia vims WR strain. This demonstrated that the RNA giving rise to CAT 
activity from pBunS(-)CAT was due to a usual product of vaccinia vims infection 
and was not dependent on the presence of T7 RNA polymerase.
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Figure 5.14 In vivo expression o f  pBunS(-)CAT. BHK cells were transfected with 
uncut (lanes 1, 5, 9 and 13) or Bbsl linearised (lanes 2, 6, 10 and 14) pBunS(-)CAT or with 
pBunS(+)CAT (lanes 3, 7, 11 and 15). C ells were also infected with vTF7-3 (lanes 1-4), 
Bunyamwera virus (lanes 5 -8 ), vTF7-3 and Bunyamwera virus (lanes 9 -12 ) or no virus (lanes 
13-16). The experiment was designed to see if the negative stranded T7 transcript expected 
during vTF7-3 infection could be replicated by Bunyamwera virus proteins and produce positive 
stranded RNA which could be translated to give CAT enzyme. W hile the no virus and 
Bunyamwera virus alone controls were negative as expected, activity from pBunS(-)CAT was 
detected, dependent on vTF7-3 infection and independent o f co-infection with Bunyamwera virus.
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C loram -
phenicol
vTF7-3
Figure 5.15 Expression of CAT from pBunS(-)CAT b y  vaccinia virus. BHK 
cells were transfected with either pBunS(+)CAT, which expresses CAT in the presence o f T7 
polymerase supplied by vTF7-3, or pBunS(-)CAT from which T7 transcripts are anti sense to 
CAT m RNA. Infection with vTF7-3 (lanes 1-3) resulted in CAT expression from  
pBunS(+)CAT as expected (lane 3). CAT activity was also detected in vTF7-3 infected cells 
transfected with pBunS(-)CAT (lane 2)). Transfection in the absence o f vaccinia virus (lane 4) 
resulted in no detectable CAT activity while infection with wild type (WR strain) vaccinia virus 
(lanes 5 -7 )  resulted in strong expression o f CAT from pBunS(-)CAT (lane 6) demonstrating that 
a vaccinia virus protein (not T7 RNA polymerase which is only present during vTF7-3 
infection) is the cause o f the observed activity. Very low level CAT activity was also detected 
for pBunS(+)CAT in the presence o f  WR strain vaccinia virus although the activity was 
negligible compared to vTF7-3 dependent expression as expected. This suggested a cryptic 
vaccinia virus promoter was present in pBunS(-)CAT.
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Vaccinia virus gene expression is temporally controlled from two types of 
promoter (early or late, with constitutively expressed genes having both types of 
promoter). Both early and late vaccinia virus promoters have been well 
characterised (Davison & Moss 1989 a, b) and so it was possible to examine 
sequences in the construct to see if a cryptic vaccinia virus promoter existed 
which might explain the unexpected expression of pBunS(-)CAT.
The vaccinia virus late promoter contains a TAAAT motif which if mutated 
drastically reduces expression from it (Davison & Moss 1989b). This motif was 
found in the Bunyamwera virus S segment cDNA upstream of the N protein open 
reading frame. While the flanking sequences differed from those found in 
vaccinia virus, the thorough mutagenesis study of Davison & Moss (1989b) made 
it possible to assess whether the sequence found in the Bunyamwera virus cDNA  
would likely act as a vaccinia vims late promoter. Figure 5.16 shows the position 
of the potential cryptic promoter and compares its sequence with the vaccinia 
virus promoter and the activity resulting from saturation mutagenesis 
performed in recombinant vaccinia viruses (Davison & Moss 1989b). For 
vaccinia virus, mutations to the sequence flanking the critical TAAAT motif 
produce either an increase or decrease of gene expression. When the sequences 
found flanking the TAAAT motif of the Bunyamwera vims cDNA were applied to 
the findings of the mutagenesis study (stars on relevant columns in the graph of 
Figure 5.16) only one nucleotide would be expected to result in significantly 
decreased promoter activity while four are associated with greatly enhanced 
expression (3-4  fold stimulation). The mutagenesis data was compiled from the 
effects of single point mutations but Davison & Moss (1989b) also tested activity 
of the combined predicted optimum flanking sequences and found activity 
increased 6-fold which was greater than any of the component single site 
alterations. This suggests that the effect of the single unfavourable nucleotide in 
the Bunyamwera virus cDNA sequence (the C residue immediately 3' to the 
TAAAT motif—which still produces -30% activity of wild type), might easily be 
compensated for by the four extremely favourable bases present at other positions 
(the 'activity product' of each is -60-fold greater than wild type vaccinia virus 
sequence).
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Figure 5.16 Cryptic vaccinia virus promoter in  Bunyamwera virus cDNA. After 
vaccinia virus dependent CAT expression was detected from pBunS(-)CAT (see Figure 5.15), 
examination of die construct sequence revealed a potential cryptic vaccinia virus promoter in the 
5' non-translated region o f die Bunyamwera virus S segment cDNA (?pV on construct map). 
Transcripts initiating in diis region would be expected to contain translation competent CAT 
sequences. The Bunyamwera virus sequence contains die critical TAAAT m odf found in die 
vaccinia virus 28kD late promoter (boxed sequence in line up o f vaccinia and Bunyamwera virus 
sequences). The Bar chart shows die effect o f saturation mutatagenesis of the promoter or 
flanking nucleotides in vaccinia virus recombinants expressing (3 galactosidase from the 28kD  
promoter (Davison & Moss 1989b). The basal level for wild type promoter is 1 (dotted line) 
while die activity associated with each of die odier three possible nucleotides (in the order 
GATC widi die wild type base left out) at each position, is shown as vertical bars. Mutation of  
the TAAAT m otif drastically reduces activity while alteration o f flanking sequences either 
increases or decreases activity (bars extending above or below die basal level dotted line 
respectively). Flanking mutations equivalent to substitudon with corresponding Bunyamwera 
virus nucleotides are marked widi stars at die top o f the relevant column.
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5.7 CAT reporter constructs : summary
A construct, pBunS(+)CAT, was assembled which gives a Bunyamwera virus S 
segment cRNA-like transcript containing a copy of the bacterial reporter gene 
CAT. This construct was used in transfection experiments to determine suitable 
expression conditions. Transfection using Transfectace™, a comercially available 
liposome preparation, resulted in higher levels of expression than obtained by 
conventional calcium phosphate mediated transfection. Various multiplicities of 
infection with vTF7-3 were examined to supply T7 RNA polymerase in vivo 
while keeping vaccinia virus-induced cpe to a minimum: 5pfu/cell was found to 
permit efficient expression of CAT from the reporter construct.
Packaging of the synthetic reporter RNA into Bunyamwera virus particles could 
not be demonstrated. Carry-over in supernatants of transfected cells of DNA, 
vTF7-3 and transfection facilitator resulted in significant transfer of activity from 
cells not infected with Bunyamwera virus. Where Bunyamwera virus was 
present, CAT activity was significantly diminished. The higher CAT levels found 
in the absence of Bunyamwera virus prevented identification of any Bunyamwera 
vims specific activity.
A second construct was built, pBunS(-)CAT, which was designed to produce 
CAT activity only if T7 transcribed RNA could be copied by Bunyamwera vims 
proteins. Transfection of this construct into vTF7-3 infected cells produced CAT 
activity even in the absence of Bunyamwera virus. This unpredicted activity was 
found to be due to a vaccinia vims protein other than T7 RNA polymerase present 
in the recombinant vTF7-3, since it could also be induced by infection with non 
recombinant (WR strain) vaccinia virus. Comparison of the constmct sequence 
with the well characterised promoter sequences of vaccinia vims indicated a 
potential vaccinia vims late promoter-like sequence in the 5' non-coding region of 
the Bunyamwera virus S segment cDNA, just upstream of the protein coding 
sequences. This sequence is thought to act as a cryptic promoter producing 
positive stranded (mRNA like) transcripts from pBunS(-)CAT in the presence of 
vTF7-3 and so account for the unexpected CAT activity.
The potential cryptic promoter sequence was also present in the whole segment 
constructs investigated in Chapters 3 and 4 and so would be expected to have 
given rise to incorrect RNA transcripts in these earlier studies and may therefore 
have been partly responsible for the failure of this approach.
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As an alternative to transcribing RNA in vivo in the presence of replicating helper 
virus, attempts were made to assemble RNP in vitro using viral proteins and 
synthetic RNA. Transfection into virus infected cells of RNP reconstituted in 
vitro may allow Bunyamwera virus specific replication of synthetic RNA. This 
was the approach used for the rescue of synthetic RNA by influenza virus 
(Luytjes et al 1989). For Bunyamwera virus, the ability to reconstitute RNP in 
vitro may prove particularly useful since it has been shown previously that RNP 
can be transfected into cells and replicated by L protein expressed by a 
recombinant vaccinia virus (Jin & Elliott 1991). This may allow expression of 
synthetic RNP without the need for a replicating helper Bunyamwera virus and so 
may ultimately allow rescue of whole virus by in vitro transcription of cDNAs 
corresponding to all three genome segments.
6.1 CsCl density gradient analysis to assess bunyavirus RNP 
reconstitution.
As discussed in Section 1.9, bunyavirus nucleocapsids are stable in high salt 
concentrations and can be isolated from infected cell lysates or disrupted virions 
by centrifugation through preformed CsCl gradients. In contrast, the RNP of 
orthomyxoviruses dissociate into protein and RNA components under these 
conditions, while for other negative strand RNA viruses such as members of the 
Rhabdoviridae and Paramyxoviridae RNP stability in high salt concentrations is 
also observed. RNP bands at a density of 1.31g/ml while RNA pellets (>1.4g/ml) 
and free protein is found as a diffuse band towards the top of the gradient. For a 
TST41 rotor centrifuge tube, a 6ml preformed gradient containing 20-40% (w/w) 
CsCl overlayed with 5ml sample/low salt buffer will give densities of ~1.45g/m l- 
l.lg /m l over the original 6ml volume. Following centrifugation to equilibrium, 
the RNP bands at the centre of the gradient (see Figure 6.1). For Bunyamwera 
virus sufficient intracellular RNP is present in the cell monolayer of one or two 
large (175 cm2) flasks to allow visual detection.
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Figure 6.1 Banding of Bunyamwera virus RNP in CsCl density gradients. 
Diagramatic representation o f the distribution o f protein and RNA following centrifugation 
through continuous prefonned 20-40% (w/w) CsCl density gradients. Cellular and viral mRNA  
pellets while RNA encapsidated as RNP bands at a characteristic density below free proteins and 
small molecules. The top portion represents a TST41 gradient tube in which an infected cell 
lysate has been loaded and separated into protein, RNA and RNP components. The graph shows 
the type of profile found by quantifying protein and RNA in fractions of the gradient.
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Smaller amounts of RNP can be detected, by scintillation counting of gradient 
fractions, if either their RNA or protein component is radioactively labelled. The 
density of each fraction can be determined by refractive index measurement 
which is related to concentration, and therefore density, of a given salt solution.
For reconstitution experiments labelled RNA was transcribed in vitro by including 
either a 32P or 35S(aS) labelled NTP. When applied to gradients as naked RNA, 
the label was found at the bottom of the gradient (RNA pellet) and also at the top 
of the gradient (unincorporated label) depending on the degree o f purification 
used to separate the RNA from small molecules. Successful formation o f an RNP 
would result in detecting radioactivity in an intermediate band of characteristic 
density (1.31g/ml). CsCl gradients could therefore be used as a useful indicator of 
RNP formation.
6.2 Attempted encapsidation during ongoing translation of N protein.
One possible source of N protein for reconstitution studies is from in vitro  
translation of mRNA transcribed from recombinant plasmid. pTF/BunN (Chapter 
3) can be transcribed and translated in vitro to form Bunyamwera virus N and 
NSs proteins. The RNA produced from pTF/BunN has heterologous sequences 
flanking the N protein open reading frame and so would not be expected to be 
specifically encapsidated by N protein. RNA transcribed from pBunS(-)CAT has 
termini identical to Bunyamwera virus S segment and is therefore thought to 
contain encapsidation signals for N protein recognition.
As an alternative to incubating RNA with preformed protein, attempts were made 
to encapsidate pBunS(-)CAT RNA by transcribing it while N protein was being 
translated from preformed pTF/BunN RNA. A requirement for rescue of reovirus 
RNA was that the RNA was first translated in a rabbit reticulocyte lysate (Roner 
et al 1990). Protein synthesis was shown to be required although nuclease 
analysis suggested that encapsidation of RNA by newly translated proteins did 
not occur. Nevertheless, for bunyaviruses encapsidation by newly translated 
proteins might occur by allowing polymerisation of N protein onto nascent 
RNA— as is expected to occur in vivo for bunyaviruses which replicate entirely in 
the cytoplasm. To investigate this possibility, a rabbit reticulocyte lysate was used 
to translate N protein from preformed RNA and was supplemented with a T7 
transcription reaction containing pBunS(-)CAT template to see whether the 
nascent RNA could be efficiently encapsidated by newly translated N  protein.
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N protein was labelled with 35S methionine and a control reaction lacking the 
pBunS(-) CAT template was included (reactions performed by E. Dunn and R.M. 
Elliott).
The products of these reactions were analysed on CsCl density gradients to see if 
any 35S labelled protein had banded lower down the gradient than the diffuse 
banding expected for free protein. Figure 6.2 shows the distribution of 
radioactivity for fractions of each gradient and demonstrates no clear difference 
in the presence or absence of pBunS(-)CAT template suggesting that no RNP was 
formed. Parallel gradients showed RNP to band in fractions 12, 13 and 14 which 
are well separated from fraction 20 and onwards where rising counts, due to the 
less dense free protein and label, are observed. Therefore in this experiment, no 
RNP formation was observed when pBunS(-)CAT RNA was transcribed in a 
reticulocyte lysate in which Bunyamwera virus N protein was being
translated from preformed RNA.
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Figure 6.2 Attempted encapsidation during N protein synthesis. In vitro transcribed 
BunN mRNA was translated in a rabbit reticulocyte lysate containing a transcription mix to 
synthesise RNA from pBunS(-)CAT RNA in the presence o f  ongoing N protein translation (N 
mRNA + pBunS(-)CAT DNA). A control reaction contained equivalent components but lacked 
pBunS(-)CAT DNA template (N mRNA). Proteins were labelled with 35S methionine. The 
products o f both reactions were analysed by CsCl gradient centrifugation. Scintillation counting 
of fractions was used to determine the distribution o f label in the gradient. In a parallel gradient 
RNP was shown to band in fractions 12, 13 and 14. No peak o f counts is seen in this region 
suggesting no RNP was formed. The increasing counts seen towards die top o f the gradient 
(fraction 20 onwards) are as expected for free protein and unincorporated label.
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6.3 Reconstitution using denatured RNP as a protein source.
For influenza virus, reconstitution of synthetic RNPs had been achieved by 
dissociating RNP in high salt concentrations and physically separating protein 
and RNA before mixing the protein with fresh, synthetic RNA. Because of their 
relative instability in high salt solutions, influenza virus RNP could be dissociated 
and their components separated simply by centrifugation through preformed 
CsCl/glycerol gradients et al 1989). Clearly this approach would not be
applicable to the RNPs o f bunyaviruses which are stable in high salt 
concentrations. For VSV nucleocapsids the technique was successfully modified 
by including in the gradients 3M guanidinium chloride, a strongly 
denaturing salt. Gradient fractions were analysed by SDS PAGE to identify those 
containing denatured N protein which were then pooled. After dialysis to remove 
the denaturant, new RNP complexes could be formed by incubating the renatured 
protein with synthetic RNA (Moyer e ta l  1991).
Guanidinium denatured Bunyamwera virus nucleocapsids were examined to see if  
the N protein could be renatured and used for in vitro RNP reconstitution. CsCl 
gradient purified RNP was recentrifuged through CsCl gradients containing 3M 
guanidinium thiocyanate. Reduced CsCl concentrations were used to maintain the 
required density range. Suitable adjustment was determined empirically by 
weighing measured volumes of solutions formed by mixing three volumes of 4M 
guanidinium thiocyanate with 1 volume of CsCl solution. The resultant density 
range would result in intact RNP banding near the bottom with free protein 
occuring further up the tube. These gradients were sufficiently denaturing to 
allow separation of N protein from the RNA as judged by the appearance o f a 
visible protein band well above the position expected for RNP. The visible band 
was shown to contain N protein by SDS PAGE analysis. Denatured N  protein was 
mixed with labelled in vitro transcribed RNA and the guanidinium denaturant 
removed by dialysis. It was hoped that removal of the denaturant would allow 
renaturation of the N protein onto the synthetic RNA. CsCl gradient analysis of 
the renaturation reactions revealed that the label was concentrated in the pellet 
suggesting that no RNA had banded as a RNP complex. Visually, the even 
suspension of denatured protein formed an irregular precipitate on removal of the 
denaturant suggesting that the protein formed aggregates (data not shown). 
Attempts to prevent aggregation involved performing the renaturation in larger 
volumes in the hope that the N protein would bind to RNA before self- 
aggregating. Using N protein denatured by guanidinium thiocyanate, no
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conditions were found which enabled banding of synthetic RNA as RNP when 
analysed by CsCl gradients.
6.4 Reconstitution of influenza virus RNPs using m icrococcal 
nuclease treated cores as protein source.
In addition to the use of CsCl gradient purified proteins for reconstituting 
influenza virus RNP, protein derived from native RNP by nuclease digestion has 
been successfully used (Seong & Brownlee 1992a). Detergent-disrupted virus 
was treated with micrococcal nuclease (MCN) to degrade influenza virus RNA 
while leaving functional proteins. MCN requires calcium ions for activity and so 
can be inactivated by chelating the calcium ions with EGTA. After MCN 
inactivation, the nuclease-treated influenza virus 'cores' were incubated with short 
influenza virus-like RNA transcripts synthesised in vitro. The use of EGTA as a 
chelating agent allowed the presence of free magnesium ions for subsequent 
transcription assays since, unlike EDTA, EGTA specifically chelates Ca2+ ions 
while leaving Mg2+ free in solution. Analysis showed that the synthetic RNA was 
recognised and used as template for transcription by the influenza virus proteins. 
The MCN-treated cores were also used to assemble synthetic RNP using a 
chimeric influenza-like RNA containing an antisense copy of the CAT gene, 
which could be expressed in vivo following transfection into cells.
6.5 Preparation and nuclease treatment o f Bunyamwera virus RNP
For influenza virus, MCN treated cores were prepared from purified virus grown 
in eggs. Since Bunyamwera virus does not grow to very high titre in tissue culture 
and does not grow in eggs, the best yields of purified RNP are obtained from 
infected cells by CsCl gradient centrifugation.
Intracellular RNPs were prepared by centrifuging infected cell lysates to 
equilibrium through preformed 20^10% (w/w) CsCl gradients (see Chapter 2). 
The visible RNP band was harvested and dialysed against lOmM Tris HC1 
(pH7.4), lOmM NaCl and ImM EDTA. Typically final preps contained 5 0 -  
500ng/(il protein (measured by Bradford assay) depending on the amount of cell 
extract loaded to the gradient. On Coomassie blue-stained SDS PAGE gels, the N  
protein was the predominant band although low levels o f other contaminating 
proteins were usually observed (Figure 6.3).
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Prior to MCN digestion, samples were redialysed in 5()mM Tris (pH8), 50mM 
NaCl and ImM CaCl2 to remove the EDTA (which would inhibit the Ca2+ 
dependent MCN) and to slightly raise the pH to the optimum level for MCN. 
Reaction mixes were assembled each containing 10|ig (protein content) RNP and 
varying amounts of MCN. These were incubated at 37"C or 25"C for three hours 
to determine conditions which degraded viral RNA. Analysis of N protein in 
MCN treated RNPs by Coomassie blue stained SDS PAGE (Figure 6.3), 
demonstrated that the N protein remained intact by the treatment. For RNA 
analysis, reactions were halted by phenol extraction and the RNA precipitated, 
denatured in glyoxal and electrophoresed through 1% agarose for Northern 
transfer. Hybridisation was with a labelled S segment RNA, transcribed in vitro 
from appropriate cDNA constructs, as a probe. Figure 6.4 shows the effect of 
MCN treatment on the S segment RNA. The signal for naked RNA is abolished 
by 0.05units MCN in 30 minutes. For RNP, the band representing intact S 
segment RNA is replaced by a smear of smaller fragments of heterogeneous size 
following MCN digestion. This smear probably represents smaller protected 
fragments. For binding studies, 25'C was adopted for MCN digestion. The 
reaction was scaled up and digestion of the endogenous RNA to smaller protected 
fragments confirmed by Northern analysis for each batch.
Units MCN
Figure 6.3 N protein analysis after micrococcal nuclease digestion of RNP. RNP 
was digested with MCN as described for Figure 6.4. Following digestion, N protein was examined 
by SDS PAGE and Coomassie blue staining. No evidence of degradation o f the N protein was 
observed. These reactions were performed at 25°C.
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Figure 6.4 Degradation of Bunyamwera virus S segment RNA by micrococcal 
nuclease digestion of RNP. RNP preps (lOgg protein content) were digested with various 
amounts o f micrococcal nuclease in the presence o f ImM CaCU at pH 8 for 3hr at 25°C or 37°C. 
Degradation products were purified by phenol extraction and ethanol precipitation. Samples were 
denatured in glyoxal, electrophoresed through 1% agarose and blotted to nylon for Northern 
analysis using ^2P labelled riboprobes transcribed in vitro (S segment + and - strand probes). The 
left panel shows complete degradation of naked S segment RNA in 30min using 0.05 units MCN. 
For RNP, the S segment RNA is degraded to smaller fragments for all conditions tested. 
Increasing amounts o f MCN produced slightly increased degradation. At 37°C a weak signal 
corresponding to intact S RNA was also observed at all MCN concentrations while no full length 
band was seen at 25 °C.
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6.6 Bunyamwera virus RNP reconstitution
After MCN digestion, EGTA was added to a final concentration o f 5mM to 
chelate the Ca2+ ions required for MCN activity and so prevent degradation of 
added synthetic RNA. Following the protocol of Seong and Brownlee (1992a) for 
influenza virus RNP reconstitution, in vitro transcribed Bunyamwera virus-like 
RNA was incubated with MCN treated RNP at 30°C for lhr.
To assess binding, reactions containing labelled RNA were applied to preformed 
20-40% CsCl gradients and centrifuged to equilibrium (32,000 rpm for 16Hr at 
12°C in TST41 rotor). Gradients were then fractionated from the bottom and 
portions of each fraction were analysed for radiolabel content (by liquid 
scintillation counting) and density (by refractometry). Figure 6.5 shows reactions 
analysed in this way containing l|ig  protein and 0 .5 -1 .5p,g labelled RNA. For 
each, a peak was observed in fractions 7-10  which correspond to densities 1.3- 
1.35g/ml. No equivalent peak was found following analysis of a gradient loaded 
with labelled RNA alone (no incubation with MCN treated RNP). These results 
suggest that proteins in the MCN-treated RNP associated with the labelled RNA  
to produce RNP of similar buoyant density to that expected for native bunyavirus 
RNP.
6.7 Controls.
To investigate whether the observed banding o f in vitro  transcribed RNA  
incubated with MCN treated RNP was due to formation of a Bunyamwera virus­
like RNP, a number of control incubations were performed and analysed. Naked 
RNA alone failed to band (graph B, Figure 6.5)— demonstrating that some 
component of the MCN treated RNP was responsible for the banding. 
Components of the MCN/RNP mixture were tested to see if any gave rise to 
artefactual binding. Native RNP, not treated with MCN, was examined to see if  
the binding was due to a contaminating protein. The same experiment would 
address the possibility that the banding was due to the synthetic RNA binding to 
the protected Bunyamwera virus RNA detected by Northern analysis of the MCN 
treated RNP (Figure 6.4) since if this occui^d, intact RNP would also be expected 
to bind the synthetic RNA.
157
Chapter 6: In vitro RNP reconstitution.
&u
/—v
C /Da
so.u
Q.
b
c/D
3
5c
a
8 0 0 l(ig protein 
0.5|ig RNA
6 0 0
4 0 0
200
0
10 200
r  1.5
1.4
-  1.3
-  1.2
1.1
fraction no.
8 0 0 No protein 
1.5|ig RNA
6 0 0
4 0 0
200
0
200 10
r  1.5
1.4
1
'ob
a
a
1
'5b
a
1.1
fraction no.
Figure 6.5 CsCl gradient analysis of in vitro reconstituted RNP. a 35S-Labelled RNA  
transcribed in vitro from pBunS(-)CAT was incubated for 30 minutes with MCN treated RNP 
( lg g  protein). A control reaction contained no MCN-treated RNP. Reactions were analysed by 
CsCl gradient centrifugation as described in the text. The radiolabel content o f each fraction was 
determined by liquid scintillation counting and the density determined by refractometry. Naked 
RNA (graph B), pelleted while analysis of reactions which included MCN treated RNP (graphs A 
and C&D next page) revealed a peak of radioactivity in die region o f the gradient where RNP is 
expected to band. (Figure continued next page).
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Figure 6.5 continued.
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Figure 6.6 compares the gradient profiles of labelled RNA incubated with MCN 
treated or native Bunyamwera virus RNP. All components are exactly duplicated 
except for the absence of MCN in the native RNP reaction. Some radiolabel was 
detected in gradient fractions where RNA incubated with native RNP was 
analysed. The distribution of these was clearly different to that found when the 
incubation was with MCN treated RNP, which gave a strong peak as observed 
previously. This suggests that neither a contaminating cellular protein nor intact 
fragments of native RNP was responsible for the binding.
A formal possibility exists that a component of cellular origin is responsible for 
the banding of the synthetic RNA but that it requires MCN digestion to be 
activated. This possibility could be tested by nuclease treating fractions of a 
gradient loaded with uninfected cell extract and testing to see if these can produce 
banding of in vitro transcribed RNA. This control was not done and it is 
questionable as to whether a minor contaminant could be present in sufficient 
quantities to account for the degree of density shift and the amount of RNA 
handed.
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Figure 6.6 Micrococcal nuclease digestion is required for in vitro  RNP 
reconstitution. To test if intact Bunyamwera virus RNP or contaminating proteins in the RNP 
prep were responsible for formation of the RNP com plex containing synthetic RNA, CsCl 
gradient profiles were compared for reconstitution reactions performed using native or MCN  
digested RNP. The graph shows that Banding o f the synthetic RNA in CsCl gradients is 
dependent on the RNP used for reconstitution having been digested with MCN.
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The native RNP control did not include micrococcal nuclease which might itself 
bind RNA to cause a density shift This possibility was tested by incubating MCN 
with the synthetic RNA in the presence of 5mM EGTA to prevent the nuclease 
degrading the RNA. The distribution of label in fractions of gradients loaded with 
this mixture revealed a peak at a similar position as that found when MCN treated 
RNP was used. This suggested that the micrococcal nuclease itself, or a 
contaminant present in it, can bind RNA sufficiently stably to produce a density 
shift in CsCl gradients (graph A, Figure 6.7). However, this experiment had used 
at least a 10-fold excess of MCN and the amount of RNA banded was negligible 
when compared to RNA incubated with MCN-treated RNP (graph B, Figure 6.7). 
The binding observed for MCN treated RNP incubated with synthetic RNA is not 
therefore due to binding of MCN to the RNA.
Together these data suggest that the MCN-treated RNP can associate with in vitro 
transcribed Bunyamwera virus-like RNA to form RNP complexes which are 
stable in high salt and which band at a density similar to native bunyavirus RNPs.
6.8 Co-transcriptional encapsidation.
For in vivo rescue of synthetic influenza virus RNP (Enami & Palese 1991), co- 
transcriptional encapsidation was found to be more efficient than the previous 
method of mixing pre-synthesised RNA with CsCl-purified proteins. This 
involved supplementing the T7 polymerase in vitro transcription reaction with the 
CsCl-purified proteins thus providing opportunity for nascent RNA to be 
encapsidated as it was being transcribed. Protein obtained by nuclease treatment 
of influenza virus RNP also functioned in co-transcriptional encapsidation and 
improved the efficiency of rescue following transfection into influenza virus 
infected cells (Seong & Brownlee 1992a; B. Seong personal communication).
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Figure 6.7 RNA incubated with micrococcal nuclease bands in CsCl gradients. 
RNA was incubated with 5 units o f micrococcal nuclease in the presence o f 5mM EGTA to 
prevent degradation of the RNA by the calcium-dependent enzym e (pBunS(+)CAT RNA + 
MCN). When analysed on a 20-40% CsCl gradient, radioactivity was detected in fractions around 
the middle of the gradient (A). In vitro reconstituted RNP (pBunS(-t-)CAT RNA + MCN treated 
RNP), containing identical RNA but incubated with MCN-treated RNP (MCN content <0.5 units), 
was analysed on a parallel gradient and found to produce a much greater peak (B). The y-axis 
scale o f the two graphs is different— graph B shows the two traces superimposed on the same 
scale.
162
Chapter 6: In vitro RNP reconstitution.
For influenza virus, short (15 minute) transcription reactions, in the presence of 
NP and polymerase proteins, had been shown to allow maximium rescue (Enami 
& Palese 1991). Longer incubation reduced the efficiency of in vivo replication of 
the RNP. The protocol developed for influenza virus was investigated to see if 
MCN digested Bunyamwera virus RNP could co-transcriptionally encapsidate 
RNA. 15|ig MCN treated RNP was added to an in vitro T7 RNA polymerase 
transcription reaction containing pBunS(-)CAT DNA template. The reaction 
contained 35S(aS) CTP and a reduced concentration o f CTP to allow efficient 
labelling of RNA. Transcription was halted after 15 minutes by chilling on ice 
and adding EDTA to 2mM final concentration. The reactions were centrifuged 
through 20-40% CsCl density gradients to determine if the labelled RNA had 
been encapsidated by N protein to form a RNP.
Figure 6.8 compares the distribution of radiolabel in gradients loaded with the 
products of a coupled transcription/encapsidation reaction. The two control traces 
are of gradients loaded with identical rections except for omission of either 
template DNA or nuclease treated RNP ('DNA only' and 'protein only' controls).
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Figure 6.8 Co-transcriptional encapsidation of pBunS(-)CAT RNA. In vitro 
transcription from pBunS(-)CAT DNA template was performed in the presence o f MCN treated 
RNP to see if the newly transcribed RNA could be encapsidated in N protein. Control reactions 
were identical except for the omission of either MCN treated RNP (DNA only) or template DNA  
(protein only). The graph compares the gradient profiles o f the three reactions. The reaction in 
which pBunS(-)CAT was transcribed in the presence of MCN treated RNP (DNA+protein) shows 
a peak corresponding to RNA banded in fractions 8 -1 4  as observed previously for RNP 
reconstituted in vitro by incubating preformed RNA with MCN treated RNP. No equivalent peak 
is seen for either of the control reactions.
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When pBunS(-)CAT was transcribed in the presence of MCN-treated RNP, gradient 
analysis revealed a peak corresponding to banded RNA. The distribution was 
broader than previously observed for reconstitution by incubating preformed RNA 
with MCN treated RNP and may reflect partially encapsidated transcripts. No peak 
of radioactivity was detected in the position expected for RNP in gradients loaded 
with reactions performed in the absence o f either MCN treated RNP or template 
DNA.
6.9 Transfection studies.
Numerous attempts were made to detect Bunyamwera virus specific CAT activity 
in cells transfected with in vitro  reconstituted RNP containing pBunS(-)CAT 
RNA. Various multiplicities of Bunyamwera virus and several independent virus 
stocks were used as helper and transfection was performed using different 
amounts of reconstituted RNP and at varying times post infection. The CAT 
assays were sufficiently sensitive to detect extremely weak background 
acetylation in extracts from uninfected cells. No Bunyamwera virus specific 
activity was detected. Controls to assess transfection efficiency o f the protein 
/RNA complexes were not routinely undertaken. Such controls involved  
performing the RNP transfection assay developed for study of a recombinant 
vaccinia virus expressing the Bunyamwera virus L protein (Jin & Elliott 1991) 
and required Northern analysis of test and several internal control transfections. 
Three transfection methods were used: Lipofection using Transfectace™  
according to the manufacturers (BRL) instructions; calcium phosphate mediated 
transfection; and DEAE dextran transfection. The first two methods have 
confirmed applicability to transfection of RNA/protein complexes as judged by 
their use in the RNP transfection assay (H. Jin & R.M. Elliott personal 
communication), while the dextran method has been used in this context for 
influenza virus RNP transfection (Luytjes et al 1989).
In addition three different cell lines were used: BHK cells and CV1 cells both 
support bunyavirus replication and both are suitable for transfection o f RNPs (H.
Jin personal communication), and 293 cells which gave consistently good 
transfection efficiencies for influenza virus RNP rescue. None of these cell lines 
enabled detection of Bunyamwera virus specific expression of the synthetic RNP.
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6.10 Efficiency of reconstitution
Since the free radiolabel remaining after ethanol precipitation of the in vitro  
transcribed RNA remains in solution at the top of the gradients, the ratio of 
counts in the banded and pelleted fractions gives an estimate of the proportion of 
RNA encapsidated. Gradients were analysed for reactions containing ljig  
pBunS(+)CAT RNA reconstituted with 5 or 20|ig MCN treated RNP (Figure 
6.9). Counts were summed for six fractions centred on the peak, with counts from 
3 of each of the flanking fractions subtracted as background. After correction for 
fraction volume, the total banded counts were compared to the counts present in 
the pellet which represent naked RNA. 66% and 78% of the counts were found 
banded for the 5 fig and 20jig MCN/RNP reconstitution respectively. This value 
does not account for RNA lost by degradation which appeared to be different in 
each case as the total counts were 7*4 x 104 and 1*28 x 105 cpm respectively. As a 
total of the starting activity of the precipitated transcription reaction, <5% of the 
counts were accounted for by the summed pellet and banded fractions. This may 
reflect degradation to single nucleotide although the difference is probably largely 
due to co-precipitation of unincorporated label by the single ethanol precipitation 
used to prepare the RNA. The activity of transcripts purified away from free label 
by electrophoresis was ~10% of the apparent activity measured by direct counting 
of the precipitated transcription mix.
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Figure 6.9 B in d in g  o f  RNA to 5 or 2 0 |ig  MCN treated RNP. l^ g  pBunS(+)CAT  
RNA was incubated with 5 or 20|ig MCN treated RNP and binding assessed by CsCl gradient 
analysis. Counts for six fractions containing the peak were summed and corrected for background 
by subtracting counts for three fractions either side o f the peak. After correcting for fraction 
volume, total banded RNA was compared to pelleted (unencapsidated) RNA. In the 5|ig  
reconstitution 66% of the combined banded/pelleted counts were found to be banded while in the 
20gg reaction 78% of counts were banded.
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6.11 Loss of binding to purified RNA
The products of in vitro  transcription reactions were phenol extracted and 
precipitated prior to use in binding studies. Since a single strong band was present 
when examined on ethidium bromide-stained gels, no further purification was 
routinely used. For transfection experiments the maximum ratio of correct 
transcript was desirable and so gels containing electrophoresed labelled RNA  
were fractionated and radioactivity measured to assess the size distribution of 
RNA present. Significant quenching was observed, presumably due to the 
presence of agarose but counting of gel blocks o f equal proportions allowed 
comparison to be made. Surprisingly, considering the apparantly clean band seen 
by ethidium bromide staining, only ~ 10-25% of the counts were found in the 
band. Significant quantities of radioactivity were detected both above and below  
the sharp visible band which probably represented transcripts from a low  
proportion o f circular templates and premature termination or degradation 
products.
Full length RNA was purified by cutting the sharp band from agarose gels and 
retrieving the RNA by binding to silica matrix in the presence of high salt using a 
commercially available kit (RNaid™). When RNA purified in this way was 
incubated with micrococcal nuclease-treated RNP and analysed by CsCl gradient 
centrifugation, the RNA failed to band. Several factors could have contributed to 
the loss of binding activity and an experiment was performed to investigate some 
of these.
Several differences would be expected between the content of gel purified RNA  
and directly precipitated RNA. The binding activity of directly precipitated RNA 
was used as a positive control and compared with the binding ability o f RNA 
receiving one of the following treatments:
1) RNaid™ purified bulk RNA—i.e. no gel purification (was binding ability 
destroyed as a consequence of being treated with the kit reagents?).
2). RNaid™ purified from agarose gel in the absence of ethidium bromide (did 
the agarose gel electrophoresis have an effect on binding ability?).
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3) Gel purified in the presence of ethidium bromide and then RNaid™ purified 
(did ethidium bromide carry over occur and interfere with binding?).
4) Free labelled NTP used in place of RNA in the binding reaction (was the 
binding artefactual and caused by free label which would be lost during RNaid™ 
purification).
5) Gel purified in the presence of ethidium bromide and RNaid™ purified but 
binding carried out in 10 or ImM DTT (included as a precaution since in the 
original reconstitution when binding inhibition had been noted, ImM DTT was 
used while all earlier studies had included lOmM DTT).
Binding was only observed in one sample— the bulk RNA which had not been 
treated with the RNaid™ kit (figure 6.10). When free label was used in place of 
RNA in the reconstitution incubation, no banding of counts was observed 
demonstrating that RNA and not NTP band the MCN treated RNP. All other 
samples which failed to band in CsCl gradients had been purified by RNaid™.
A pair of reactions differing only in use or not of RNaid™ showed that this 
method o f purification was responsible for loss of binding ('bulk RNA' and 
'RNaided bulk RNA', Figure 6.10). Possible explanations include that the 
RNaid™ treatment either left behind some inhibitory component or removed 
some essential factor required for binding. Losses o f RNA were not the cause 
since gel analysis before and after purification demonstrated good recovery. RNA 
purified by the kit is suitable for routine translation and enzyme manipulations of 
RNA and so carry over of some inhibitory compound (whose effect was 
complete— no binding at all was observed) would be surprising. One possibility 
which remains to be tested is that free NTP, which would be removed by silica 
matrix purification, is required for binding.
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Figure 6.10 Loss of binding of purified RNA to MCN treated RNP. In vitro RNP 
reconstitution was attempted by incubating MCN treated RNP with RNA which had received one 
of die following treatments: (Bulk RNA)— Transcription reaction phenol extracted, ethanol 
precipitated, dissolved in water and used directly; (RNaided Bulk RNA)— Same as 'Bulk RNA* 
but additionally purified by silica matrix binding using commercially available reagents; (ImM  
DTT)— as 'Gel+etbr' with reconstitution reaction containing ImM DTT; (lOmM DTT)— as 'ImM 
DTT but reconstitution included lOmM DTT; (Free CTP)— No RNA, reconstitution with labelled 
CTP replacing RNA; (gel (no etbr))— Transcription reaction electrophoresed through 1% agarose, 
RNA band located by staining a duplicate lane with ethidium bromide, excised and purified by 
binding to silica matrix; (Gel + etbr)— same except RNA band visualised by direct staining with 
ethidium bromide. The reactions were analysed on CsCl gradients. Only one reaction gave a peak 
in the gradient expected for RNP formation. With the exception o f the 'Free CTP' reaction (which 
also gave no peak), all other reactions contained RNA which had been purified by binding to 
silica matrix.
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6.12 Anomalous transcription from pBunS(-)CAT
As an alternative to generating run off transcripts from Bbsl linearised pBunS(-) 
CAT, transcription template was generated by PCR using a primer containing a 
T7 promoter and a primer to generate the exact viral cDNA terminus to allow run 
off transcription to yield viral like transcripts. When examined on non-denaturing 
gels, transcripts from the PCR generated template migrated slower than the 
transcript seen for Bbsl cleaved pBunS(-)CAT. If gels were overloaded with 
pBunS(-)CAT RNA, in addition to the major RNA band, a minor band of slower 
mobility could be detected which had a similar mobility to that of the transcript 
from PCR generated template (see Figure 6.11).
<z
Q
Figure 6.11 In vitro transcription from Bbsl cleaved pBunS(-)CAT and from 
template prepared by PCR. A 1% agarose gel stained with ethidium bromide revealed a 
unique faint band resulting from transcription using PCR generated template (lanes 3 & 4). 
Transcription from Bbsl-cleaved pBunS(-)CAT (lanes 1 & 2) produced a major species o f faster 
mobility (lower arrow) and also a minor band of similar mobility to that observed for transcripts 
from PCR generated template (upper arrow).
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Comparison of the mobility of the PCR generated template with a BstEII-digested 
phage X size ladder on an agarose gel, revealed it to be the size expected for the 
construct insert. Since the PCR fragment had been amplified from pBunS(-)CAT 
DNA, this too must have insert of correct size. Therefore the appearance o f the 
fast major band in the RNA transcribed from pBunS(-)CAT is not as expected. 
Either of two possibilities may account for the extra band, both of which can be 
tested experimentally. Firstly, during Bbsl digestion of the template, a second 
shorter template might be generated either by contaminating enzyme or star 
activity (no Bbsl site is present in CAT or Bunyamwera virus S segment cDNA  
and, at least for the 180 nt at the run off end of the construct, no point mutations 
had occufed which might have introduced a site). This possibility could be tested 
by digesting the PCR generated template with Bbsl prior to transcription (no sites 
present) and checking the size of the resultant transcript. Appearance of the faster 
migrating transcript would indicate that an aberrant cleavage o f the DNA had 
occured and resulted in a run off transcription end closer to the promoter.
A second possibility is that a relatively minor degradation o f the Bbsl-generated 
run off transcription end results in a transcript which, although only slightly 
shorter than expected, had a markedly different mobility when electrophoresed 
under non denaturing conditions, due to a difference in secondary structure. This 
might be feasible if template degradation had resulted in loss o f 3' terminal 
sequences involved in pan handle formation. The two species observed then 
would represent circular (pan handle containing) molecules o f slow mobility and 
linear transcripts of almost the same size but significantly faster mobility due to 
the absence of the pan handle. Denaturing gel electrophoresis would lessen the 
difference in band mobilities by destroying the hydrogen bonding responsible for 
pan handle formation and so any difference would then reflect size difference.
If the major fast-mobility transcript from pBunS(-)CAT is incorrect this would 
explain the inability to detect Bunyamwera virus specific CAT expression of 
transfected RNPs reconstituted in vitro using RNA transcribed from this 
construct.
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6.13 L protein activity in MCN treated RNP.
For influenza virus, MCN treated cores were used to reconstitute short synthetic 
templates which were transcribed by endogenous polymerase complex (Seong & 
Brownlee 1992a). This property was exploited to assess promoter activity from 
mutated synthetic RNA templates in vitro (Seong & Brownlee 1992b). While in 
principle endogenous polymerase activity o f reconstituted RNP may not be 
essential for in vivo replication in the presence o f a helper virus, such activity 
would be required for in vitro transcription studies and would allow extremely 
useful studies to be conducted for bunyaviruses whose promoters have yet 
to be formally defined. As a preliminary step to developing such technology, 
MCN treated Bunyamwera virus RNP was tested for evidence of endogenous L 
protein activity.
CsCl gradient purified native RNP are known to be reduced in L protein activity 
presumably due to effects o f the high salt gradients (H. Jin personal 
communication). To decrease any denaturing effect of the CsCl, gradients were 
redesigned by including glycerol and reducing CsCl concentrations. A 
discontinuous gradient was established by overlaying steps of decreasing density 
CsCl/glycerol as shown in Figure 6.12. The steps were designed such that RNP 
(density = 1.31 g/ml) would band at an interface between two of the fractions. 
Centrifugation of such gradients containing low molecular weight dyes suggested
f
that little diffusion or density changes occured and that RNP could be harvested 
at the predicted interface. Coomassie blue stained SDS PAGE gels showed a 
strong band of the size expected for N protein in material harvested from the 
expected region of the gradient. Following MCN digestion, RNP purified from 
the combined CsCl/glycerol gradient was shown to be capable of binding in vitro 
transcribed RNA. RNP prepared in this way contained slightly more 
contaminating proteins than in those harvested from continuous CsCl gradients.
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Figure 6.12 Combined CsCl/ glycerol gradient for isolation of transcriptionally 
active B u n y a m w era  virus RNP. In order to reduce losses of, or damage to, the associated L 
protein, a gradient with reduced CsCl concentrations was designed to achieve sufficient density to 
band RNP. The step gradient was established using mixtures of CsCl and glycerol. The density of 
each mixture was determined by weighing measured volumes o f solution. The choice of steps was 
arbitrary except for die 1.3g/ml layer which was designed to allow harvesting o f RNP (1.31g/ml) 
at die lower interface (arrow head).
To test for evidence of L protein activity in the MCN digested RNP, a 
transcription mix was added (Final concentrations: ImM ATP, 0.5mM GTP and 
CTP, 150fiM UTP—including a 32P UTP at final activity 60Ci/mmole, 50mM 
Tris HC1 pH 7.8, 50mM KC1, lOmM NaCl, ImM DTT and 5mM MgCl2.) For 
influenza virus MCN-treated cores, the endogenous fragments of RNA remaining 
after nuclease digestion were shown to act as transcription template in the 
absence of added synthetic RNA (B. Seong personal communication). Therefore 
the protected RNA fragments observed by Northern analysis of MCN-treated 
Bunyamwera virus RNP might be expected also to act as transcription templates. 
Reactions were performed at 25'C, 30°C or 37°C in the presence or absence of 
dinucleotide ApG which is known to slightly stimulate transcription from 
bunyavirus RNP. Figure 6.13 shows the products of the reactions separated on a 
20% acrylamide denaturing gel. A major band is seen in all reactions. Increasing 
the temperature reduced the strength of the signal while presence of ApG 
increased the signal. The effects of temperature and ApG are consistent with the 
findings for similar analysis of influenza virus MCN treated cores and with the 
known properties of bunyavirus in vitro transcription assays.
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+ApG -ApG
Figure 6.13 E n d o g e n o u s  transcription from  M C N  treated RNP. In vitro transcription 
reactions were performed at 25°C, 3 0 C  and 37°C in the presence or absence of ImM ApG, for 20 
hours. Products were phenol extracted, ethanol precipitated, denatured in 90% formamide and 
electrophoresed through 20% acrylamide containing 7M urea as denaturant. The a - 32P UTP 
labelled products were visualised by autoradiography of the dried gel. A major product (arrow) is 
seen for all reactions. The strength of die signal decreases for reactions performed at successively  
higher temperatures and at each temperature is stronger when ApG was present in die reaction.
The necessary analysis to demonstrate that the signals observed are genuine 
transcription products and not artefacts remain to be conducted. Presuming the 
signals do represent transcripts from digested fragments of RNA, it is interesting 
to note that a single major band is present. Transcription from randomly cleaved 
RNA templates would be expected to produce a ladder of products. Interestingly, 
at the same position in the native RNP control, there is a faint signal of the same 
mobility suggesting a tendency for transcripts to terminate at this point. The 
signal for native RNP is much weaker than that for MCN treated RNP transcribed 
under the same conditions and with equivalent N protein content (compare the 
first and last lanes of Figure 6.13). Also present from the intact RNP templaled
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reaction was a ladder of shorter products (on lesser exposure a ladder could be 
seen in place of the blurred signal in the lower part of the last lane of Figure 
6.13).
Although the gel did not include size markers, the major band was estimated to 
represent a transcript ~22nt long by fitting the mobilities of the ladder observed 
for intact RNP to logarithmic graph paper— the best line of migration distance to 
integer logarithm gave a gradient and axis intercept similar to that obtained by 
plotting the migration of the bromophenol blue and xylene cyanol dyes to their 
predicted co migration sizes.
The estimated length coincides with the predicted length of the pan handle of the 
S segment. It is difficult to judge whether this coincidence is significant 
especially considering that the pan handle lengths for the three segments are all 
different and a 20% gel should easily resolve single base differences.
While promising, these results are extremely preliminary and formal 
demonstration that the signal represents a genuine transcript has still to be 
attempted.
6.14 Summary of in vitro reconstitution studies and future work
The data presented in this chapter, while far from complete, suggests that in vitro 
reconstitution of Bunyamwera virus RNP may be feasible. The gradient analysis 
of in vitro reconstituted RNP provides preliminary evidence that encapsidation of 
synthetic Bunyamwera virus-like RNA can occur in vitro using micrococcal 
nuclease treated RNP as a protein source. Density measurement of gradient 
fractions containing reconstituted RNP are consistent with the density expected 
for native RNP although direct comparison with labelled native RNP has yet to be 
conducted.
Further work is needed to clarify whether Bbsl digestion of the pBunS(-)CAT 
construct produces the correct run off transcription end or whether aberrant 
cleavage occurs. This can be readily tested as suggested, by similar digestion of 
PCR generated template. If necesary the transcripion template could be generated 
by PCR routinely, by optimising cycling conditions to enable maximum yield of 
correct product. Once it is established that the correct RNA can be transcribed, 
transfection of in vitro reconstituted RNP into cells infected with Bunyamwera 
virus, or the L protein expressing recombinant vaccinia vims (Jin & Elliott 1991), 
can be re investigated.
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7.1 In vitro RNP reconstitution.
As discussed in Section 6.12, before further transfection studies are undertaken to 
attempt to rescue in vitro reconstituted RNP, further work is needed to clarify 
whether Bbsl digestion of the pBunS(-)CAT construct produces the correct run 
off transcription end or whether aberrant cleavage occurs. This can be readily 
tested as suggested, by similar digestion of PCR generated template. If necesary 
the transcription template could be generated by PCR routinely, by optimising 
cycling conditions to enable maximum yield o f correct product. Once it is 
established that the correct RNA can be transcribed, transfection of in vitro 
reconstituted RNP containing CAT reporter RNA into cells infected with 
Bunyamwera virus, or the L protein expressing recombinant vaccinia virus (Jin & 
Elliott 1991), can be reinvestigated.
The possibility that micrococcal nuclease digested Bunyamwera virus RNP 
retains L protein activity (Section 6.13) can be tested further by attempting to 
replicate a short model RNA in vitro , according to the protocol developed for 
influenza virus of Seong and Brownlee (1992a). This involves incubating the 
MCN treated RNP with a short, in vitro transcribed, RNA which has 3' terminal 
nucleotides identical to the 3' terminus of vRNA and a 5' portion which is of 
different sequence to bunyavirus RNA. Radiolabelled transcripts produced in this 
reaction can be characterised by RNase T1 mapping to see if  they are indeed the 
complement of the added model template and were therefore produced by RNA- 
templated transcription.
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Oligodeoxynucleotides for production o f a suitable RNA template have been 
designed and synthesised to enable this experiment to be conducted. Seong and 
Brownlee( 1992a) used partial duplex DNA to synthesise template RNA from a 
T7 promoter in the duplex region. The oligonucleotides designed to adapt this 
methodology to produce a Bunyamwera virus vRNA-like model template are 
shown in Figure 7.1. In vitro T7 RNA polymerase transcription would be used to 
produce unlabelled template RNA. Since the T7 system produces transcripts of 
varying lengths, gel purification of the full length template RNA may be desirable 
in the first instance although for the influenza virus system, size purification was 
not necessary (B. Seong personal communication). The model RNA would then 
be reconstituted with MCN treated Bunyamwera virus RNP (Section 6.5 and 6.6), 
and a transcription mixture added which included a-32p CTP (Section 6.13). The 
oligonucleotides used to produce the template RNA are designed such that a 
CTP-labelled transcript produced by Bunyamwera virus L protein using the 
model RNA as a template, would have a characteristic RNase T1 digestion 
pattern. This would enable model RNA-templated transcripts to be distinguished 
from transcripts originating from endogenous RNA (see Section 6.13). In 
addition to short unlabelled fragments, RNase T1 (which cleaves 3' to G residues 
in RNA) digestion would produce radiolabelled fragments 8, 6, 4 and 3 
nucleotides long respectively (see Figure 7.1). The 3mer product (CCC) is 
templated by the first three 5' nucleotides o f the T7 transcript which may be 
heterogeneous (B. Seong personal communication) and so this fragment may be 
less abundant than the others and mono- and di nucleotide fragments may be 
present.
The success of such an experiment would permit detailed promoter analysis by 
comparing transcription levels from model RNAs carrying defined mutations. 
This method was used to assess the activity of synthetic influenza virus promoters 
in a systematic mutagenesis study (Seong & Brownlee 1992b). In addition to 
providing the first details o f the promoter requirements for bunyavirus 
transcription, a successful outcome would also provide clear evidence that 
reconstitution was occuring and that therefore transfection studies using RNP 
containing reporter RNA should, in principle, succeed.
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Annealed oligodeoxynucleotides 
forming partial duplex
5 '  TAATACGACTCACTATAGGG
3 1 ATTATGCTGAGTGATATCCCG CACTCGCCCGACCTCATG TGATG A 5 ’
/ T7 RNA polymerase in vitro transcription Bunyavirus vRNA-like 
5 ' GGGCGUGAGCGGGCUGGAGUACACUACU 3 ' model RNA
Reconstitution with MCN  
treated RNP.
. .  Add transcription mix.
T (including a  labelled CTP)
Product expected if
3 ' CCCGCACUCGCCCGACCUCAUGUGAUGA 5 ' RNA-templated
transcription occurs.
RNase T1 analysis.
▼
* + * * +  * •*■ * * ★ ★ ★
3 ' CCC + 3 ' GCACUC + 3 ' GCCC + 3 ' GACCUCAU
(Labelled Fragments)
+ 3 ' GU + 3 ' GAU + 3 ' GA 
(Unlabelled)
Figure 7.1 In vitro reconstitution and transcription of bunyavirus model RNA. 
Two oligodeoxynucleotides (top) are annealed to make a template for T7 transcription from the 
T7 promoter (underlined) to yield a bunyavirus 3’ terminal vRNA-like model RNA. This model 
RNA (with bunyavirus sequences shown in bold type) is reconstituted with MCN treated RNP 
and a transcription mix added including a -32P CTP. Analysis o f the resulting labelled products 
using RNase T1 (which cleaves 3' o f G residues) produces radiolabelled fragments o f 8, 6 ,4  and 
3 nucleotides in length (positions where radioactive phosphate may occur are marked with an 
asterisk— MCN cleaves leaving a 3' phosphate hence the transfer o f label where a C residue was 
3' to a target G residue).
T1 products expected if 
bunyavirus-dependent 
transcription occured.
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1 2  In vivo Transcription of cDNA.
Two difficulties were identified with the use of the vTF7-3 T7 polymerase 
expression system for in vivo transcription from bunyavirus cDNA (Chapters 3 
and 5). The first o f these was that transcripts produced were not o f unique 
length, possibly due to recircularisation o f transfected linear cDNA templates 
(Section 3.7). The second problem was that transcripts were occuring from 
Bunyamwera virus S segment cDNA constructs which were thought to be 
originating from a cryptic vaccinia virus late promoter (Section 5.6). Both these 
problems can be addressed and further attempts be made to transcribe' and 
replicate plasmid derived RNA in vivo. The suitability of the vTF7-3 expression 
system for this type o f work has recently been demonstrated by the production 
of VSV DI particles entirely from cDNA (Pattnaik et al 1992).
The cryptic vaccinia virus promoter can be readily mutated to a non-functional 
form. The extensive promoter-mutagenesis study of Davison and Moss (1989b) 
demonstrated that mutation of any residue in the TAAAT motif of the promoter 
results in dramatic reduction of promoter activity (see Figure 5.16 Section 5.6). 
The choice of bases to mutate would be based on sequence comparison of the 
relevant region o f the Bunyamwera virus S segment with other bunyavirus S 
segments. Figure 7.2 shows sequence comparison o f this region between 
Bunyamwera and Maguari virus S segment cDNAs. Despite an overall 83% 
identity between the two S segments, the region o f the Bunyamwera virus S 
segment cDNA which contains the cryptic vaccinia promoter is less conserved. 
Therefore, it may prove possible to mutate this region of non-coding RNA  
without seriously affecting any function it might have. Based on the Maguari 
virus sequence, suitable alteration might be achieved by mutating the Bun 
TAAAT to Mag CAGAT. Confirmation that the mutations had reduced the 
promoter strength to negligible levels could be directly obtained by transfecting 
pBunS(-)CAT DNA (suitably mutated) into cells infected with WR strain 
vaccinia virus (see Figure 5.15; Section 5.6) where CAT activity should be 
absent or only barely detectable if promoter activity has been destroyed.
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5 ' . . . C TATTAAATC C AAC . . . 3 ' Bun S (49-62)
5 ' . . . CAATCAGATCCAAC . . . 3 ' M ag S (50-63)
Figure 7.2 Sequence comparison between Bunyamwera and Maguari virus S 
segment cDNA in the region of the cryptic vaccinia virus promoter. Top strand 
shows Bunyamwera virus S segment cDNA nucleotides 49-62 which contains a motif resetting 
the core of a vaccinia virus late promoter (underlined). Bottom strand shows the equivalent 
region of Maguari virus cDNA demonstrating that this region is not highly conserved between 
bunyaviruses.
The problem of generating transcripts in vivo , which have precise 3 ’ termini, was 
recently overcome by incorporating ribozyme sequences down stream of the 
required transcript produced using the vTF7-3 vaccinia virus T7 polymerase 
expression system (Ball 1992). This system was applied to produce VSV  
defective interfering (DI) particles which originated entirely from cDNA clones 
(Pattnaik et al 1992). It had been shown previously that VSV DI particles could 
be replicated when infected into cells expressing the L, N, and NS proteins from 
plasmids using the vTF7-3/T7 polymerase system (Pattnaik & Wertz 1990). If the 
M and G proteins were also expressed, again from T7 promoter plasmids, the 
replicated DI genomes could be packaged into DI particles which budded from 
cells (Pattnaik & Wertz 1992). In these experiments the VSV-like template was a 
genuine DI nucleocapsid but the system was developed further to allow  
replication, encapsidation and packaging into DI particles, of RNA transcribed in 
vivo from transfected cDNA (Pattnaik et a l 1992). To achieve this, a T7 
transcription plasmid was constructed which contained a V SV  DI cDNA  
followed by DNA coding for the hepatitis delta virus (HDV) antigenomic 
ribozyme, followed by a terminator o f T7 RNA polymerase transcription. T7 
transcripts from this vector contained DI RNA sequences upstream of the HDV  
ribozyme and transcribed sequence from the T7 terminator. The ribozyme was 
positioned such that autocatalytic cleavage released DI genome RNA with the 
exact 3’ terminus required. When the DI genome RNA was transcribed in vivo by 
T7 RNA polymerase supplied by VTF7-3 and in the presence o f all five VSV  
gene products produced from cotransfected T7 expression vectors, the RNA was 
encapsidated, replicated and packaged into budding VSV DI particles. This 
impressive achievement demonstrates that the VTF7-3 expression system can be 
used to produce in vivo transcripts with precisely defined termini.
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Pattnaik et al. (1992) also mapped the transcription start sites o f the DI RNA  
produced from T7 promoters. One construct examined had the three G residues 
(required for optimal transcription) following the TATA of the T7 promoter (see 
Section 5.4.2 and Figure 5.8). In vTF7-3 infected cells this construct produced 
transcripts which initiated predominantly on the first G residue or the A residue 
immediately 5' to it. T7 DI transcripts having four or two non-DI nucleotides at 
their 5' termini, but with the correct 3' termini, were efficiently replicated 
whenVSV proteins were expressed. The extra nucleotides were removed on 
further replication of the DI RNA by VSV proteins. For existing Bunyamwera 
virus S segment cDNA reporter constructs (chapter 5) the G residues have been 
replaced by the first viral nucleotides 5 AGT (Figure 5.8). Although influenza 
virus like T7 transcripts, which require the same 5' nucleotides (Section 5.4.2) 
have been replicated by helper virus, replacement of the G residues with AGT 
may lead to inefficient production of transcripts initiating 51 AGT (D. 
Kolakofsky personal communication). Since the VSV work suggests that 
additional 5' nucleotide can be tolerated, future Bunyamwera virus S segment 
constructs could include G residues between the TATA of the T7 promoter and 
the 5' terminus of the viral cDNA. Two other modifications o f the VSV DI 
transcript were apparent (Pattnak et al. 1992). Firstly, a proportion o f the T7 
transcripts had one extra 5' terminal nucleotide not coded for in the cDNA  
construct. This was thought to be due to a guanylyl transferase coded for by 
vaccinia virus as an extra 5’ nucleotide was also observed on natural DI 
genomes replicated in the presence of vaccinia virus but not when the DI particle 
was infected alone. The second modification was a 2 ’ 3 ’-cyclic phosphate group 
on the 3 ’ terminal nucleotide of the DI RNA resulting from the ribozyme 
cleavage mechanism. Although viral RNA normally has a hydroxyl group at its 
3’ terminus, if  present, the 2 ’; 3-cyclic  phosphate did not prevent recognition 
and replication of the plasmid derived RNA.
The vTF7-3 transcription system, used in conjunction with the HDV  
antigenomic ribozyme, may therefore be of use for producing bunyavirus-like 
RNA in vivo  and replicating it using recombinant viral proteins. Full length 
cDNA clones of all three Bunyamwera virus gene segments are available (R.M. 
Elliott personal communication) and these could be modified to include the 
required ribozyme and termination sequences. The Bunyamwera virus S 
segment CAT construct (Chapter 5) could also be modified and tested to see if  
CAT activity, dependent on infection with Bunyamwera virus, can be 
demonstrated.
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The HDV anti genomic ribozyme cleaves 5 ’ to its recognition sequence and 
therefore can be used to produce RNA terminating with any 3 ’ nucleotides 
(Perrotta & Been 1991; Pattnaik et al 1992). As a first step towards modifying 
existing constructs, two overlapping oligonucleotides were synthesised. These 
were designed to produce, following annealing and extension by D NA  
polymerase, a double stranded fragment containing the ribozyme sequence (see 
Figure 7.3). The upstream end of the ribozyme DNA (5* top strand in Figure 
7.3) starts 5' GGG... which are nucleotides 1, 2 and 3 of the ribozyme. This end 
could be ligated to a Smal cut vector to recreate a Sma I site into which 
sequences coding the required RNA could be cloned as a blunt ended fragment. 
RNA transcribed would then be automatically cleaved immediately 5' to the first 
G residue and so produce an RNA with a 3' terminus corresponding exactly to 
the blunt ended fragment inserted into the Sma I cleaved vector. The fragment 
could also be used to modify existing constructs. pUCBunS(-)CAT (Chapter 5) 
can be cleaved with Bbs I and end-filled to produce a blunt ended linear vector 
into which the blunt ribozyme fragment can be cloned. Resultant plasmids with 
the correctly oriented ribozyme can be cleaved at the unique BamHI site 
immediately downstream of the ribozyme and ligated to a BamHI T7 RNA  
polymerase terminator obtained by digestion of a pET T7 expression plasmid 
(Promega).
The final construct should, when transfected into cells infected with vTF7-3, 
produce a transcript ~1100 nucleotides long which is autocatalytically cleaved to 
give an RNA molecule with a 3' end identical to the Bunyamwera virus S 
segment (Fig. 7.4). A vRNA-like transcript produced in this way carrying an 
antisense CAT gene should only produce CAT activity if it is first recognised 
and replicated by bunyavirus proteins. These proteins can be supplied either by 
infection with Bunyamwera virus or as recombinant proteins expressed from 
cDNAs. Active Bunyamwera virus L protein can be expressed either from a 
recombinant vaccinia virus (Jin 1991; Jin & Elliott 1991) or from transfected 
plasmids (Jin & Elliott 1992). N protein can be supplied by transfection o f  
pTF/BunN as discussed in Chapter 3. Together the N  and L proteins should be 
sufficient for replication and expression o f the plasmid-derived RNA. Co­
expression of the M segment glycoproteins (G. Nakitare & R.M. Elliott personal 
communication) may allow budding of virus-like particles. The rescue o f VSV  
DI particles from cDNA (Pattnaik e ta l  1992) provides an impressive precedent 
and demonstrates the suitability of the vTF7-3/ribozyme system for this type of 
work. In principle, the application of this technology to bunyaviruses should be 
possible as the number o f viral-protein expression constructs required is less
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than for VSV. Successful replication of synthetic RNA might rapidly lead to 
rescue of a bunyavirus entirely from cDNA. Full length cDNAs exist for all 
three genome segments of Bunyamwera virus and these could be modified to 
produce precisely terminated RNAs by the inclusion o f ribozyme sequences. 
The availability of T7 based expression constructs for all viral gene products 
makes it unnecessary to use a bunyavirus to supply viral proteins and so no 
background of helper virus would be present during rescue experiments. Such 
technology should enable precisely defined viable mutants to be generated 
routinely even when the mutants are partially growth restricted.
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W C C-G
5 '  GUACACUACUGGGUCGG U-A
: II I I I I C -G
UCCAGCC C-G
G U -A  GA
G G -C  A
3 G -C  U
C U C
G C C
__________ CUC G
C-G
A-U
U -A
C-G
C-G
G-C
GAA-U
Figure 7.4 Use of HDV ribozyme to define the 3' g a g - c
terminus of Bun S CAT RNA. Top shows the modified G_c
version of pBunS(-)CAT and the positions o f the HDV ribozyme a - U
(Hep 8) and T7 terminator (O term). The ribozyme sequences are c -G
transcribed and form a structure (bottom  right) w hich  G C
autocatalyticically cleaves the transcript immediately 5' o f  the CA
GGG triplet (arrow head) to give the required 3' bunyavirus RNA  
terminus (bold type).
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